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Abstract 
Peroxisomes are highly dynamic organelles of eukaryotic cells, carrying out essential 
oxidative metabolic processes. These organelles scavenge reactive oxygen species such as 
hydrogen peroxide (H2O2) and catabolise fatty acids, which are particular hallmarks and 
highly conserved features of peroxisomes among different species. Peroxisomal proteins and 
enzymes are encoded by nuclear DNA and therefore, targeted post-translationally into the 
peroxisomal matrix. A special class of proteins, collectively called peroxins, perform certain 
cellular tasks, such as peroxisomal matrix protein import or membrane development in order 
to maintain peroxisome biogenesis as well as a constant flux of matrix proteins into 
peroxisomes. The type II AAA+ peroxins Pex1/Pex6 are a core component of the peroxisomal 
matrix protein import system. ATPases of the AAA+ family of proteins generally assemble 
into large, macromolecular machines, structurally remodelling their substrate protein, which is 
driven by the hydrolysis of ATP. The main function of Pex1/6 complexes is to release the 
receptor Pex5 from peroxisomal membranes after matrix protein import. This relocation of 
Pex5 into the cytosol ensures a constant pool of available receptor molecules for subsequent 
cycles of protein import into peroxisomes. Accordingly, certain mutations in mammalian 
Pex1/Pex6 proteins compromise peroxisome biogenesis and thus, lipid metabolism, causing 
severe genetic Zellweger diseases in humans.  
In collaboration with Professor Ralf Erdmann and colleagues at the Ruhr-Universität Bochum, 
we characterize the structure and function of the AAA+ Pex1/6 complex from yeast 
Saccharomyces cerevisiae. Single particle electron microscopy (EM) in combination with 
biochemical assays allows us to analyze how ATP turnover is related to the biological 
function of the Pex1/6 complex. This study presents EM structures of Pex1/6 complexes 
assembled in the presence of ADP, ATP, ADP-AlFx and ATPγS, providing a comprehensive 
structural characterization of the heterohexameric type II AAA+ complex in different 
nucleotide states. Our EM reconstructions reveal an unexpected triangular overall shape, 
different than observed for the closely related and well-characterized homohexameric AAA+ 
protein p97. We show that the heterohexameric Pex1/6 complex is composed of a trimer of 
heterodimers with alternating subunit arrangement of Pex1 and Pex6 moieties. Furthermore, 
our results suggest that conserved aromatic residues, lining the central pore of the Pex1/6 D2 
ring mediate substrate interactions. These residues correspond to substrate interaction regions 
in related AAA+ proteins. Comparing Pex1/6 EM reconstructions in different nucleotide states 
implicates that the mechanical function of Pex1/6 involves an N- to C-terminal protein 
translocation mechanism along the central pore. The Pex1/6 EM structures resolve symmetric 
and asymmetric large-scale domain motions, which likely create a power stroke during cycles 
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of ATP binding and hydrolysis. We conclude that Pex5 is probably partially or completely 
unfolded while it is threaded through the central pore of Pex1/6 complexes.  
In addition, ATP hydrolysis assays of Pex1/Pex6 complexes containing single amino acid 
exchanges in individual Walker B motifs reveal that not all active sites are functionally 
equivalent. In isolated complexes, ATP turnover mainly occurs in Pex6 D2 domains, while 
Pex1 subunits sustain the structural integrity of the complex. We further resolve the structures 
of Pex1/6 Walker B variants and observe mutually exclusive protomer-protomer 
communication. In the Pex1/6 complex, a Walker B mutation induces ATP hydrolysis in the 
adjacent D2 domain, presenting a structural framework of protomer-protomer communication 
in the AAA+ heterohexamer. 
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Zusammenfassung 
Peroxisomen stellen eine eigene Familie von Organellen dar, welche in nahezu allen 
eukaryotischer Zellen essentielle oxidative metabolische Prozesse ausführen. Ihre 
wesentlichen und konservierten Funktionen sind der Abbau von toxischen 
Stoffwechselprodukten wie Wasserstoffperoxid (H2O2) sowie von Fettsäuren, um die daraus 
resultierenden Produkte für weitere Stoffwechselprozesse zur Verfügung zu stellen. 
Peroxisomale Proteine und Enzyme werden von der genomischen DNA kodiert und müssen 
daher post-translational in die peroxisomale Matrix importiert werden. Eine spezielle 
Proteinklasse, sogenannte Peroxine, übernehmen bei diesem Prozess spezifische Aufgaben, 
wie den Import peroxisomaler Proteine oder die Synthese peroxisomaler Membranen, um die 
Biogenese von Peroxisomen und eine ständige Verfügbarkeit von peroxisomalen Proteinen zu 
gewährleisten. Die Typ II AAA+ Proteine Pex1/Pex6 spielen eine zentrale Rolle im Import 
peroxisomaler Matrixproteine. Generell bilden ATPasen der AAA+ Proteinfamilie multimere  
makromolekulare Maschinen, welche die Konformation ihrer Substratproteine unter ATP 
Verbrauch modifizieren. Die molekulare Funktion von Pex1/Pex6 in diesem Prozess ist die 
Freisetzung des Rezeptors Pex5 aus der peroxisomalen Membran nach dem erfolgten Import 
von Matrixproteinen. Diese Rückführung von Pex5 ins Zytosol erfolgt unter dem Verbrauch 
von ATP und stellt eine gleichbleibende Menge an freien Rezeptormolekülen für weitere 
Importzyklen zur Verfügung. Einzelne Mutationen in Pex1 oder Pex6 beeinträchtigen die 
Biogenese von Peroxisomen erheblich und stören dadurch den Lipidstoffwechsel. Daher 
führen diese Mutationen im Menschen zu folgenschweren genetische Krankheiten, die im  
Zellweger Spektrum zusammengefasst werden.  
In Kollaboration mit der Arbeitsgruppe von Professor Ralf Erdmann von der Ruhr-Universität 
Bochum, charakterisieren wir deshalb die Struktur und Funktion des AAA+ Pex1/6 
Komplexes der Hefe Saccharomyces cerevisiae. Zu diesem Zweck untersuchen wir den 
strukturellen Aufbau von Pex1/Pex6 Komplexen mittels Einzelpartikel-
Elektronenmikroskopie (EM) und analysieren dessen biologische Funktion in biochemischen 
und genetischen Experimenten. In der vorliegenden Arbeit beschreiben wir die 
unterschiedlichen Strukturen des Pex1/6 Proteinkomplexes in Anwesenheit von ADP, ATP, 
ADP-AlFx und ATPγS. Unsere EM Rekonstruktionen des Pex1/6 Komplexes zeigen eine 
unerwartete dreieckige Form, welche sich von bekannten Strukturen des sehr ähnlichen, gut 
charakterisierten AAA+ Proteins p97 unterscheidet. Pex1/6 Hexamere bestehen aus 
alternierend angeordneter Pex1 und Pex6 Untereinheiten und bilden damit ein „Trimer von 
Heterodimeren“. Aus genetischen Experimenten schließen wir, dass stark konservierte, 
aromatische Aminosäurereste die Interaktion zwischen Pex1/6 Komplexen und ihrem 
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physiologischen Substrat vermitteln. Diese säumen die zentrale Pore der Pex1/6 D2 Domäne 
und ihre Position entpricht den Substratbindestellen in verwandten ATPasen der AAA+ 
Proteinfamilie. Der Vergleich der Pex1/6 Strukturen in unterschiedlichen Nukleotid-
gebundenen Stadien legt eine prozessive N- zu C-terminale Substrattranslokation entlang der 
Pex1/6 Pore nahe. In Abhängigkeit des vorhandenen Nukleotids zeigen die Pex1/6 Komplexe 
umfangreiche symmetrische sowie asymmetrische Bewegungen in den D2 AAA+ Domänen. 
Diese Domänenbewegungen generieren möglicherweise die treibende Kraft für die 
Prozessierung von Pex5 durch die Pore und entfalten dabei das Zielprotein entweder komplett 
oder teilweise.  
Darüberhinaus zeigen wir in ATPase Assays, dass sich die hydrolytische Aktivität der Pex1 
oder Pex6 D2 Domänen erheblich voneinander unterscheidet. In aufgereinigten Pex1/6 
Proteinkomplexen wird ATP scheinbar nur in den D2 Domänen von Pex6 hydrolysiert, 
während die Bindung von ATP in den Pex1 D2 Domänen die Komplexbildung unterstützt. 
Zusätzlich zeigt die strukturelle Untersuchung von Pex1/6 Komplexen mit mutiertem 
Walker B Motiv spezifische Interaktionen zwischen benachbarten Pex1/Pex6 Protomeren. 
Diese Interaktionen zeigen, dass die Mutation einer Walker B Untereinheit ATP Hydrolyse in 
der benachbarten Untereinheit induziert. Daher bilden diese Interaktion möglicherweise die 
molekulare Grundlage für die Kommunikation zwischen einzelnen Domänen im Pex1/6 
Komplex. 
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1 Introduction 
Peroxisomes are indispensible for a fully functional metabolism in humans. Malfunction of 
peroxisomes or defects during their biogenesis have grave consequences and manifest in 
clinical syndromes of the serious Zellweger spectrum. On-going peroxisome research already 
established robust mechanistic models for peroxisome biogenesis and function among species. 
Although the metabolic processes of human peroxisomes and the inherited disorders involved 
might be of particular clinical interest, a variety of yeast organism have proofed their rational 
as model system. Likewise, in this study, yeast homologs of human AAA+ Pex1/6 proteins are 
structurally characterized extending existing concepts of their role as key components of 
peroxisomal biogenesis on a molecular level. Notably, mutations in mammalian Pex1/Pex6 
proteins are the predominant cause for severe Zellweger phenotypes (Geisbrecht et al., 1998). 
A wealth of genetic and biochemically data on peroxisomes accumulated over the last three 
decades. However, in subsequent chapters key features and redundant biochemical processes 
of peroxisomes are described, thus mainly referring to studies available for yeast 
Saccharomyces cerevisiae (S. cerevisiae). Otherwise, species-specific results are stated 
correspondingly. 
 
1.1 Peroxisomes - a new family of organelles  
Peroxisomes were initially described by electron microscopical analysis of mouse kidneys and 
classified as so called microbodies (Rhodin, 1954). Upon the first isolation of mammalian 
microbodies, a peroxide-producing-oxidase and catalase were extracted as the primary 
enzymes (De Duve and Baudhuin, 1966). Both proteins are involved in ana- and catabolism of 
hydrogen peroxide (H2O2), changing the name of the newly discovered organelle to 
peroxisome over time. Besides scavenging reactive oxygen species such as H2O2, also 
oxidative breakdown of fatty acids was found to be compartmentalized in peroxisomes 
(Lazarow and De Duve, 1976). Hence, peroxisomes evolved as protective organellar 
compartments, shielding oxidation reactions, which would be otherwise harmful for the cell. 
Advances in cytochemical stains revealed during morphological studies of eukaryotic cells 
that peroxisomes are widespread among most cell types (Hruban et al., 1972). It became 
evident that peroxisomes adopt their number and size dynamically in individual cell or tissue 
types according to environmental cues. Veenhuis et al. (1987) discovered in budding yeast 
S. cerevisiae that progression and protein content of peroxisomes is significantly up regulated 
upon consumption of oleic acid. Furthermore, studies in rodents discovered that peroxisome 
abundance and size is induced five to nine fold, particularly in liver cells, when the animals 
1 Introduction 
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are treated with synthetic peroxisome proliferators (Fahimi et al., 1982; Reddy et al., 1982). It 
appears that peroxisome function requires structural adaption of the entire compartment, 
resulting in organelles with a varying diameter of 0.1-1 µm (Lazarow and Fujiki, 1985). 
Peroxisomes consist of single lipid bilayers that round off a grainy matrix crowded with a 
multitude of soluble matrix proteins, able to form electron-dense crystalline core structures 
(Angermuller and Fahimi, 1986). Peroxisomes do not enclose DNA and distinct from other 
organelles, all matrix proteins are synthesized in the cytosol and traverse post-translationally 
into peroxisomes (Lazarow and Fujiki, 1985). Notably, peroxisomal membranes are 
impermeable to virtually all metabolites in vivo (Wanders and Waterham, 2006a). Hence, 
peroxisomal membrane transporters have to actively navigate metabolites, such as electron 
carriers (e.g. NAD/H+, Bernhardt et al., 2012) and nucleotides (ATP, Palmieri et al., 2001) or 
even fully folded proteins across the peroxisomal membrane (Walton et al., 1995).  
The oxidative breakdown of H2O2 and fatty acids are evolutionary conserved processes in 
peroxisomes among species. Nevertheless, peroxisomes fulfil many key aspects of lipid 
metabolism and not surprisingly, specialized versions of the organelle exist. Plant peroxisomes 
house the glyoxylate cycle, which is the core enzymatic reaction for carbohydrate anabolism 
in plant seeds, thus the organelles are termed glyoxysomes (Breidenbach and Beevers, 1967). 
Peroxisomes of human pathogens Trypanosoma, namely glycosomes, orchestrate common 
peroxisomal proteins with glycolytic enzymes, thus partitioning the otherwise cytosolic 
glycolysis reaction to glycosomes (Opperdoes et al., 1977). Peroxisomes of filamentous fungi, 
like Neurospora crassa, differentiate into Woronin bodies on a central hexagonal, crystalline 
core, serving as plug upon cell damage (Liu et al., 2011).  
 
1.2 Functions of peroxisomes 
Besides the mitochondria and ER, peroxisomes are the major sites of oxygen consumption, 
which form H2O2 as metabolic precursor for oxidative downstream pathways. 
Compartmentalization of those reactions allows efficient and protective metabolic processing. 
Furthermore, catabolism of fatty acids provides a constant flux of high-energy intermediates, 
subsequently used for ATP synthesis in mitochondria. Hence, peroxisomes perform dedicated 
biological functions in order to maintain cell physiology and a vast repertoire of organism-
specific metabolic processes has evolved (Islinger et al., 2012). 
 
1.2.1 Peroxisome metabolism from yeast to men 
Amongst other biochemical pathways, processing of fatty acids is a particular hallmark and a 
highly conserved feature of peroxisomes among species (Poirier et al., 2006) Notably, in 
1 Introduction 
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plants and fungi peroxisomes are the sole site of fatty acid β-oxidation (Tolbert, 1981). In 
contrast, metabolism of fatty acids in mammalian and human cells is targeted to both, 
peroxisomes and mitochondria (Wanders, 2000). While branched and very long chain fatty 
acids (VLCF) are degraded solely in peroxisomes, breakdown of long chain and medium 
chain fatty acids (LCFA, MCFA) occurs in mitochondria. During the process of β-oxidation, 
carbon-carbon bonds are ruptured thereby liberating chemical energy stored in the covalent 
bond. In this way fatty acids are converted into more polar molecules, facilitating further 
degradation, and their breakdown generates acetyl-CoA metabolites as vital energy source and 
reduced electron acceptors FADH2/NADH+H+ (Hiltunen et al., 2003).  
Furthermore, mammalian peroxisomes are crucial for ether lipid (plasmalogen) biosynthesis, 
which are fundamental components of heart and neuronal tissue (Nagan and Zoeller, 2001). 
Plasmalogens account for up to 80 % of ethanolamine phospholipids in myelin and are 
thought to be involved in oxidative stress protection (Brosche and Platt, 1998). Ether lipid 
anabolism is distributed between peroxisomes and ER, though. However, the first two steps of 
the metabolic process include strictly peroxisomal enzymes (Wanders, 2004). Moreover, the 
adult human liver processes roughly 500 mg cholesterol to bile acid daily, which in turn is 
essential for dietary fat adsorption upon micelle formation or emulsifying cholesterol and fat-
soluble vitamins (Ferdinandusse and Houten, 2006). The conversion of intermediate to mature 
bile metabolites involves β-oxidation, which occurs entirely in peroxisomes of human liver 
cells (Russell, 2003). Additionally, peroxisomes exclusively accomplish α-oxidation of 
branched fatty acids, like phytanic acid (Jansen and Wanders, 2006). In phytanic acid, a 
methyl group occupies the carbon 3 position, thus oxidative removal of the alkyl group in 
form of CO2 is mandatory to produce β-oxidation suitable metabolites, in this case pristanic 
acid (van den Brink and Wanders, 2006). Farther, peroxisomes are linked to cellular redox 
regulation and the generation of reactive oxygen species (ROS), thus suggesting a connection 
to pathological processes of age-related diseases and a considerable contribution to molecular 
reactions resulting in aging (Titorenko and Terlecky, 2011; Lizard et al., 2012).  
Additionally, molecular pathways in plant leaf peroxisomes involve macromolecular enzyme 
complexes, catalysing main reactions of photorespiration (Heupel and Heldt, 1994). In 
Arabidopsis thaliana, core enzymes of fatty acid oxidation together with an increasing number 
of newly identified ancillary enzymes control anabolism of hormonal signal molecules such as 
jasmonites and auxins (Baker et al., 2006; Kienow et al., 2008). In Caenorhabditis elegans or 
insects, pheromone production is amenable to peroxisomes (Joo et al., 2010; Spiegel et al., 
2011). Also, industrial scale production of beta-lactam antibiotic penicillin relies on metabolic 
reactions catalysed in peroxisomes of filamentous fungi Penicillium chrysogenum (Kiel et al., 
2005b).   
1 Introduction 
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1.2.2 β-Oxidation of fatty acids 
The key steps of lipid catabolism in peroxisomes are well conserved and I thus focus 
specifically on yeast S. cerevisiae in this section. A profound overview of fatty acid β-
oxidation and related biochemical processes in mammalian cells is provided in Wanders and 
Waterham (2006a).  
Yeast replenish the amount of fatty acids needed either through de novo synthesis or 
exogenous sources (Tehlivets et al., 2007). Notably, an impaired fatty acid synthetase, the key 
enzyme in endogenous fatty acid synthesis, is compensated by uptake of external fatty acids 
(Dirusso et al., 2000). In yeast cells, exogenous long-chain fatty acids (LCFA, Figure 1.1) are 
imported and concurrently activated with coenzyme A (CoA) by acyl-CoA synthetases Fat1, 
Faa1, Faa3 and Faa4 (Black and DiRusso, 2007). Acyl-CoA thioesters (acyl-CoA), products 
of the nucleotide dependent fatty acid activation reaction, shuttle towards the peroxisomal 
membrane and translocate into the peroxisomal lumen aided by heterodimeric ATP binding 
cassette (ABC) transporters Pxa1-Pxa2 (van Roermund et al., 2012). In contrast, free medium-
chain fatty acids (MCFC) are activated intra-peroxisomal through acyl-CoA synthetase Faa2 
(Hettema et al., 1996). The adenine nucleotide transporter Ant1 maintains the required pool of 
free ATP (Palmieri et al., 2001).  
The actual β-oxidation is divided into 4 reactions, progressing through dehydrogenation, 
hydrogenation, dehydrogenation and finally thiolytic cleavage (Figure 1.1, I-IV). In the initial 
step acyl-CoA is oxidized to trans-∆2-enoyl-CoA, generating a double bond between the 
second and third carbon atom, catalysed by the acyl-CoA oxidase Fox1. Released electrons of 
this reaction are directly transmitted to oxygen to yield the toxic by-product H2O2, which in 
turn is degraded by catalase Cta1, thereby regenerating electron carrier FADH2. Further 
processing of trans-∆2-enoyl-CoA yields enantioselective L3-ketoacyl-CoA by Fox2, 
generating L3-hydroxyacyl-CoA as an intermediate. Concomitantly, electron acceptor NAD+ 
is reduced to NADH. The thiolase Fox3 performs thiolytic cleavage, the final step of the β-
oxidation, where 3-ketoacyl-CoA is fragmented into acetyl-CoA and acyl-CoA shortened by 
two carbon units. Remaining acyl-CoA molecules undergo repetitive cycles of β-oxidation 
until the entire fatty acid chain is cleaved into acetyl-CoA. Fatty acids with an odd-number of 
carbon atoms are cleaved into acetyl-CoA and propionyl-CoA as final products. (Hiltunen et 
al., 2003; Poirier et al., 2006).  
Acetyl-CoA moieties are essential metabolites for subsequent energy production. Acetyl-CoA 
units are either directed to the mitochondrial matrix by the carnitine acetyl transferase Cat2 to 
be subjected to the citric acid cycle (TCA) for subsequent ATP synthesis in mitochondria, or 
localized to both, the cytosol and peroxisome for biosynthesis of carbohydrates or amino acids 
throughout the glyoxylate cycle (Rottensteiner and Theodoulou, 2006).  
1 Introduction 
 11 
 
Figure 1.1 Peroxisomal β-oxidation in S. cerevisiae. Schematic overview of processes involved in S. 
cerevisiae lipid catabolism. (1) Transport of free long-chain fatty acids (LCFA) into the cytosol, 
handled by acyl-CoA synthetases Fat1, Faa1, Faa3 and Faa4. (2) Activation of LCFAs through ATP 
dependent transfer of coenzyme A (CoA) resulting in acyl-CoA intermediates. (3) LCFAs translocate 
into the peroxisomal lumen via heterodimeric ABC transporters Pxa1-Pxa2. (4) ATP consuming 
activation of medium-chain fatty acids (MCFA) through acetyl-CoA synthase Faa2, stimulated by Ant1.  
(5) Acyl-CoA intermediates, derived from LCFA or MCFA activation, undergo β-oxidation, which is 
divided into 4 reactions (Hiltunen et al., 2003; Poirier et al., 2006): (I) dehydrogenation by acyl-CoA 
oxidase Fox1, yielding harmful H2O2. Catalase Cta1 degrades H2O2, thereby regenerating electron 
carrier FADH2. (II) Hydrogenation by Fox2. (III) Dehydrogenation by Fox2, electron acceptor NAD+ 
is reduced to NADH. (IV) Thiolytic cleavage by thiolase Fox3, yielding acetyl-CoA and acyl-CoA 
shortened by a two-carbon unit (-C2). (6) Acetyl-CoA molecules enter glyoxylate cycle for biosynthesis 
of carbohydrates or amino acids. (7) Carnitine acetyl transferase Cat2 directs acetyl-CoA units to the 
mitochondria for ATP synthesis downstream of the TCA cycle (not shown). (8) Remaining acyl-CoA 
molecules undergo repetitive cycles of β-oxidation until the entire fatty acid chain is cleaved. 
 
1.3 Peroxisome biogenesis - S. cerevisiae peroxins (Pex) 
Work by Erdmann et al. (1989) on targeting signals of peroxisomal proteins in S. cerevisiae 
identified mutant yeast strains defective in proper assembly of functional peroxisomes. Those 
mutants grow normally on glucose but fail to metabolize oleic acid as the sole carbon source 
(onu: oleate-non-utilizing-phenotype). Moreover, peroxisomal matrix enzymes are 
mislocalised to the cytosol and detectable peroxisomes are significantly reduced as observed 
1 Introduction 
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by electron microscopy. Those phenotypes result from single gene mutations and 
corresponding mutants are termed pex (peroxisomal assembly) mutants and related gene 
products peroxins (Erdmann and Kunau, 1992; Distel et al., 1996). Hence, peroxins (Pex) are 
indispensible for the accurate formation of peroxisomes. At present, 33 Pex proteins have been 
identified in yeast, regulating peroxisome homeostasis and adaption to cellular needs (Platta 
and Erdmann, 2007; Tower et al., 2011). Distinct groups of Pex proteins are responsible for 
peroxisomal matrix protein import and membrane development. Considerably progress has 
been made unravelling the role and function of individual Pex proteins in peroxisome 
synthesis, which are outlined in the following sections. 
 
1.3.1 Matrix protein import: translocation across the peroxisomal membrane 
The peroxisomal proteome consists of up to 50 different matrix enzymes (Schluter et al., 
2010). However, peroxisomes do not enclose genomic DNA and distinct from other 
organelles, all matrix proteins are nuclear encoded and synthesized on polyribosomes in the 
cytosol (Lazarow and Fujiki, 1985). Hence, for constant flux of peroxisomal matrix proteins, 
target proteins have to be directed post-translationally into peroxisomes.  
The majority of peroxisomal matrix proteins are fused to a C-terminal peroxisomal targeting 
sequence type 1 (PTS1), defined by a degenerate serine-lysine-leucine (SKL) motif (Brocard 
and Hartig, 2006). The soluble receptor protein Pex5 recognizes and binds PTS1 containing 
proteins (McCollum et al., 1993; Van der Leij et al., 1993; Szilard et al., 1995; van der Klei et 
al., 1995), associating into a mobile receptor-cargo complex (Figure 1.2). An alternative, less 
frequent import route is used by PTS type 2 (PTS2) proteins, which are detected by the 
cytosolic import receptor Pex7. The PTS2 is located at the N-terminus of corresponding 
matrix proteins and covers a non-canonical nonapeptide (Lazarow, 2006). In S. cerevisiae, 
stable interactions between Pex7 and target PTS2 proteins depend on additional peroxins, 
namely Pex18 and Pex21 (Schliebs and Kunau, 2006).  
For cargo delivery it is hypothesized that only cargo-associated Pex5 or Pex7, respectively, are 
capable to shuttle towards the peroxisomal exterior, interacting with a membrane bound 
ternary docking complex consisting of peroxisomal membrane proteins Pex13, Pex14 and 
Pex17 (Rucktäschel et al., 2011). It was reported that primary interactions of cargo-loaded 
PTS1 receptor Pex5 occur with Pex14, whereas PTS2 receptor Pex7 initially associates with 
Pex13 (Girzalsky et al., 2010). Once assembled, PTS1 target proteins traverse across the 
membrane into the peroxisomal lumen. However, the detailed molecular mechanisms of cargo 
translocation still remain puzzling. Intriguingly, peroxisomes efficiently import large protein 
oligomers and even 9 nm gold particles (Walton et al., 1995), although no translocon-like 
structure has been observed so far (Smith and Aitchison, 2009). Hence, the available data led 
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to several models, including the membrane invagination model (McNew and Goodman, 1996) 
and the transient pore hypothesis (Erdmann and Schliebs, 2005). The latter assumes that 
membrane bound Pex5/Pex14 temporarily constitute a protein conducting channel, specific for 
peroxisomal matrix protein translocation. Indeed, published studies support the model of a 
short-lived peroxisomal membrane translocon consisting of self-integrating Pex5/Pex14 
moieties (Platta et al., 2014).  
 
 
Figure 1.2 PTS1 import into peroxisomes. Soluble receptor Pex5 associates with the target PTS1 
protein in the cytosol, subsequently shuttling towards the peroxisomal membrane. Cargo-loaded Pex5 
interacts with membrane protein 14, which in turn constitutes the peroxisomal docking complex 
together with Pex13 and Pex17. PTS1 release presumably involves the formation of a transient 
translocon, comprising at least Pex5/Pex14 moieties. Association of Pex8 with Pex5 might support 
cargo release into the peroxisomal lumen.  
 
Accordingly, the process of cargo protein release into the peroxisomal lumen remains 
unknown. However, it became evident that intraperoxisomal protein Pex8 associates with 
Pex5 downstream of the docking event, probably participating in cargo detachment (Rehling 
et al., 2000). Furthermore, Rayapuram and Subramani (2006) report a connection of the 
docking complex to the heteromeric RING (really interesting new gene)- type complex, which 
is bridged by Pex8 (Figure 1.3). The trimeric RING-domain containing complex consists of 
Pex2, Pex10 and Pex12, each of which is a catalytically active E3 ligase (El Magraoui et al., 
2012), since mono- or polyubiquitination of unloaded Pex5 are mandatory for efficient 
receptor export (Platta et al., 2004; Kragt et al., 2005). Pex5 destined for protein degradation 
by the 26 S proteasome is polyubiquitinated by the RING-type E3 ligases Pex2/Pex10 and 
polyubiquitin chain attachment is supported by ubiquitin activating (E1-) enzyme Uba1 (Hicke 
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et al., 2005) and ubiquitin-conjugating (E2-) enzyme Ubc4 (Kiel et al., 2005a). Reasons for 
26S degradation of Pex5 are either an impaired export machinery or faulty receptor proteins. 
In contrast, monoubiquitination of Pex5 is somewhat distinct, as the ubiquitin attachment site 
comprises a conserved cysteine instead of a common lysine, which is recognized by E2 
enzyme Pex4 and E3 ligases Pex10/Pex12 (Platta et al., 2007; Williams et al., 2007). Pex4 
anchors to the peroxisomal membrane via association with the membrane protein Pex22 
(Williams et al., 2012). The single step ubiquitination of Pex5 is decisive for subsequent 
receptor recycling, recovering Pex5 for succeeding rounds of peroxisomal matrix protein 
import (Figure 1.3).  
 
 
Figure 1.3 Ubiquitin dependent export of PTS1 receptor Pex5. Subsequent to PTS1 cargo release, 
Pex5 is monoubiquitinated (Ub) through the sequential action of ubiquitin-activating E1 enzyme Uba1, 
ubiquitin-conjugating E2 enzyme Pex4 and E3 ubiquitin ligase Pex12. ATP dependent receptor release 
is completed through AAA+ proteins Pex1/Pex6. Proteins Pex1/Pex6 anchor to the peroxisomal 
membrane via interactions with integral transmembrane protein Pex15. Ubiquitin dehydrolase Ubp15 
removes monoubiquitin from Pex5 prior to new rounds of PTS1 import. 
 
The export of either mono- or partially polyubiquitinated, cargo-free Pex5 from the membrane 
is an ATP consuming mechanism and relies on the soluble AAA+ proteins Pex1/Pex6 (Platta 
et al., 2005). The heteromeric complex associates with integral membrane protein Pex15 via 
Pex6 at the cytosolic side of the peroxisomal membrane (Birschmann et al., 2003; Rosenkranz 
et al., 2006). However, the detailed mechanism of energy consuming receptor release and 
interactions of Pex5 with the ATPase complex Pex1/Pex6 is still under debate. Available data 
is summarized and discussed in more detail in section 1.6. Subsequent to Pex5 export and 
prior to a new import cycle, ubiquitin markers have to be enzymatically cleaved. Recently, the 
deubiquitinating enzyme Ubp15 has been identified as the hydrolase consecutively removing 
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single ubiquitin moieties from Pex5 in S. cerevisiae (Debelyy et al., 2011).  
Intriguingly, studies of S. cerevisiae PTS2 co-receptor Pex18 revealed an identical mono- and 
polyubiquitination pattern (Hensel et al., 2011), while no evidence on Pex7 ubiquitination, 
degradation or release exists. The current knowledge on the detailed mechanism of cargo-
release and PTS2 receptor export remains fragmentary.  
Switching from a soluble to a membrane-integrated state is a remarkable feature of the PTS1 
receptor Pex5 and distinct from other organelles like mitochondria or the endoplasmatic 
reticulum (ER). Furthermore, energy consuming processing of ubiquitinated Pex5 by AAA+ 
proteins Pex1/Pex6 might be the driving force for concomitant cargo translocation along the 
transient pore, summarized in the export-driven-import model (Schliebs et al., 2010). 
Strikingly, similar mechanisms involving recognition and ATP dependent membrane release 
of ubiquitin labelled substrates by an AAA+ complex exist in cellular pathways like ERAD 
(endoplasmatic-reticulum-associated-degradation). 
 
1.3.2 Peroxisomal membrane development 
Mutations in PEX genes that compromise matrix protein import results in organellar remnants, 
which still recruit peroxisomal membrane proteins (‘ghosts’, Schrader and Fahimi, 2008). 
Hence, underlying mechanisms of matrix protein import and development of peroxisomal 
membranes are distinct from each other.  
In analogy to peroxisomal matrix proteins, the majority of peroxisomal membrane proteins 
(PMPs) are translated on free polyribosomes in the cytosol and post-translationally inserted 
into the membrane (Rucktäschel et al., 2011). Class I PMPs comprise an internal membrane-
targeting signal (mPTS), which is recognized by the cytosolic import receptor protein Pex19 
(Jones et al., 2004; Rottensteiner et al., 2004). The mPTS is not strictly conserved, covering a 
transmembrane domain that assists membrane insertion and a Pex19 binding stretch 
(Girzalsky et al., 2010). Additionally, farnesylation of Pex19 is an essential prerequisite for 
precise mPTS recognition and protein stability (Rucktäschel et al., 2009). In human skin 
fibroblasts, Pex19-cargo complexes are subsequently recruited to the peroxisomal membrane 
via docking to membrane protein Pex3 (Fang et al., 2004). Studies in CHO cells imply that 
insertion of target PMPs into the peroxisomal membrane is ATP dependent (Matsuzono and 
Fujiki, 2006) Analysis of PMP import in yeast Pichia pastoris suggest that the structural 
integrity of membrane protein complexes is achieved through chaperone-like functions of 
Pex19 (Snyder et al., 2000). However, underlying molecular mechanisms are still focus of 
research. 
Class II PMPs (e.g. Pex3) do not encompass an intrinsic mPTS and traffic to the peroxisomal 
membrane via the ER (Hettema et al., 2014). Signal sequences of Pex3, required for ER 
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shuttling, are identified (Fakieh et al., 2013) and insertion into the ER membrane involves the 
Sec61 translocation machinery and the GET pathway, similar to secretory proteins (Schuldiner 
et al., 2008; Thoms et al., 2012). Target PMPs are exported in a vesicle-mediated transport 
relying on Pex19, cytosol and ATP (Lam et al., 2010; Agrawal et al., 2011) resulting in fully 
functional peroxisomes (van der Zand et al., 2010).  
 
 
Figure 1.4 Import of peroxisomal membrane proteins. Class 1 peroxisomal membrane proteins 
(PMP-I) are recognized and bound by Pex19 (19) in the cytosol and shuttled towards the peroxisomal 
membrane. After docking to membrane protein Pex3, PMP-I are inserted into the peroxisomal 
membrane. Class 2 peroxisomal membrane proteins (PMP-II) traverse to peroxisomes via the 
endoplasmatic reticulum. Vesicle transport through the cytosol is assessed in the presence of Pex19 and 
ATP. 
 
1.4 Pex1 and Pex6 are AAA+ proteins 
Functional Pex1 and Pex6 were one of the first proteins identified to be essential for 
peroxisomal biogenesis in S. cerevisiae (Erdmann et al., 1991; Voorn-Brouwer et al., 1993). 
Strong sequence homology of yeast Pex1/Pex6, cell division protein p97 (yeast Cdc48) or 
vesicle fusion protein NSF (yeast Sec18), suggested a novel family of ATPases, commonly 
termed AAA family (ATPases with diverse functional activities, Kunau et al., 1993). 
Members of the AAA family feature a conserved nucleotide binding domain comprised of up 
to 230 amino acids, covering a Walker A and Walker B motif, which are indispensible for 
ATP binding and hydrolysis (Walker et al., 1982). As revealed by multiple sequence 
alignments, Pex1 and Pex6 group into the class of type II AAA+ proteins, featuring two 
consecutive nucleotide binding domains (D1 and D2, Figure 1.5 A), flanked by less conserved 
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N- and C-terminal stretches (Patel and Latterich, 1998; Neuwald et al., 1999). In contrast to 
type II AAA+ proteins p97/Cdc48, only the D2 domain of either Pex1 or Pex6 are 
evolutionary conserved among related AAA+ proteins (Beyer, 1997). Beyer (1997) also shows 
that despite degeneration of Pex1/Pex6 D1 domains, non-canonical motifs for either 
nucleotide binding and/or hydrolysis can be found in this domain. This is in line with 
publications showing that orthologs of the D1 domains of Pex1 or Pex6 are less conserved 
(19-28 %) compared to the D2 domains (29-52 %), implying a greater significance of the 
second AAA+ domain. An additional region of high sequence conservation, which is typically 
found in all AAA+ proteins, called the second region of homology (SRH), was identified in 
the Pex1 D2 domain, highlighting the close sequence based relationship of the peroxins to 
type II AAA+ proteins p97 and NSF or ClpA and ClpB - type proteins (Ogura et al., 2004).  
 
 
Figure 1.5 S. cerevisiae Pex1/Pex6 domain organization and crystal structure of murine Pex1 N-
terminal domain. (A) Schematic domain structure representation of full-length Pex1 and Pex6 
protomers in comparison with p97 and NSF (N, N-terminal domain; D1/D2, AAA+ domain 1/2). 
Conserved structural motifs and residues of the AAA+ domain are indicated as follows: Walker A (A, 
magenta bars), Walker B (B, turquoise bars), second region of homology (SRH) comprising arginine 
finger residues (yellow dots). Non-canonical Walker A and B motifs are indicated as dotted lines. (B) 
Ribbon diagram shows kidney shaped fold of Pex1 N domain (yellow, pdb-ID: 1WLF). Superposition 
with mammalian p97 N domain (grey, pdb-ID: 3qq7) or (C) mammalian NSF N domain (green, pdb-ID: 
1qcs) gives a similar overall folding topology.  
 
Structural studies of active type II AAA+ proteins p97 or NSF revealed a hexameric domain 
arrangement assembled around a central cavity with similar overall dimensions (Lenzen et al., 
1998; Zhang et al., 2000; Lee et al., 2003a). Global nucleotide induced conformational 
changes, observed in crystal structures and cryo-EM reconstructions (Pye et al., 2006; Zhao et 
al., 2012) suggest that AAA+ proteins use the energy of ATP hydrolysis to act on distinct 
substrates in the cell. The sequence homology of Pex1/Pex6 to p97 and NSF indicates a 
similar mechanism during cycles of ATP binding and hydrolysis. However, thus far structural 
analyses of Pex1 and Pex6 AAA+ proteins led to the crystal structure of only the N-terminal 
180 amino acids of murine Pex1 (Shiozawa et al., 2004), resembling the N domains of p97 
and NSF (Figure 1.5 B, C). The extreme N-terminus of Pex1 depicts a double ψ-barrel fold, 
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which consists of two distinct subdomains, accommodating a shallow groove. The 
corresponding indentation in p97 and NSF N-termini allows specific adaptor protein binding 
(Yu et al., 1999; Dreveny et al., 2004). A comparable function could be assumed for Pex1 
NTD, however structural or biochemical evidence is missing. Notably, in p97 and NSF the 
distance between N and D1 domains ranges between 30-60 amino acids (Shiozawa et al., 
2004). In contrast, up to 250 amino acids link the crystalized N-terminal part of Pex1 to its D1 
domain.  
 
1.5 Pex1 and Pex6 form an ATP-dependent heteromeric complex 
ATP dependent in vivo and in vitro interaction of Pex1 and Pex6 was initially described in 
yeast Pichia pastoris (Faber, 1998) and verified in S. cerevisiae (Birschmann et al., 2005) and 
Hansenula polymorpha (Kiel et al., 1999), in plants (Goto et al., 2011) and humans (Tamura, 
1998). Pex1/Pex6 complex formation in S. cerevisiae was revealed by co-immunoprecipitation 
and yeast-two-hybrid analysis, excluding homo-oligomerisation of the two peroxins 
(Birschmann et al., 2005). The study further implies that the interaction occurs via the less 
conserved first AAA+ domain of Pex1 or Pex6 and strictly depends on nucleotide binding to 
the Pex1 D2 domain (Figure 1.6). In the context of peroxisomal biogenesis, the authors show 
in oleate growth assays of Pex1/Pex6 Walker mutants, that nucleotide binding and hydrolysis 
in Pex1 D2 domains is essential for complex function in vivo. This is in line with previous 
studies emphasizing ATP binding and hydrolysis in the Pex6 D2 domain for unrestricted 
growth of S. cerevisiae under oleic acid conditions (Birschmann et al., 2003). Respective 
Pex1/Pex6 Walker or null mutants encompass peroxisomal remnants (‘ghosts’) that partially 
contain peroxisomal membrane proteins but mislocalise matrix proteins to the cytosol 
(Birschmann et al., 2005).  
Since functional type II AAA+ proteins assemble into higher oligomers (Ye et al., 2004), the 
capability of S. cerevisiae Pex1/Pex6 to form higher molecular weight complexes was recently 
characterized by analytical size exclusion chromatography (Saffian et al., 2012). The authors 
demonstrate that in the presence of ATP, Pex1 and Pex6 form heterohexameric complexes 
with a 1:1 stoichiometry. Furthermore, ATP depletion through apyrase treatment results in 
complex disassembly and verifies the importance of nucleotide for complex stability. In 
analogy to Birschmann et al. (2005), Pex1 and Pex6 do not form homohexamers, only gel 
filtration fraction corresponding to Pex1 homotrimers could be observed. Finally, impaired 
ATPase activity upon N-ethylmalemide treatment verified that nucleotide binding to the Pex1 
D2 domain is indispensible for complex formation in vivo and in vitro (Saffian et al., 2012).  
In terms of complex formation, consequences of nucleotide binding and hydrolysis in 
mammalian Pex1/6 complexes differs from the results obtained for the yeast orthologs 
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(Tamura et al., 2006). Complex formation requires nucleotide binding to both, Pex1/Pex6 D1 
and D2 domains and hydrolytic activity in the second AAA+ domain of Pex1. Furthermore, 
Tamura et al. (2006) characterized the complementation activity of Pex1/Pex6 Walker mutants 
and similar to S. cerevisiae Pex1/Pex6, functional D2 domains are mandatory for peroxisome 
biogenesis in mammalian cells. Additionally, ATP binding to the mammalian Pex6 D1 is 
required for fully functional peroxisomes. Equivalent to yeast mutants, aberrant mammalian 
Pex1 or Pex6 results in peroxisomal remnants and accumulation of peroxisomal matrix 
proteins in the cytosol, as observed by electron microscopy of CHO cells (Tsukamoto et al., 
1995; Tamura et al., 1998). Notably, in humans mutations in either the PEX1 or the PEX6 
gene are the most common cause for serious peroxisomal biogenesis disorders (Geisbrecht et 
al., 1998). 
 
 
Figure 1.6 Comparison of ATP dependent functions of S. cerevisiae and human Pex1 and Pex6 
proteins. Assembly of S. cerevisiae Pex1/Pex6 is mediated through Pex1 or Pex6 D1 domains, 
accompanied by ATP binding to the Pex1 D2 domain. Functional complexes in yeast require ATP 
binding and hydrolysis in Pex1/Pex6 D2 domains (left). Complex assembly of human Pex1/Pex6 relies 
on hydrolytic activity in Pex1 D1 and nucleotide binding to Pex1 D2 and Pex6 D1/D2 domains. 
Peroxisome biogenesis in humans is maintained through ATP binding to Pex6 D1 and nucleotide 
hydrolysis in Pex1/Pex6 D2 domains (right). 
 
To date, only a few heterohexameric AAA+ protein complexes have been identified. Besides 
Pex1/6, DNA helicases Ruvb1/Ruvb2 (Lakomek et al., 2015), proteasomal Rpt ATPases (Bar-
Nun and Glickman, 2012) and the mitochondrial Yta10/Yta12 complex (Augustin et al., 2009) 
assemble into active AAA+ type I and type II heterohexamers. While for most of those AAA+ 
complexes structural analyses are available (Lee et al., 2011; Lander et al., 2012), revealing 
significant ATP dependent conformational dynamics, comparable studies for full-length 
Pex1/6 do not yet exist.  
  
1 Introduction 
 20 
1.6 Scope of Pex1/6 at the peroxisomal membrane  
The dual localization of the Pex1/6 complex, switching between the cytosol and the outer 
peroxisomal membrane (Rosenkranz et al., 2006), points towards certain molecular dynamics 
and structural flexibility. The authors suggest that the Pex1/6 complex assembles in the 
cytosol and navigates to the peroxisomal exterior upon interaction with integral membrane 
protein Pex15. The latter is exclusively localized to the peroxisomal membrane (Elgersma et 
al., 1997) directing most of its protein sequence towards the cytosol, whereas the C-terminus 
faces the peroxisomal lumen (Figure 1.3). Birschmann et al. (2003) demonstrated direct 
association of the Pex15 cytosolic domain with the Pex6 N-terminus, including a dual role of 
nucleotide binding and hydrolysis, most likely regulating attachment and release of the Pex1/6 
complex from the peroxisomal membrane. The study suggests that nucleotide binding to Pex6 
D1 stimulates interaction with Pex15, whereas hydrolysis activity in Pex6 D2 triggers 
detachment of the Pex1/6 complex. Notably, communication of the AAA+ complex with 
Pex15 solely occurs via Pex6 and is independent of Pex1. Obviously, recruitment of the 
Pex1/6 complex depends on nucleotide occupancy and hydrolytic activity of Pex6 AAA+ 
domains and an N-terminal conformation allowing flexible alteration between a membrane 
bound and an unbound arrangement of Pex1/6.  
Interaction with Pex15 links Pex1/6 complexes to the import of peroxisomal matrix proteins 
during which Pex1/6 relocates the cargo-free PTS1 receptor Pex5 to the cytosol (see section 
1.3.1). Earlier reports could show that the cellular distribution and localisation of human Pex5 
is ATP dependent (Dodt and Gould, 1996). Follow up studies demonstrated that docking of 
cargo-associated Pex5 with the peroxisomal membrane is ATP independent, whereas 
recycling of Pex5 requires ATP (Gouveia et al., 2003). Subsequently, yeast and human Pex1 
and Pex6 were connected to the extraction of Pex5 from peroxisomal membranes (Miyata and 
Fujiki, 2005; Platta et al., 2005). Approaches to delineate the role of S. cerevisiae Pex1/6 
during recycling of Pex5 included in vitro export systems (Platta et al., 2005). The authors 
found ubiquitination of Pex5 at the peroxisomal membrane as crucial feature for Pex1/6 
dependent receptor export (Figure 1.3). Furthermore, ATP binding and hydrolytic activity in 
D2 domains of both, Pex1 and Pex6, are essential for Pex5 dislocation (Platta et al., 2005). 
Otherwise, ubiquitinated Pex5 stays associated to the membrane. Since compromised ATP 
hydrolysis in Pex1 D2 does neither affect assembly with Pex6 nor interferes with Pex15 
mediated linkage to the outer peroxisomal membrane, hydrolytic function might be attributed 
specifically to Pex5 release. Thus, the energy of ATP hydrolysis generated in Pex1/6 
complexes is believed to structurally remodel Pex5 in order to liberate the receptor from its 
membranous environment (Grimm et al., 2012). As demonstrated in pull down assays, Pex1/6 
co-purifies a multicomponent assembly, comprised of Pex15, Pex5, Pex8 and factors of the 
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docking and RING-domain containing subcomplexes (Rosenkranz et al., 2006). However, 
direct interaction between the Pex1/6 complex and Pex5 has not been observed so far. Hence, 
either adaptor proteins or post-translational modifications (e.g. ubiquitination) might initiate 
and control Pex5 export (Kiel et al., 2005a; Kragt et al., 2005).  
Concomitantly to or downstream of Pex5 release deubiquitinating (DUB) enzyme Ubp15 
removes mono-ubiquitin moieties from Pex5 (Debelyy et al., 2011). The authors show that 
connection of Ubp15 to the export process occurs through binding to the Pex6 D1 domain. 
Intriguingly, comparable interactions have been observed for AAA+ protein p97/Cdc48 and 
DUB enzymes VCIP135/Otu1, which modulate ubiquitin chains on substrate proteins for 
either recycling or proteasomal degradation (Jentsch and Rumpf, 2007; Meyer et al., 2012). 
Although polyubiquitination of aberrant Pex5 is attributed to different enzymes, previous 
studies suggest that Pex1/6 complexes also enhance export of polyubiquitinated Pex5 for 
subsequent targeting to the proteasome (Platta et al., 2004; Kiel et al., 2005a). Hence, the 
purpose of mono- or polyubiquitination of Pex5 can be separated in an essential intrinsic step 
of peroxisomal matrix protein import or in a quality control process through the proteasome-
ubiquitin system (Thoms and Erdmann, 2006). 
ATP consumption by Pex1/6 complexes supplies the overall energy required for the 
mechanical relocation of Pex5 to the cytosol, intimately linking import and export activities at 
the peroxisomal membrane. In order to gain further insight into the molecular mechanism of 
Pex1/6 complexes in action, structural studies of the AAA+ assembly could be of great 
significance.  
 
1.7 Peroxisomal biogenesis disorders (PBDs) 
To date, a remarkable number of yeast pex mutants, deficient in assembling functional 
peroxisomes, have been identified through genetic phenotype complementation approaches 
(Platta and Erdmann, 2007). This led inevitably to the determination of human Pex homologs 
using homology probing (Gould and Valle, 2000) or cloning of mammalian cDNA, 
functionally complementing phenotypes of peroxisome-deficient CHO cells (Fujiki et al., 
2006). As mentioned previously, peroxisomes host a plethora of essential ana- and catabolic 
reactions, which are crucial for cell survival from yeast to men (see section 1.2.1). Hence, 
malfunctioned peroxisome synthesis caused by defects in metabolic enzymes or biogenesis 
factors leads to organellar dysfunction in humans. Correspondingly, a heterogeneous group of 
severe, autosomal recessive disorders has evolved. As depicted in Figure 1.7, those diseases 
are clinically classified into two groups: (1) peroxisomal biogensis disorders and (2) isolated 
peroxisomal enzyme deficiencies (Steinberg et al., 2006; Wanders and Waterham, 2006b).  
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Figure 1.7 Overview of peroxisomal biogenesis disorders (PBDs). The diagram summarizes PEX 
genes corresponding to their cellular tasks, which are known to be aberrant in peroxisomal 
biogenesis disorders. Resulting clinical phenotype(s) of mutated PEX genes is given below (ZSS: 
Zellweger syndrome spectrum; ZS: Zellweger syndrome; NALD: neonatal adrenoleukodystrophy; IRD: 
infantile Refsum disease; RCDP: rhizomelic chondrodysplasia punctata). Biochemical markers linked 
to X-ALD (X-linked adrenoleukodystrophy), Zellweger syndrome, NALD, IRD or RCDP are shown as 
elevated (é), decreased (ê) or wild type (wt) levels (VLCFA: very long-chain fatty acids). Specific 
clinical phenotypes of either X-ALD, the Zellweger syndrome spectrum or rhizomelic chondrodysplasia 
punctata type 1 are given in insets. Colour code is as follows: genotypes, biochemical or clinical 
phenotypes linked to X-ALD (grey insets), genotypes, biochemical or clinical phenotypes linked to ZS, 
NALD or IRD (light blue), genotypes, biochemical or clinical phenotypes linked to RCDP (light green). 
 
Among single enzyme defects, mutations in the ALD gene, coding for human ABC transporter 
protein ALDP, are most frequently, causing X-linked adrenoleukodystrophy (Mosser et al., 
1993; Gartner, 2000). It mainly affects peroxisomes of the nervous system and the adrenal 
glands, where ADLP-dependent ABC transporters fail to actively supply peroxisomes with 
fatty acids. This in turn results in accumulation of saturated VLCFA in the plasma of adrenal 
cortex and inflammatory myelination defects (Berger and Gärtner, 2006).  
Defects in peroxisomal biogenesis disorders (PBDs) trace back exclusively to mutations in the 
PEX gene family and a total of 14 complementation groups (CGs), covering 14 distinct human 
PEX genes, have been identified (Fujiki et al., 2014). PBDs group in two subtypes, namely 
Zellweger syndrome spectrum (ZSS) and Rhizomelic chondrodysplasia punctata (RCDP) 
type 1 (Figure 1.7, Waterham and Ebberink, 2012). 
RCDP patients suffer from a mutation in their PEX7 gene (Braverman et al., 2002; Motley et 
al., 2002) that encodes the PTS2 receptor protein (see section 1.3.1). Thus, import of PTS2 
1 Introduction 
 23 
type matrix proteins is impaired. Amongst others, metabolic consequences comprise increased 
levels of VLCFA, deficient ether lipid synthesis or impaired phytanic acid breakdown 
(Hoefler et al., 1988). Hence, for diagnostic purposes levels of VLCFA, plasmalogens and 
phytanic acid could be determined either in patient’s blood plasma or in established fibroblast 
cell lines. However, RCDP type 1 results in significant clinical phenotypes including 
shortening of proximal front bones (rhizomelia), abnormal facies or growth and psychomotor 
retardation (Wardinsky et al., 1990). Since life expectancy ranges from 1 year up to young 
adulthood, RCDP could be considered as a milder form of peroxisomal biogenesis disorders. 
Mutations in the remaining 13 PEX genes cause fatal diseases, which are biochemically and 
phenotypically distinct from RCDP. Those are collectively grouped into the Zellweger 
syndrome spectrum. The latter comprises three clinical disorders with highly similar 
phenotypes. Those are the Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD) 
and infantile Refsum disease (IRD), with ZS being the most and IRD the least severe disorder 
(Waterham and Ebberink, 2012) 
At least 70 % of all ZSS patients harbour a mutation in PEX1 (Steinberg et al., 2006). The 
human AAA+ protein is a functional ortholog of S. cerevisiae Pex1, thus essential for 
peroxisomal matrix protein import and Pex5 export upon interaction with human Pex6 (Dodt 
and Gould, 1996; Tamura, 1998). Hence, protein import into peroxisomes is compromised and 
peroxisomal matrix proteins are mislocalised to the cytosol. Up to 90 different mutations have 
been identified in human PEX1 (Ebberink et al., 2011). However, two altered alleles are most 
frequently found in ZSS patients: I700fs and G843D (Reuber et al., 1997; Collins and Gould, 
1999). The I700fs allele is related to decreased mRNA levels resulting in a complete loss of 
PEX1 function (null allele). In contrast, Pex1G834D results in a temperature-sensitive 
phenotype with limited binding of Pex1G834D to human Pex6 (Imamura et al., 1998). 
Notably, respective patients are typically mildly affected. Clinical phenotypes strongly depend 
on the corresponding genotypes, since patients homozygous for Pex1I700fs typically do not 
survive the first year of life (Poll-The et al., 2004), whereas Pex1G843D hetero- or 
homozygosity displays intermediate or mild clinical phenotypes (Majewski et al., 2011). 
PEX1 deficiency affects matrix protein import and thus, β-oxidation of (VLC) fatty acids and 
specifically bile acid intermediates. Consequently, elevated levels of VLCFA or bile acid 
serve as diagnostic disease markers in customized screens (Johnson et al., 2001). Based on 
phenotypic heterogeneity, pathologies of PEX1 mutations cover the whole spectra of ZSS (ZS, 
NALD, IRD), including profound hypotonia, hepatic malfunction, deafness, degeneration of 
myelin and respiratory complications (Figure 1.7).  
Deficiencies in human PEX6 are the second most common cause for ZSS disorders 
(Waterham and Ebberink, 2012). However, there is no evidence for a common defect in Pex6 
and mutations occur along the entire PEX6 coding sequence, accumulating in exon 1 
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(Ebberink et al., 2010). Notably, PEX6 mutations, which were identified in 21 ZSS patients, 
imply modifications causing premature stop codons (Steinberg et al., 2004). Moreover, in 
studies of PEX6 mutant CHO cell lines, a temperature-sensitive phenotype was observed, 
possibly reflecting a similarly mild clinical progression as for Pex1G834D (Imamura et al., 
2000). The metabolic consequences of PEX6 defects reflect those described for PEX1 
mutations. Hence, for diagnostic purposes levels of VLCFA, plasmalogens and bile acid could 
be determined either in patient’s blood plasma or in established fibroblast cell lines. Patients 
with an aberrant PEX6 develop clinical features associated to ZS and NALD, which are 
craniofacial abnormalities, leukodystrophy, dysfunction of neuronal migration or seizures and 
spasticity (Figure 1.7). 
Besides PEX1 and PEX6, additional mutations in PEX genes associated with either an import 
defect (PEX5, PEX26, PEX2, PEX10, PEX12), reduced peroxisomal proliferation (Pex11β) or 
impaired membrane development (PEX3, PEX19, PEX16) have been identified and linked to 
ZSS (Fujiki et al., 2014).  
 
1.8 The molecular functions and structures of AAA+ protein complexes  
The family of AAA (ATPases associated with divers cellular activities) proteins was found 
based on sequence homology of the nucleotide binding regions of their early members, 
including Pex1/Pex6, p97, NSF and TBP-1 (Erdmann et al., 1991; Kunau et al., 1993). AAA 
proteins are P-loop NTPases and unifying signature sequences are the Walker A and Walker B 
motif, which interact with incoming nucleotides (Walker et al., 1982). Following systematic 
sequence analyses and structural comparison of proteins homologous to the AAA family 
resulted in an extended class of evolutionary related AAA proteins, designated AAA+ 
superfamily (ATPases associated with various cellular activities; Neuwald et al., 1999). 
Despite functional specialisation, a common theme of AAA+ proteins includes assembly into 
large, macromolecular machines, structurally remodelling proteins or oligonucleotides with 
mechanical force derived from ATP utilization (Tucker and Sallai, 2007).  
 
1.8.1 Topology of the nucleotide binding domain 
In AAA+ proteins, nucleotide binding takes place at a homologous protein domain that is 
present once in type I AAA+ proteins, whereas type II AAA+ proteins consist of two 
nucleotide binding domains (Figure 1.8 A; Patel and Latterich, 1998). It was shown that the 
preceding N-terminal domains of some AAA+ complexes engage with adaptor proteins 
(Birschmann et al., 2003; Dreveny et al., 2004). The ATPase domain is composed of an α/β 
core domain, followed by a small C-terminal, α-helical subdomain (Figure 1.8 B, C; Erzberger 
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and Berger, 2006.). The large N-terminal α/β core features a central Rossmann fold, including 
five parallel β-sheets, which sequentially arrange in a 5-1-4-3-2 topology (Hanson and 
Whiteheart, 2005). The Rossmann fold comprises the Walker A motif, also called phosphate 
binding (P)-loop, which is formed by the consensus sequence GXXXXGK[T/S] (Walker et 
al., 1982). The Walker A lysine is essential for nucleotide binding, coordinating the γ 
phosphate group of bound ATP thereby promoting catalysis (Ye et al., 2004). Upon exchange 
to alanine, ATP binding to the ATPase domain is abrogated (Matveeva et al., 1997; Babst et 
al., 1998). Notably, Walker A mutations can also affect hexamerisation in type II AAA+ 
proteins (Schirmer et al., 1998; Mogk et al., 2003). The Walker B motif of AAA+ proteins 
contains two acidic amino acids, preceded by several hydrophobic residues (hhhhDE, Walker 
et al., 1982). At the nucleotide binding pocket, Walker B aspartate coordinates the Mg2+ ion, 
whereas glutamate primes a water molecule for the subsequent nucleophilic attack on the ATP 
γ phosphate resulting in ATP hydrolysis (Iyer et al., 2004). It was reported, that conservative 
mutations within the Walker B motif (D→N or E→Q) typically allow ATP binding but impair 
nucleotide hydrolysis (Weibezahn et al., 2003; Dalal et al., 2004). Hence, AAA+ proteins 
captured in an ATP bound state in vitro likely reflects the substrate-engaged state in vivo, 
which can be very useful to investigate the functions of AAA+ complexes.  
Zhang and Wigley (2008) demonstrated in a comprehensive analysis of AAA+ crystal 
structures that binding of ATP induces a switch in the Walker B glutamate from an active into 
an inactive state (glutamate switch). The authors propose a model in which hydrogen bonds of 
a neighbouring β2 asparagine attract the glutamate, thereby withdrawing the acidic residue 
from the nucleotide-binding pocket. Thus, ATP hydrolysis would not occur until interactions 
with the substrate are fully established.  
Studies of Walker B mutations in mammalian NSF revealed significant differences between 
amino acid changes in either the D1 or D2 domain (Whiteheart et al., 1994). While alterations 
in the D1 domain drastically reduce ATP turnover, equivalent mutations within the D2 domain 
only slightly disturbs hydrolytic activity. Thus, the authors concluded a separation of function 
between D1/D2 domains, divided into an oligomerisation domain (D2) and a hydrolysis active 
domain (D1), which was also discovered for other type II ATPases in subsequent studies 
(Schlee et al., 2001; Nishikori et al., 2011). However, the responsibility of individual AAA+ 
domains concerning catalytic activity and oligomerisation varies among AAA+ proteins. 
While murine p97 D1 domain is crucial for ATP dependent hexamerisation (Wang et al., 
2003), the D2 is the major site of p97 ATPase activity (Song et al., 2003). Within the central 
Rossmann fold the Walker A and Walker B motif locate at the N-terminal end of α1 and in 
β3, respectively (Figure 1.8 B, C).  
Additionally, a conserved sensor motif (sensor 1) was identified C-terminally of the Walker 
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motifs positioned in the connecting loop between β4 and α4, likely participating in intra-
subunit communications and nucleotide hydrolysis (Guenther et al., 1997; Hattendorf and 
Lindquist, 2002). In crystal structures of AAA+ proteins, polar sensor 1 residues (TN) align 
between the Walker A and Walker B motif, oriented towards the nucleotide binding pocket 
(Wendler et al., 2012). Sensor 1 mutations eliminate enzymatic activity of corresponding 
AAA+ proteins (Zhao et al., 2010). The location of the sensor 1 motif designates the 
beginning of another highly conserved stretch, named the second region of homology (SRH, 
Lupas and Martin, 2002).  
 
 
 
Figure 1.8 Organization and structure of the AAA+ nucleotide-binding domain. (A) Domain 
organization: Type I AAA+ proteins have one nucleotide-binding domain (AAA+ D1) while type II 
AAA+ proteins comprise two ATPase domains in one polypeptide chain (AAA+ D1/D2), each 
preceded by a N-terminal domain. (B) Crystal structure of an individual p97 D2 AAA+ protein domain 
(pdb-ID: 3CF3). Highly conserved structural elements are indicated according to the colour code in (C). 
As a member of the classic AAA clade, p97 contains an alanine instead of an arginine within its sensor 
2 motif and the conserved glutamate switch aspartate is replaced by lysine. Nucleotide (ATP) derives 
from an FtsH crystal structure (pdb-ID: 2CEA). (C) Secondary structure according to the p97 crystal 
structure in (A), showing the position of key residues and corresponding consensus sequences. (D) p97 
D2 domain depicted as full hexamer. Individual AAA+ subunits are colored alternately white and grey 
with functional key residues highlighted as in (B). Two ATP molecules, highlighted by black dashed 
lines, exemplify positions of nucleotide.  
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Besides the sensor 1 motif, the SRH contains conserved arginine residues, termed arginine 
fingers, which contribute to overall ATPase activity and complex stability of functional AAA+ 
oligomers (Ogura et al., 2004). In AAA+ assemblies arginine fingers stabilize the emerging 
negative charge upon ATP hydrolysis in opposing AAA+ protomers, sustaining the 
organization of ATP binding pockets at subunit interfaces (Karata et al., 1999). While two 
arginine fingers are present in classic AAA proteins, only one is conserved throughout the 
superfamily of AAA+ proteins (Wendler et al., 2012). Those arginine residues are situated 
between α4 and β5 of the large, central α/β subdomain (Figure 1.8 B, C). 
Likewise, the small α-helical domain, C-terminally of the Rossmann fold, contains a 
conserved arginine residue, described as sensor 2 motif (Muller and Schulz, 1992). In classic 
AAA proteins this arginine residue is replaced by an alanine (Neuwald et al., 1999). The 
sensor 2 residues (GAR) are positioned in α7 and contribute to ATP hydrolysis. Thus, 
mutations disturb nucleotide turnover, sometimes related to compromised ATP binding 
(Ogura et al., 2004). Surprisingly, mutational studies in ClpX demonstrated that the region 
around the sensor 2 motif in helix α7 is essential for substrate unfolding (Joshi et al., 2003). 
Correspondingly, domain motions of the C-terminal, helical subdomain relative to the large 
α/β core domain around the connecting hinge have been confirmed in subsequent crystal 
structures of ClpX (Glynn et al., 2009).  
AAA+ proteins have been analysed extensively in structural studies, revealing examples of 
pentameric (Simonetta et al., 2009), hexameric (DeLaBarre and Brunger, 2003) and 
heptameric (Lee et al., 2003b) arrangements of identical subunits in AAA+ holoenzymes. 
Upon oligomerisation, ATP biding sites are positioned at the interfaces between individual 
AAA+ subunits and most, if not all AAA+ oligomers feature a central pore (Figure 1.8 D). 
Furthermore, it was reported that substrate interactions occur via conserved pore loops, which 
line the central channel of AAA+ complexes (Yamada-Inagawa et al., 2003; Lum et al., 2004; 
Siddiqui et al., 2004). Thus, substrate processing is inevitably linked to the assembly of 
individual AAA+ subunits into active oligomers. Many AAA+ proteins comprise an aromatic-
hydrophobic-glycine (ϕhG) pattern in the substrate-binding loop region 1, positioned before 
helix α2. Additionally, substrate interacting residues line pore loop region 2, arranged in helix 
α3 (White and Lauring, 2007). Upon hexamerisation, substrate-binding pore loops face 
towards the symmetry axis of the AAA+ complex (Figure 1.8 D). It was reported that in 
AAA+ translocase ClpX or chaperone ClpB those central pore residues are crucial for an 
unfolding-coupled translocation of substrate proteins (Weibezahn et al., 2004; Martin et al., 
2008). However, details concerning underlying molecular mechanisms are still fragmentary. 
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1.8.2 From structure to mechanism  
Established through comprehensive analyses of sequence-based relationships and 
juxtaposition of available crystal structures of the AAA+ core domains, AAA+ proteins are 
classified in distinct clades (Iyer et al., 2004; Ammelburg et al., 2006; Erzberger and Berger, 
2006; Wendler et al., 2012). AAA+ assemblies group into 4 basic clusters: the PACTT 
group/PSI superclade (including H2-insert, PS-II insert and HCLR clade), the extended AAA 
group/classic clade, the HEC group (including clamp loader and initiator clade) and the 
helicase superfamily III.  
Pex1/Pex6 AAA+ proteins belong to the extended AAA group, together with other type I or 
type II ATPases, like p97/Cdc48, NSF/Sec18, ClpA and ClpB-type of proteins, bacterial 
protease FtsH, proteasomal Rpt proteins, Rubisco activase or members of the katanin family 
(Erzberger and Berger, 2006). AAA+ modules of the classic group have two arginine fingers 
but lack a canonical sensor 2 motif (Figure 1.8 B-D; Wendler et al., 2012). Members of the 
classic clade function in a variety of cellular tasks, including peroxisome biogenesis (Pex1, 
Pex6; Erdmann et al., 1991, Voorn-Brouwer et al., 1993), ER-associated degradation (ERAD) 
of misfolded or damaged proteins (p97/Cdc48; Meyer and Weihl, 2014), homo- and 
heterotypic membrane fusion (NSF/Sec18; Wilson et al., 1989, Püschel et al., 1994), 
microtubule-severing in mitosis/meiosis or flagellar physiology (katanin; Quarmby, 2000), 
protein disaggregation (Hsp104/ClpB; Sanchez and Lindquist, 1990), or protein proteolysis 
(ClpAP or FtsH, Figure 1.9; Ogura and Wilkinson, 2001).  
 
 
Figure 1.9 Functions and subcellular localization of AAA+ proteins. Representation of a schematic 
eukaryotic cell, including cell compartments and multiprotein complexes (adapted from Ogura and 
Wilkinson, 2001). Canonical functions of individual AAA+ proteins are indicated, including 
prokaryotic members. 
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Despite variegated subcellular localizations and low functional similarities, AAA+ complexes 
generally consume ATP to power reactions, which are certainly linked to substantial 
conformational remodelling of substrate proteins (Tucker and Sallai, 2007). Proficient 
enzymatic processivity of AAA+ proteins depends on oligomerisation into ring shaped 
assemblies, most frequently hexamers (Singh and Maurizi, 1994; Whiteheart et al., 1994; 
Krzewska et al., 2001; Mogk et al., 2003; Greenleaf et al., 2008). Negative stain and cryo 
electron microscopy (EM) studies demonstrated that AAA+ proteases ClpA and ClpX 
translocate target proteins through their central pore towards the peptidase chamber of ClpP 
for final protein degradation (Ortega et al., 2000; Ishikawa et al., 2001). Since early crystal 
structures of related AAA+ protein NSF or p97 depicted narrow central pores (Lenzen et al., 
1998; Zhang et al., 2000), which would restrict the entry to the inner channel of even smallest 
folded proteins, biochemical studies investigated and verified the capacity of ClpA and ClpX 
to mechanically unravel fully folded substrate structures (Hoskins et al., 1998; Singh et al., 
2000). Substrate unfolding is linked to another characteristic feature shared among ATPases of 
the extended AAA group. Those members contain a small helical insertion before helix α2 
within the AAA core domain (Erzberger and Berger, 2006), which is directed towards the 
central axis in hexameric complexes (Figure 1.8 B-D). This accessory, clade specific element 
was shown to be crucial for substrate specific enzymatic activity of hexameric AAA+ 
complexes ClpA and p97 (Hinnerwisch et al., 2005; DeLaBarre et al., 2006). Indeed, the α-
helical insertion connects to or includes residues of pore loop 1, which contains a highly 
conserved axial aromatic-hydrophobic-glycine pattern ([Y/F/W][V/F/I]G) in many AAA+ 
proteins and protrudes from every AAA+ subunit into the central pore (Martin et al., 2008). 
Comparative structural studies of bacterial protease HslU by Wang et al. (2001) proposed for 
the first time that a conserved tyrosine residue in pore loop 1 transmits nucleotide dependent 
movements of the hexameric AAA+ ring to the substrate protein, resulting in an unfolding-
coupled translocation mechanism. The authors suggest that HslU threads target substrates 
through the central pore concurrently unfolding target protein structures. Follow-up studies on 
HslU (Park et al., 2005) and related prokaryotic proteases ClpX (Siddiqui et al., 2004; Martin 
et al., 2008) or FtsH (Yamada-Inagawa et al., 2003) confirmed that conserved axial pore 
residues are associated with substrate binding and/or threading coupled to ATP turnover. 
Likewise, biochemical analyses could show that hexameric type II AAA+ oligomers ClpB or 
Hsp104 actively translocate substrate molecules through their central pore (Weibezahn et al., 
2004; Tessarz et al., 2008). Furthermore, mutations of those tyrosines within substrate binding 
loop regions in ClpB/Hsp104 compromise substrate recognition and processing, hinting at a 
substantial contribution of those residues in translocation (Lum et al., 2004; Weibezahn et al., 
2004; Tessarz et al., 2008). 
Cross-linking studies of type II AAA+ protein ClpA have demonstrated that substrate proteins 
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directly engage with tyrosines of three substrate-binding loop regions, arranged along the pore 
of ClpA D1 and D2 (Hinnerwisch et al., 2005). The authors show that particularly mutations 
of the functional tyrosine in the ClpA D2 domain allow direct binding of substrate protein 
concomitantly blocking translocation and unfolding of the polypeptides. Hence, Hinnerwisch 
and colleagues suggest that the attachment of substrate proteins depends on interaction with all 
three axial pore loops but translocation is driven by out of plane movements of the more active 
D2 domain along the central axis upon ATP hydrolysis.  
Also, p97 actively interacts with target molecules via substrate-binding loop 2 in the D1 
domain (Figure 1.10; DeLaBarre et al., 2006). Furthermore, the authors demonstrated that 
non-conservative mutations of aromatic residues within pore loops of p97 D1 or D2 
significantly affected p97 function in ERAD. Reminiscent of ClpA, a functional aromatic 
residue of p97D2 undergoes large conformational changes along the pore axis upon ATP 
hydrolysis, highlighted by structural comparison of ADP and AMPPNP bound p97 crystal 
structures (DeLaBarre et al., 2006), However, a threading mechanism has not yet been shown 
for p97. Furthermore, DeLaBarre and colleagues propose that target polypeptides cannot enter 
the narrow central pore of the p97 D1 domain. 
 
 
Figure 1.10 Localisation of substrate-interacting pore loops in p97. (A) Side view cartoon 
representation of p97 (pdb-ID: 3CF3). Two opposing protomers of the p97 hexamer are shown. Pore 
facing loops are highlighted in green and grey dashed line indicates central symmetry axis. Structural 
elements of p97 are colored according to Figure 1.8. Aromatic residues p97H317 and p97W551 are depicted 
as green spheres. (B) Cartoon representation of p97 D1 and D2 cross-section views (pdb-ID: 3CF3). 
Aromatic residues p97H317 and p97W551 are shown as green sticks. 
 
Subsequent structural characterisations of p97 led to a model in which the energy of 
nucleotide hydrolysis is transmitted via long-range conformational changes from D1 and D2, 
respectively, to the N-terminal domains, which interact with substrate proteins (Davies et al., 
2008). In contrast, recent cryo-EM studies propose a threading mechanism for Cdc48, the 
archeal ortholog of p97 (Barthelme et al., 2014).  
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Movements of substrate-binding elements are likely connected to the hydrolytic activity in 
individual AAA+ subunits. Four models of ATP turnover have been proposed in order to 
describe the coordination of hydrolysis cycles among hexameric AAA+ arrangements and thus 
substrate translocation: stochastic, rotational, sequential or synchronized/concerted ATP 
hydrolysis (Figure 1.11 A, Lyubimov et al., 2011). Differences in nucleotide occupancy 
coupled to the arrangement of ATPase sites visualized through structural studies support one 
mode of “firing” or another.  
 
 
Figure 1.11 Models for coordination of NTP hydrolysis and nucleotide dependent arrangement of 
poor loops in AAA+ hexamers. (A) In the stochastic/probabilistic model, ATP binding (ATP) and 
hydrolysis (ADP) occurs in monomers independent of residual protomers (?). In the rotational model, 
only three subunits are active at different stages of the reaction cycle. Sequential nucleotide binding and 
hydrolysis occurs at six active ATPase sites proceeding from one neighbouring protomer to the next 
along the ATPase ring. Synchronized ATP binding and hydrolysis happens at all ATPase sites at the 
same time (adapted from Bush and Dixon, 2012). (B) Exposure of asymmetrically arranged pore or 
DNA-binding loop residues in either the base subunits of the substrate-bound 26S proteasome or the E1 
helicase bound to DNA (adapted from Nyquist and Martin, 2014). 
 
In the presence of different nucleotides, virtually all crystal structures of p97 show a 
homogeneous nucleotide occupancy in the hexamer (Zhang et al., 2000; Huyton et al., 2003; 
Davies et al., 2008). p97 assembles in symmetric ring structures featuring a tight arrangement 
of AAA+ domains (Figure 1.10 B). Hence, a concerted model for ATP hydrolysis can be 
assumed, in which all protomers bind and hydrolyse nucleotide simultaneously. Notably, in 
the presence of the transition state analogue ADP-AlFx, p97 shows an unequal nucleotide 
loading in the D2 domain (DeLaBarre and Brunger, 2005). While the D1 domain is 
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permanently occupied by ADP (Huyton et al., 2003), ATP binding and hydrolysis in p97 D2 
could rather follow a rotary sequence.  
In line with concerted nucleotide binding and hydrolysis in p97, structural and biochemical 
data available for related AAA+ proteins NSF and SV40 Ltag propose a concerted mechanism 
of nucleotide turnover (Gai et al., 2004; Zhao et al., 2012). Accordingly, it was suggested that 
ATP binding and hydrolysis mainly levers substrate-interacting loops locally up and down the 
central ring axis without significantly changing the relative orientations of the protein domains 
(Gai et al., 2004; DeLaBarre and Brunger, 2005). In contrast, Wendler et al. (2009) could 
show that hydrolysis competent Hsp104 forms hexameric complexes enclosing a large central 
cavity, deviating from the inter-locked arrangement observed in crystal structures of related 
AAA+ proteins, indicating remarkable conformational switching dynamics while cycling 
through different nucleotide states. Accordingly, these and related cryo-EM studies of NSF 
(Chang et al., 2012) or p97 (Rouiller et al., 2002) revealed a global conformational flexibility 
of the AAA+ subunits in the hexamer during the ATPase cycle, inducing nucleotide dependent 
domain movements of entire AAA+ sites within one ring and/or relative to the second ring.  
Sub-stoichiometric or mixed nucleotide occupancy of AAA+ domains has been observed in 
structural studies of homohexameric AAA+ proteases HslU and ClpX or enhancer binding 
protein PspF (Bochtler et al., 2000; Wang et al., 2001; Martin et al., 2005; Stinson et al., 
2013), suggesting rather a rotational or sequential model for the ATPase cycle. Notably, 
Stinson et al. (2013) also provide structural and biochemical data supporting a 
stochastic/probabilistic mechanism for ATP turnover and function in ClpX, in which 
hydrolysis events would occur independently at individual protomers.  
Despite full nucleotide loading, asymmetric arrangements of individual AAA+ domains within 
hexameric assemblies of protease FtsH (Suno et al., 2006), papillomavirus E1 helicase 
(Enemark and Joshua-Tor, 2006; Sanders et al., 2007) or related RecA-like protein T7 gp4 
helicase (Singleton et al., 2000) have been observed, further supporting rotational or 
sequential rounds of NTPase activity and indicating a preferred order of nucleotide states. 
Additionally, crystal structures of ClpX and HslU demonstrate that individual ATPase 
domains hold a certain degree of freedom, allowing the small α-helical subdomains to move 
flexibly relative to the corresponding central α/β large subdomain around the connecting 
hinge (Wang et al., 2001; Glynn et al., 2009). Thus, protomer interfaces change during the 
ATPase cycle, likely allowing directed intersubunit communication in order to coordinate 
accurate substrate processing. Similar results were obtained in symmetry-free cryo-EM 
reconstructions of Hsp104, depicting altered subunit interfaces resulting in protomer 
conformations that suggest varying nucleotide states within the homohexamer, hinting at 
sequential ATP consumption (Wendler et al., 2009). However, as most type I or type II AAA+ 
complexes are homo-oligomers, the characterization of inter-domain and intra-domain 
1 Introduction 
 33 
communication between AAA+ domains has been difficult to address. Primary studies are 
reported on the heterohexameric type I AAA+ Yta10/Yta12 complex (Augustin et al., 2009). 
The authors show that the protomers arrange in an alternating fashion, allowing mutational 
studies in only a subset of AAA+ domains and thus, examining possible protomer-protomer 
communications. Their results demonstrate that the nucleotide state of one subunit type 
(Yta12) influences ATP turnover in adjacent subunits (Yta10). Augustin et al. (2009) propose 
a model in which regulated ATP hydrolysis in adjoining Yta10/Yta12 subunits results in a 
rotational power stroke of pore loop 1, unfolding and translocating the polypeptide through the 
pore by rotational substrate hand-off. However, whether such mechanism applies to related 
AAA+ proteins has to be examined further. 
Still, it is not known whether substrate-interacting pore loops move only locally in order to 
thread the substrate along the pore or nucleotide dependent movements of entire subunits 
participate in the translocation process. Single particle analyses of actively translocating 26S 
proteasomes or functional NSF complexes demonstrate that the AAA+ rings accommodate a 
distorted symmetry (Matyskiela et al., 2013; Zhao et al., 2015), resulting in a spiral 
arrangement of individual subunits (Figure 1.11 B). This domain organization is assumed to 
be functionally relevant for substrate processing. Comparable arrangements have been found 
in the E1 helicase and the RecA-type Rho or DnaB helicases (Nyquist and Martin, 2014). 
Single molecule studies on the translocation process of hexameric ClpX and pentameric ϕ29 
packaging motor suggests that the hydrolysis cycle follows radially around the spiral staircase 
accompanied by prompt large-scale conformational changes of entire ATPase subunits, 
thereby escorting the substrate downwards the pore (Moffitt et al., 2009; Aubin-Tam et al., 
2011; Maillard et al., 2011; Chistol et al., 2012). Subsequently, AAA+ domains would occupy 
the initial spiral arrangement ready for the next round of substrate translocation.  
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1.9 Aim of this study 
AAA+ proteins Pex1 and Pex6 from yeast S. cerevisiae form nucleotide dependent 
heterohexameric complexes (Saffian et al., 2012). Pex1/6 use the energy from ATP turnover 
to dislocate the import receptor Pex5 from the peroxisomal membrane back to the cytosol 
(Platta et al., 2005). According to the export driven import model, ATP dependent release of 
Pex5 by Pex1/6 is coupled to cargo translocation across the peroxisomal membrane and thus 
sustains the overall energy requirement of matrix protein import into peroxisomes (Schliebs et 
al., 2010). Previous studies established that functional D2 domains of Pex1 and Pex6 are 
essential to act on Pex5 and maintain peroxisome biogenesis (Birschmann et al., 2003; 
Birschmann et al., 2005; Platta et al., 2005). Proteins from the AAA+ family typically 
assemble into large, macromolecular protein complexes, structurally remodelling their 
substrate proteins using the energy from ATP consumption (Tucker and Sallai, 2007). It was 
shown for several AAA+ proteins that substrate processing involves a threading mechanism 
through the central pore of assembled complexes (Weibezahn et al., 2004; Hinnerwisch et al., 
2005; Martin et al., 2008; Tessarz et al., 2008). However, details concerning the functional 
mechanism or structural architecture of AAA+ complex Pex1/6 are still fragmentary.  
In this study, we solve the three-dimensional structure of the Pex1/6 complex from 
S. cerevisiae using negative stain electron microscopy (EM). In order to obtain satisfactory 
protein concentrations for structural analysis part of this study includes developing a strategy 
for the overexpression of recombinant Pex1 and Pex6 in S. cerevisiae. Our comprehensive EM 
analysis of Pex1/6 complexes in the presence of different nucleotides resolves intermediate 
steps of the ATPase cycle of Pex1/6, revealing energy creating conformational states, which 
could fit the model of Pex5 dislocation in vivo. Additionally, the overall architecture gives an 
explicit overview of substrate or adaptor interactions sites and their spatial arrangement 
around or within the AAA+ assembly. Structural analyses in combination with biochemical 
assays of Pex1/6 Walker B complexes demonstrate that the ATPase sites within the complex 
are functionally non-redundant and provide a profound insight on cooperativity or protomer-
protomer communication within the Pex1/6 complex. 
Our data provide a model, which might apply to the function and mechanism of Pex1/6 
complexes in the human system. Hence, the here presented study could be of fundamental 
relevance in order to understand the molecular consequences of Pex1/6 dysfunction and thus, 
help to develop future therapeutic treatments for Zellweger patients. 
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2 Material and Methods  
Unless stated otherwise, chemicals were of pro analysis quality and purchased from either 
Carl Roth GmbH + Co. KG (Karlsruhe), Fluka/Sigma Aldrich Chemie GmbH (Seezen), 
Merck (Darmstadt), Invitrogen GmbH (Karlsruhe), Roche Diagnostics GmbH (Mannheim) or 
VWR International GmbH (Darmstadt). Yeast and bacterial media components and 
supplements were purchased from ForMedium (Norfolk, UK). Liquid media were autoclaved 
20 minutes at 120°C before use.  
2.1 Oligonucleotides, plasmids, strains and culture conditions 
2.1.1 Oligonucleotides 
Oligonucleotides used in this study were purchased from Metabion International AG 
(Martinsried) and are listed in Table 2.1-2.4.  
 
Table 2.1 Primers used in this study generating PEX1/PEX6 galactose overexpression plasmids. 
 
Name Sequence (5’ -> 3’) Restriction site(s) 
PEX1-fwd 
CGAACCAAGCTTATGACGACGA
CCAAGAGGTTG 
HindIII 
deltaN-R189-PEX1-fwd 
AAAAAAGCTTATGCGTTTGGTG
AAGGCTGAG 
HindIII 
PEX1-rev 
GCCGACTCTCCCTTATGGGATCC
CAAC 
BamHI 
PEX6-Topo-fwd 
AAAAGGTACCATGAAGGCATCG
CTTACGTTT 
KpnI 
His6-PEX6-Topo-fwd 
AAAAGGTACCATGCATCATCAT
CATCATCATAAGGCATCGCTTA
CGTTT 
KpnI 
PEX6-Topo-rev 
AAAAGGATCCAGCACCTTCAAA
ATTAGC 
BamHI 
Spacer-TEV-ProtA-fwd 
GATTCGGATCCGATTATGATATT
CCAACTACT 
BamHI 
Spacer-TEV-ProtA-rev 
TCCGCGGGGAAGTCAACCTGAG
GATCCGCCG 
BamHI 
PEX1-D2-E798Q-fwd 
CTATTTTTTGACCAATTCGATTC
GATCGCGCCA 
PvuI 
PEX1-D2-E798Q-rev 
TGGCGCGATCGAATCGAATTGG
TCAAAAAATAG 
PvuI 
PEX6-D2-E832Q-fwd 
TGTGTCATATTTTTTGATCAAAT
CGATTCAGTAGCA 
BclI 
PEX6-D2-E832Q-rev 
TGCTACTGAATCGATTTGATCAA
AAAATATGACACA 
BclI 
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Table 2.2 Primers used generating PEX1/PEX6 plasmids for oleate growth assays.  
 
Name Sequence (5’ -> 3’) Restriction site(s) 
Prom-PEX1-Topo-fwd 
AAAATCTAGATAATTCTATGTA
ACCTCGATGGC 
SacI 
Prom-PEX1-Topo-rev 
AAAACTCGAGTCAGGATCCCAT
AAGGGAGAGTCGGCTACCAAT 
BamHI and XhoI 
Prom-PEX6-Topo-fwd 
AAAATCTAGAAAGAACTTTATA
TATCATGTAGC 
XbaI 
Prom-PEX6-rev 
AAAAGGTACCTTAAGCACCTTC
AAAATTAGC  
KpnI 
PEX1-D1-Y488A-fwd 
CACATCTTCGTTAAAGCTGCAG
ATTGTGAAACATTGC 
PstI 
PEX1-D1-Y488A-rev 
GCAATGTTTCACAATCTGCAGC
TTTAACGAAGATGTG 
PstI 
PEX1-D1-H495A-fwd 
GCGGATTGTGAAACGCTAGCTG
AGACATCAAATTTA 
NheI 
PEX1-D1-H495A-rev 
TAAATTTGATGTCTCAGCTAGC
GTTTCACAATCCGC 
NheI 
PEX1-D2-F771A-fwd 
CAGAGATTTTAAACAAGGCGAT
CGGTGCCAGCGAACA 
PvuI 
PEX1-D2-F771A-rev 
TGTTCGCTGGCACCGATCGCCTT
GTTTAAAATCTCTG 
PvuI 
PEX1-D2-R855K-fwd 
TTAAGACCGGGAAAGCTTGACA
AAAGTGTGATCTGT  
HindIII 
PEX1-D2-R855K-rev 
ACAGATCACACTTTTGTCAAGC
TTTCCCGGTCTTAA  
HindIII 
Pex1-D2-D797N-fwd 
ATTCTATTTTTTaACGAGTTCGA
TTCgATcGCGCCAAAG 
PvuI 
Pex1-D2-D797N-rev 
CTTTGGCGCgATcGAATCGAACT
CGTtAAAAAATAGAAT 
PvuI 
PEX6-D1-Y528A-fwd 
ACATCTAAGATTATTGGCGCCA
TTAGGGCTAAATGTG 
NarI 
PEX6-D1-Y528A-rev 
CACATTTAGCCCTAATGGCGCC
AATAATCTTAGATGT 
NarI 
PEX6-D1-R607K-fwd 
GATAACGTGCCCTCGAGCTTTA
AATCACATATGAGA  
XhoI  
PEX6-D1-R607K-rev 
TCTCATATGTGATTTAAAGCTCG
AGGGCACGTT ATC  
XhoI 
PEX6-D1-R611K-fwd 
GATCACATATGAAATTTGAGAT
CTTAGTACCCGTTC 
BglII 
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Name Sequence (5’ -> 3’) Restriction site(s) 
PEX6-D2-Y805A-fwd 
GAACTGTTGAATATGGCGATCG
GTGAGAGTGAAGCTA 
PvuI 
PEX6-D2-Y805A-rev 
TAGCTTCACTCTCACCGATCGCC
ATATTCAACAGTTC 
PvuI 
PEX6-D2-R892K-fwd 
GCACTACTAAGCCCGGGAAAAT
TCGATAAATTGTTA 
SmaI 
PEX6-D2-R892K-rev 
TAACAATTTATCGAATTTTCCCG
GGCTTAGTAGTGC 
SmaI 
 
Table 2.3 Primers used in this study to verify PEX1 and PEX6 deletion strains. 
 
Name Sequence (5’ -> 3’) 
PEX1-confirmationA ATGAGTCCATAATACTGTACTGGCG 
PEX1-D TATATATGCAACTTCGGATTTCGTT 
PEX6-confirmationA TCACTTGGATGAAAAATTACTGAAA 
PEX6-D AAAAGGTGTTGCTTCATATACCATC 
 
Table 2.4 PEX1 and PEX6 sequencing primers used in this study. 
 
Name Sequence (5’ -> 3’) 
Sequ-PEX1-1-fwd CCCCGGATCGGACTACTAG 
Sequ-PEX1-2-fwd GCATTAAGCTCTCATCTTTG 
Sequ-PEX1-3-fwd CCAGATCATGAAACTAAAT 
Sequ-PEX1-4-fwd GGCAATGATAATATAGAATA 
Sequ-PEX1-rev CTGTGGCCAAAACAG GATTG  
Sequ-PEX6-1-fwd GAACAATATACGCACCTCCC 
Sequ-PEX6-2-fwd GCAATCAAATTACAAAAATC 
Sequ-PEX6-3-fwd GCAACAAACAGACCAGACTT 
Sequ-PEX6-rev GGTACTACATTGTCTAATATG 
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2.1.2 Plasmids 
Plasmids and corresponding sources are listed in Table 2.5 and Table 2.6. 
 
Table 2.5 Plasmids used in this study for Pex1/6 overexpression. 
 
Plasmid Description  Source / reference 
pRS425-Gal1 GAL1, LEU2, 2µ, Ampr gift from C. Enenkel 
pYES2 GAL1, URA3, 2µ, Ampr Invitrogen 
pGEX-4T3-GST-PEX1E798Q Ampr, pBR322, Ptac:GST- PEX1E798Q Maria Walker 
pRS425-PEX1-TEV-ProA Ampr, LEU2, 2µ, GAL:PEX1-TEV-ProA This study 
pRS425-PEX1E798Q- 
His6-TEV-ProA 
Ampr, LEU2, 2µ, GAL:PEX1E798Q- 
His6-TEV-ProA  
This study 
pRS425-ΔN-R189-PEX1-
His6-TEV-ProA 
Ampr, LEU2, 2µ, GAL: PEX1-Δ188- 
His6-TEV-ProA 
This study 
TOPO pCR2.1-PEX6 Ampr, Kanr, pUC, f1, LacZα::PEX6 This study 
TOPO pCR2.1- 
His6-PEX6 
Ampr, Kanr, pUC, f1, LacZα:: 
His6-PEX6 
This study 
TOPO pCR2.1- 
His6-Spacer-TEV-ProA 
Ampr, Kanr, pUC, f1, LacZα:: 
His6-Spacer-TEV-ProA 
This study 
pYES2-PEX6-TEV-ProA Ampr, LEU2, 2µ, GAL:PEX6-TEV-ProA  This study 
pYES2-His6-PEX6- 
TEV-ProA 
Ampr, LEU2, 2µ, GAL:His6-PEX6- 
TEV-ProA 
This study 
pYES2-His6-PEX6E832Q- 
TEV-ProA 
Ampr, LEU2, 2µ, GAL:His6-PEX6E832Q- 
TEV-ProA 
This study 
 
Table 2.6 Plasmids used in this study for Pex1/6 oleate growth assays. 
 
Plasmid Description  Source / reference 
pRS316 URA3, CEN/ARS, Ampr ATCC® 77145TM 
TOPO pCR2.1-pPEX1 Ampr, Kanr, pUC, f1, LacZα::pPEX1 This study 
TOPO pCR2.1-pPEX6 Ampr, Kanr, pUC, f1, LacZα::pPEX6 This study 
pRS316-pPEX1 Ampr, URA3,CEN/ARS, PEX1:PEX1 This study 
pRS316-pPEX6 Ampr, URA3,CEN/ARS, PEX6:PEX6 This study 
pRS316-pPEX1Y488A Ampr, URA3, CEN/ARS, PEX1:PEX1Y488A  This study 
pRS316-pPEX1H495A Ampr, URA3, CEN/ARS, PEX1:PEX1H495A This study 
pRS316-pPEX1F771A Ampr, URA3, CEN/ARS, PEX1:PEX1F771A This study 
pRS316-pPEX1R855K Ampr, URA3, CEN/ARS, PEX1:PEX1 R855K This study 
pRS316-pPEX1D797N Ampr ,URA3, CEN/ARS,PEX1:PEX1 D797N This study 
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Plasmid Description  Source / reference 
pRS316-pPEX6Y805A Ampr, URA3, CEN/ARS, PEX6:PEX6Y805A  This study 
pRS316-pPEX6R607K Ampr, URA3, CEN/ARS, PEX6:PEX6R607K  This study 
pRS316 -pPEX6R611K Ampr, URA3, CEN/ARS, PEX6:PEX6R611K  This study 
pRS316-pPEX6R892K Ampr, URA3, CEN/ARS, PEX6:PEX6R892K This study 
 
2.1.3 Bacterial strains and culture conditions  
Escherichia coli (E. coli) strains (Table 2.7) are grown at 37°C in Luria Bertani (LB) liquid 
medium with shaking (150 rpm) or on solid LB agar plates for 16 hours (h), supplemented 
with appropriate antibiotics.  
 
LB Medium   0.5 % (w/v) yeast extract  
1.0 % (w/v) bacto trypton 
0.6 % (w/v) NaCl 
   (1.5 % (w/v) agar for solid plates) 
 
Ampicillin (amp, 100 mg ml-1) or kanamycin (kan, 34 mg ml-1) stock solutions are prepared in 
ethanol and sterile filtered (syringe-filter with 22 µm cut-off, Carl Roth GmbH + Co. KG). 
Antibiotics are added to a final concentration of either 0.1 mg ml-1 (amp) or 0.034 mg ml-1 
(kan) in liquid medium. Agar plates contained a final concentration of 0.05 mg ml-1 amp.  
 
Table 2.7 E. coli strains used in this study. 
 
E. coli strain Genotype Source / reference 
Dh5α 
F-, ø80dlacZΔM15, Δ(lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, mk+), 
phoA, supE44, λ-, thi-1, gyrA96, relA1 
(Sambrook et al., 1989) 
One Shot® TOP10 
F´[lacIq Tn10 (TetR)] mcrA Δ(mrr-
hsdRMS-mcrBC) φ80lacZ.M15ΔlacX74 
deoR recA1 araΔ139 Δ(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG 
Invitrogen 
 
2.1.4 Yeast strains and culture conditions 
Yeast strains (Table 2.8) are grown at 28°C in YPD liquid medium with gentle shaking (120-
130 rpm) or on solid YPD agar plates for 2-3 days. To select for auxotrophies, yeast strains are 
grown in either liquid complete medium (CM) while shaking (120-130 rpm) or on solid CM 
agar plates for 2-3 days, lacking appropriate amino acids. 
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YPD medium  1 % (w/v) yeast extract 
2 % (w/v) bacto peptone 
2 % (w/v) glucose 
(2 % (w/v) agar for solid medium) 
 
Complete medium 0.19 % (w/v) yeast nitrogen base (w/o AA and AS) 
(CM)   0.5 % (w/v) ammonium sulfate 
    2 % (w/v) glucose 
0.065 % (w/v) drop out powder (-his, -ura, -leu),  
0.3 % (v/v) 2 M NaOH 
 
CM is selectively supplemented with 0.01 % (w/v) leucine, 0.003 % (w/v) uracil or 
0.003 %(w/v) histidine. For induction of Pex1/6 protein expression glucose is replaced by 2 % 
(w/v) galactose. 
 
Table 2.8 Yeast strains used in this study. 
  
S. cerevisiae strain Genotype   Source / reference 
WCGa MATa his3-11,15leu2-3, 112 ura3 can GAL 
   (Heinemeyer et al.,   
1994) 
SC2044 
MATa ade2, arg4, leu2-3, 112 trp1-289 
ura3-52; Nas6Tap URA3 
Euroscarf 
Pex1-TEV-ProA + 
His6-pex6WB-TEV-ProA 
MATa his3-11, 15leu2-3, 112 ura3 can GAL, 
[pRS425-PEX1-TEV-ProA],  
[pYES2-His6-PEX6E832Q-TEV-ProA] 
This study 
pex1 WB -His6-TEV-ProA + 
Pex6-TEV-ProA 
MATa his3-11, 15leu2-3, 112 ura3 can GAL, 
[pRS425-PEX1E798Q-His6-TEV-ProA], 
[pYES2-PEX6-TEV-ProA] 
This study 
pex1 WB -His6-TEV-ProA + 
His6-pex6E832Q-TEV-ProA 
MATa his3-11, 15leu2-3, 112 ura3 can GAL, 
[pRS425-PEX1E798Q-His6-TEV-ProA], 
[pYES2-His6-PEX6E832Q-TEV-ProA] 
This study 
Δ188PEX1-His6-TEV-ProA +  
Pex6-TEV-ProA 
MATa his3-11, 15leu2-3, 112 ura3 can GAL, 
[pRS425-ΔN-R189-PEX1-His6-TEV-ProA], 
[pYES2-PEX6-TEV-ProA] 
This study 
BY 4742 MATa; his3D1; leu2D0; lys2D0; ura3D0 Euroscarf 
BY 4742Δpex1 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YKL197c::kanMX4 
Euroscarf 
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S. cerevisiae strain Genotype Source / reference 
BY 4742Δpex6 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4 
Euroscarf 
Δpex1 + Pex1 
MATa; his3D1; leu2D0; lys2D0; 
ura3D0;YKL197c::kanMX4 , 
[pRS316-PEX1] 
This study 
Δpex1 + pex1Y488A 
MATa; his3D1; leu2D0; lys2D0; 
ura3D0;YKL197c::kanMX4 , 
[pRS316-PEX1Y488A] 
This study 
Δpex1 + pex1H495A 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YKL197c::kanMX4, [pRS316-PEX1H495A] 
This study 
Δpex1 + pex1F771A 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YKL197c::kanMX4, [pRS316-PEX1F771A] 
This study 
Δpex1 + pex1 R855K 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YKL197c::kanMX4, [pRS316-PEX1R855K] 
This study 
Δpex1 + pex1 D797N 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YKL197c::kanMX4, [pRS316-PEX1D797N] 
This study 
Δpex6 +Pex6 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316-PEX6] 
This study 
Δpex6 +pex6Y528A 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316-PEX6Y528A] 
This study 
Δpex6 +pex6Y805A 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316-PEX6Y805A] 
This study 
Δpex6 +pex6R607K 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316-PEX6R607K] 
This study 
Δpex6 +pex6R611K 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316 -PEX6R611K] 
This study 
Δpex6 +pex6R892K 
MATa; his3D1; leu2D0; lys2D0; ura3D0; 
YNL329c::kanMX4, [pRS316-PEX6R892K] 
This study 
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2.2 General cloning strategy for Pex1/6 overexpression constructs 
The open reading frame of both, PEX1 and PEX6, are amplified from WCGa genomic DNA 
by PCR. PEX1 oligonucleotides produced HindIII/BamHI endonuclease cutting sites, whereas 
PEX6 primer pairs added KpnI/BamHI restriction sites and free deoxyadenosines (dA) 
overhangs to 3’ termini for subsequent TOPO TA cloning. Moreover, PEX6 is amplified using 
oligonucleotides, which are designed to add a N-terminal hexahistidin (His6-) tag downstream 
of the KpnI recognition site. After digestion with appropriate restriction enzymes, resulting 
PEX1 inserts are ligated into the multiple cloning site of plasmid pRS425-GAL1. PEX6 
fragments are inserted enzyme free into plasmid pCRTopo2.1. Restriction analysis of isolated 
plasmid DNA confirmed correct cloning of PEX1/PEX6 fragments. After restriction digest of 
pCRTopo2.1-PEX6 and pCRTopo2.1-His6-PEX6 using KpnI/BamHI enzymes, resulting 
PEX6 DNA inserts are ligated into the multiple cloning site of pYES2. Correct cloning of 
PEX6 and His6-PEX6 into pYES2 is confirmed by restriction analysis. 
The nucleotide sequence of a tobacco etch virus (TEV) cleavable protein A tag, encoding a 
spacer sequence and a TEV cleavage site followed by two IgG binding domains, is amplified 
from SC2044 genomic DNA containing a TAP (tandem affinity purification, Puig et al., 2001) 
fusion protein using primer pairs listed in Table 2.1. The protein A tag (ProA-) is inserted with 
complementary ends into the BamHI site of pRS425-PEX1 and pYES2-(His6)-PEX6, 
resulting in plasmids named pRS425-PEX1-TEV-ProA, pYES2-PEX6-TEV-ProA and 
pYES2-His6-PEX6-TEV-ProA. Restriction analysis and Sanger sequencing confirmed correct 
cloning of Pex1/Pex6 expression constructs. 
Side-directed mutagenesis PCR using custom primer pairs Pex1-D2-E798Q and Pex6-D2-
E832Q altered double stranded DNA encoding Pex1 and Pex6 Walker B motifs. Self-
complementary primers resulted in base pair exchange and thereof in translational amino acid 
exchange (pex1E798Q and pex6E832Q). Moreover, oligonucleotides introduced specific 
endonuclease recognition sequences for restriction analysis (PvuI and BclI) through nucleotide 
exchange, leaving the amino acid sequence unmodified. pYES2-His6-PEX6-TEV-ProA is 
used as wild type template for side-directed mutagenesis resulting in plasmid named pYES2-
His6-PEX6WB-TEV-ProA (Figure 4.1). Several attempts to introduce mutations in PEX1 
using template plasmid pRS425-PEX1-TEV-ProA failed. Instead, manipulated PEX1 is 
amplified from bacterial expression vector pGEX-4T3-GST-PEX1WB and cloned as 
HindIII/BamHI insert into plasmid pRS425-GAL1.  
The N-terminal truncation mutant ∆188PEX1 is produced by PCR amplification of genomic 
DNA encoding amino acids 189-1043 and ligated via HindIII/BamHI sites into plasmid 
pRS425-GAL1. Correct cloning of PEX1WB and Δ188PEX1 into pRS425-GAL1 is confirmed 
by restriction analysis. Pex1 expression constructs, carrying a mutation in the Walker B motif 
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or the N-terminal truncation, are fused to a C-terminal His6-tag followed by the TEV 
cleavable protein A tag. The affinity tag is obtained by restriction digest of plasmid 
pCRTopo2.1-His6-Spacer-TEV-ProA with BamHI and subsequent ligation into the BamHI 
cutting site downstream of PEX1WB or Δ188PEX1, resulting in expression vectors termed 
pRS425-PEX1WB-His6-TEV-ProA and pRS425-ΔN189-PEX1-His6-TEV-ProA. Restriction 
analysis and Sanger sequencing confirmed correct cloning of Pex1/Pex6 expression 
constructs. 
 
2.3 General cloning strategy for Pex1/6 plasmids used in oleate assays 
Plasmids used in oleate growth assays are generated by PCR amplification of PEX1 and PEX6 
open reading frames from WCGa genomic DNA including upstream native promotor regions 
covering endogenous oleate response elements (ORE, Einerhand et al., 1993). Resulting PCR 
fragments contained 3’ overhangs including SacI/XhoI (pPEX1) and XbaI/KpnI (pPEX6) 
endonuclease recognition sites and free dA tails. After digestion with appropriate restriction 
enzymes, pPEX1/pPEX6 inserts are inserted enzyme free into plasmid pCRTopo2.1. 
Subsequently, reactions are transformed into E. coli Dh5α and ampicillin resistant, single 
colonies are used to inoculate liquid medium supplemented with ampicillin. Restriction 
analysis of isolated, recombinant plasmid DNA confirmed correct cloning of pPEX1/pPEX6 
fragments. After restriction digest of pCRTopo2.1-pPEX1 and pCRTopo2.1-pPEX6 using 
SacI/XhoI and XbaI/KpnI enzymes, resulting DNA inserts are ligated into the multiple cloning 
site of plasmid pRS316. 
Side-directed mutagenesis PCR using custom primer pairs listed in Table 2.2 altered double 
stranded DNA encoding Pex1 and Pex6 pore loop or arginine finger residues. Self-
complementary primers resulted in base pair exchange and thereof in translational amino acid 
exchange (pex1Y488A, pex1H495A, pex1F771A, pex1D797N, pex6Y528A, pex6Y805A, pex1R855K, 
pex6R607K, pex6R611K, pex6R892K). Moreover, oligonucleotides introduced specific endonuclease 
recognition sequences for restriction analysis through nucleotide exchange, leaving the protein 
primary structure unmodified. Restriction analysis and Sanger sequencing confirmed correct 
cloning of Pex1/Pex6 constructs used for oleate growth assays. 
2.4 Molecular biological techniques 
Phusion Hot Start II High-Fidelity DNA polymerase (New England Biolabs, NEB Frankfurt) 
is used for PCR amplification of PEX1/PEX6 genes from genomic or plasmid DNA, while Pfu 
DNA polymerase (Fischer Scientific GmbH, Schwerte) is used for DNA manipulation by side-
directed mutagenesis. Restriction endonucleases and enzymes are purchased from either NEB 
or Fermentas (Fischer Scientific GmbH, Schwerte).  
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2.4.1 DNA amplification by polymerase chain reaction (PCR) 
DNA amplification from genomic or plasmid DNA is performed in a volume of 50 µl using 
primers listed in Table 2.1-2.2 and the thermocycler (Biometra T1 Thermocycler Analytik 
Jena AG, Jena) protocol shown in Table 2.9. 
 
PCR reaction:  1 µl yeast chromosomal DNA or 1 µl (1:10 dilution) plasmid DNA  
10 µl 5x High Fidelity buffer (+ MgCl2)  
1 µl [25 µM] forward primer 
1 µl [25 µM] reverse primer 
1 µl [10 mM] dNTPs 
0.5 µl [2U] Phusion Hot Start II High-Fidelity DNA polymerase  
total volume 50 µl 
 
Table 2.9 Thermocycler protocol for DNA amplification by PCR. 
 
Temperature (°C) Time (s) Cycles  
95 60 1 
95 30  
45-55 30 30 
72 30s/ 1kb  
72 300 1 
4 ∞ 1 
 
2.4.2 DNA manipulation by side-directed mutagenesis 
Point mutations are introduced in the open reading frame of PEX1/PEX6 by side-directed 
mutagenesis PCR. Primers are self-complementary containing the desired mutation and an 
endonuclease recognition site (Table 2.2-2.3). PCR reaction is performed in a volume of 50 µl 
with the thermocycler protocol listed in Table 2.10. 
 
PCR reaction:  0.5 µl plasmid DNA  
5 µl 10x Pfu buffer (+ MgCl2)  
1 µl [25 µM] forward primer 
1 µl [25 µM] reverse primer 
0.5 µl [10 mM] dNTPs 
1 µl [2.5 U] Pfu DNA Polymerase  
total volume 50 µl 
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Table 2.10 Thermocycler protocol for side directed mutagenesis 
 
Temperature (°C) Time (s) Cycles  
95 30 1 
95 30  
45-55 60 18 
68 120s/ 1kb  
68 60 1 
4 ∞ 1 
 
2 µl DpnI are added to 30 µl PCR reaction an incubated over night at 37°C to degrade 
methylated template DNA. 10 µl of DpnI treated and 10 µl of untreated PCR reaction are 
transformed into 50 µl E. coli Dh5α cells. Restriction analysis and Sanger sequencing (GATC 
Biotech GmbH, Konstanz) confirmed introduction of point mutations. 
2.4.3 Purification of plasmid DNA and DNA fragments 
Plasmid DNA is amplified by growth of E. coli Dh5α in 3 ml LB medium supplemented with 
appropriate antibiotics for 16 h with gentle shaking (Sambrook et al., 1989) in a sterile capped 
glass tube. Plasmid DNA is purified via selective adsorption to silica membranes using the 
QIAprep Spin Miniprep kit (QIAGEN, Hilden) according to manufacturer’s instructions. For 
purification and isolation of DNA fragments after separation through agarose gel 
electrophoresis the NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel, Düren) is used 
according to manufacturer’s instructions. 
2.4.4 Restriction enzyme digestion 
For restriction analysis, 3 µl purified plasmid DNA are cleaved in a volume of 20 µl using 2.5-
10 U restriction enzyme according to manufacturer’s instructions for 2 h at 37°C. In double 
digest reactions, DNA molecules are incubated with the first restriction enzyme for 2 h at 
37°C followed by addition of the second restriction endonuclease and further incubation for 
2 h at 37°C. DNA fragments amplified via PCR or isolated plasmid vector DNA for 
downstream cloning procedures are cleaved in a volume of 300 µl using 80 U restriction 
endonuclease over night at 37°C. Linearized vector DNA and complementary DNA insert are 
subsequently separated by agarose gel electrophoresis and isolated using the NucleoSpin® Gel 
and PCR Clean-up kit (Macherey-Nagel, Düren). 
2.4.5 Dephosphorylation 
To prevent self-ligation, phosphate groups at the 5’ overhang of nonattached vector DNA are 
removed through treatment with Antarctic Phosphatase (NEB). 25 µl vector DNA are 
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incubated with 5 U of Antarctic Phosphatase in a volume of 50 µl for 30 minutes at 37°C 
according to manufacturer’s instructions. The enzyme is inactivated by incubation for 
15 minutes at 65°C and 4 µl of the reaction are visualized by agarose gel electrophoresis. 
2.4.6 Ligation 
Complementary ends of DNA fragments and linearized (dephosphorylated) vector DNA are 
ligated in a molar ratio of 1 : 3. The reaction is performed in a volume of 20 µl in the presence 
of 400 U T4 DNA ligase (NEB). After incubation for 30 minutes at RT, 5 µl reaction are 
transformed in 50 µl E. coli Dh5α cells. Restriction analysis and Sanger sequencing (GATC 
Biotech GmbH, Konstanz) confirmed successful cloning. 
2.4.7 TOPO TA Cloning® 
PEX1/PEX6 destined for TOPO TA Cloning® are amplified via PCR using oligonucleotides 
that produce 3’ end deoxyadenosines (dA) of DNA inserts Table 2.1). Fresh PCR products are 
mixed with plasmid vector pCR®2.1–TOPO® which provides a complementary 
deoxythymidine (dT) tail for enzyme free cloning. TOPO® cloning reactions are performed 
using the TOPO TA Cloning® kit (Invitrogen, Karlsruhe) according to manufacturer’s 
instructions. Restriction analysis confirmed successful cloning. 
2.4.8 Agarose gel electrophoresis  
The separation of DNA molecules for sizing and comparative quantification is performed on 
0.8 % agarose gels using a horizontal electrophoresis system (peqlab PerfectBlue Gel System 
Mini M). The appropriate amount of agarose is diluted in 70 ml 1x TBE running buffer 
(90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH 8.0), microwaved until the agarose is fully 
melted and supplemented with Stain G in a ratio 1 : 70,000 (Serva, Heidelberg). DNA samples 
and 0.5 µg DNA ladder (GeneRuler DNA Ladder Mix) are mixed with 5x gel loading dye 
(90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH 8.0; 50 % (v/v) glycerol, 0.25 % (w/v) 
bromphenol blue) and separated by electrophoresis for 1 h at 100 V. Through binding of free 
DNA molecules, Stain G emits green fluorescent light when exposed to UV light. Emitted 
signals are detected using a SafeLab Imager gel documentation system (Intas, Göttingen) 
thereby visualizing DNA fragments on the agarose gel.  
2.4.9 Transformation of RuCl competent E. coli cells  
For transformation of competent E. coli cells, appropriate amount of plasmid DNA (see 
sections 3.2.3 and 3.2.7) is added to 50 µl E. coli Dh5α. After incubation on ice for 15 
minutes, cells are heat shocked at 42°C for 2 minutes and subsequently chilled on ice for 2 
minutes. Cells are supplemented with 450 µl LB medium and incubated for 1 h at 37°C with 
shaking before plated on selective LB agar plates and incubated at 37°C over night. For 
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further analysis, a single colony of transformants is used to inoculate liquid LB medium.  
2.4.10 Transformation of S. cerevisiae by electroporation 
Recombinant plasmid DNA is introduced into yeast cells by electroporation. 50 ml liquid 
YPD medium are inoculated with desired yeast strain and grown for 14 h at 28°C with shaking 
(120 rpm) until log phase (OD600 = 1.3-1.5, determined using a WPA CO8000 Cell density 
meter, Biochrom Ltd., Cambridge UK) in a sterile 100 ml Erlenmeyer flask. The culture is 
harvested by centrifugation for 5 minutes at 3000 rpm (3463 x g), 4°C in a sterile 50 ml tube. 
Subsequently, cells are resuspended in 10 ml cold sterile water and pelleted for 5 minutes at 
3000 rpm (3463 x g), 4°C. The cell pellet is resuspended in 10 ml cold 1 M sorbitol. After a 
further centrifugation step, cells are transferred in 1 ml cold sorbitol (1 M) into a pre-chilled, 
sterile 1.5 ml microcentrifuge tube and pelleted for 2 minutes at 6000 rpm (8452 x g), 4°C. 
Next, the cell pellet is resuspended in an equal volume of cold sorbitol (1 M). 1 µl 
recombinant plasmid DNA (Table 2.5 and Table 2.6) is added to 40 µl of resuspended cells in 
a pre-cooled electroporation cuvette (2 mm electrode distance, Gene Pulser Cuvette, Bio-Rad 
Laboratories GmbH, München) and incubated for 5 minutes on ice. Electroporation is carried 
out using a Bio-Rad Gene Pulser (1500 V, 25 µF, 200 Ω, t = 4.6-4.7 µsec). Cells are recovered 
by adding 1 ml cold 1 M sorbitol to the cuvette. The cell suspension is transferred to a pre-
chilled, sterile 1.5 ml microcentrifuge tube and pelleted for 2 minutes at 10000 rpm 
(14086 x g), 4°C. The pellet is resuspended in 50 µl 1 M sorbitol, spread onto agar plates 
supplemented with appropriate amino acids and incubated at 28°C for 3 days. 
2.4.11 Extraction and purification of genomic or plasmid DNA from S. cerevisiae 
For recovery of plasmid DNA from yeast or preparation of yeast genomic DNA, a single 
colony of transformants (see section 2.4.10) or desired strain (Table 2.8) is used to inoculate 
5 ml YPD liquid medium in a sterile capped glass tube. Yeast cells are grown over night at 
28°C to stationary phase while shaking (120 rpm). 3 ml overnight culture are pelleted 5 
minutes at 5000 rpm (2372 x g) at RT in a sterile microcentrifuge tube. The cell pellet is 
resuspended in 250 µl Buffer P1 (component of the QIAprep Spin Miniprep kit, QIAGEN, 
Hilden) and 100 µl sterile glass beads (0.25-0.5 mm diameter, Carl Roth GmbH, Kalrsuhe) are 
added. Yeast cells are disrupted by vortexing at highest speed 7 times for 1 minute with a 1-
minute break on ice between each run. Resulting cell lysate is transferred into a fresh 1.5 ml 
microcentrifuge tube. Further steps are carried out using buffers and silica columns included 
in the QIAprep Spin Miniprep kit (QIAGEN, Hilden). The cell lysate is mixed with buffer P2 
and inverted 4-6 times. After addition of buffer N3, tubes are inverted 10 times and 
subsequently spun 12 minutes at 13000 rpm (16060 x g) at RT. The supernatant is transferred 
to a spin column and spun for 1 minute at 13000 rpm (16060 x g) at RT. Resulting flow-
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through is discarded and spin column is washed using 750 µl PE Buffer and spun for 2 
minutes at 13000 rpm (16060 x g) at RT. After discarding the flow-through, the column is 
centrifuged for 3 minutes at 13000 rpm (16060 x g) at RT. The spin column is placed in fresh 
microcentrifuge tube and bound plasmid DNA is eluted by adding 50 µl EB buffer and 
subsequent centrifugation for 2 minutes at 13000 rpm (16060 x g) at RT. Genomic DNA is 
stored at -20°C.  
To recover plasmid DNA, 50 µl competent E. coli Dh5α cells are transformed with 5 µl 
recovered vector DNA as described in 2.4.9. For further analysis, a single colony of E. coli 
transformants is used to inoculate liquid LB medium. 
2.4.12 Frozen stocks for long-term storage 
Yeast strains are stored as glycerol stocks in 2 ml screwcap vials at -80°C. 1 ml of a late-log or 
early-stationary phase culture is mixed with 400 µl sterile 80 % glycerol and stored at -80°C.  
2.5 Protein biochemistry 
2.5.1 Overexpression of heterologous Pex proteins in S. cerevisiae  
2.5.1.1 Protein test expression  
Pex1 and Pex6 recombinant proteins are overexpressed in S. cerevisiae from 2 µ plasmids 
pRS425-GAL1 or pYES2, fused to the GAL1 promotor. To assay the expression of 
recombinant Pex1/Pex6 proteins, a time course experiment is performed. S. cerevisiae cells, 
co-transformed with pRS425-Pex1 and pYES-Pex6 overexpression constructs (Table 2.5), are 
grown in 30 ml CM medium lacking amino acid leucine and nucleobase uracil (CM –leu –ura) 
overnight at 28°C with shaking (130 rpm, GFL 3005). Next, 15 ml overnight culture are 
pelleted 3 minutes at 3000 rpm (3463 x g) in a sterile 15 ml tube and washed 2-3 times with 
10 ml sterile water. Expression of recombinant Pex1/6 proteins is induced by resuspending the 
cells in 15 ml CM -leu -ura containing 2 % and incubated at 28°C with modest shaking 
(130 rpm). After indicated time points, up to 1 x 109 cells ml-1 are harvested by centrifugation 
for 3 minutes at 13000 rpm (16060 x g) and stored at -20°C. For subsequent Western blot 
analysis (2.5.11), proteins are precipitated as described in 2.5.2 and subjected to SDS-PAGE 
2.5.9).  
To further optimize Pex1/6 overproduction for preparative large-scale purification, protein 
expression is induced from yeast cultures with varying optical densities as indicated for 16 h at 
28°C with modest shaking (130 rpm). Subsequently, 1 OD600 cells (~ 3 x 107 cells ml-1) are 
harvested by centrifugation for 3 minutes at 13 000 rpm (16060 x g) and stored at -20°C. 
Proteins are precipitated as described in 2.5.2, resuspended in 40 µl 1x Laemmli buffer (4 % 
(v/v) 50 mM Tris-HCl pH 6.8, 5 % (v/v) glycerol, 0.4 % (w/v) SDS, 0.775 % (w/v) DTT, 
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0.004 % (w/v) bromophenol blue) and 20 µl are subjected to SDS-PAGE (see section 2.5.9) 
and Western blot (see section 2.5.11). 
2.5.1.2 Protein expression for purification 
Pre-cultures for preparative Pex1/6 overproduction are grown in 100 ml CM -leu -ura for 48 h 
at 28°C while shaking (130 rpm) in a sterile 300 ml Erlenmeyer flask. The pre-culture is used 
to inoculate 4 liters of fresh YPD medium (in two sterile 5 L Erlenmeyer flasks) to an OD600 = 
0.5 and cells are allowed to grow to mid-log phase (OD600 = 3.0). Subsequently, cells are 
harvested by centrifugation for 10 minutes at 4000 rpm (3.501 x g), 4°C, using a SLC–6000 
rotor (Sorvall RC Evolution centrifuge, Thermo Fisher Scientific, Inc., Waltham (MA), USA) 
and washed 3 times with 25 ml sterile water. Protein expression is induced by resuspending 
cell pellets in 4 L CM -leu -ura medium containing 2 % galactose (in two sterile 5 L 
Erlenmeyer flasks) for 16 h at 28°C with shaking (130 rpm). Cells are pelleted (SLC-6000, 
10 minutes at 3.501 x g, 4°C) and washed with 25 ml cold water. Cell pellets (approximately 
2 x 10 g wet weight) are flash frozen in liquid nitrogen and stored at -80°C. 
2.5.2 Yeast cell lysis and protein precipitation according to Yaffe and Schatz, 1984 
For analysis of protein expression in total yeast cell extracts, S. cerevisiae cell pellets (up to 
1 x 109 cells ml-1) are resuspended in 1 ml dH2O, supplemented with 160 µl 1.85 M NaOH and 
85 µl 2-mercaptoethanol and incubated for 10 minutes on ice. Next, disrupted cells are mixed 
with 160 µl 50 % trichloroacetic acid and incubated for 10 minutes on ice. Precipitated 
samples are pelleted by centrifugation at 13000 rpm (16016 x g) for 3 minutes, 4°C and 
washed with 500 µl ice-cold acetone (3 minutes at 16016 x g, 4°C). Resulting pellets are air – 
dried for 10-15 minutes and if not stated otherwise, resuspended in 150 µl 1 x Laemmli buffer 
and 15 or 20 µl are subjected to SDS-PAGE (see section 2.5.9) and Western blot (see section 
2.5.11). 
2.5.3 Mechanical yeast cell disruption using a bead beater  
Unless stated otherwise, all protein purification procedures are carried out at 4°C with pre-
cooled equipment. For affinity purification of native Pex1/6 complexes, harvested cells are 
mechanically disrupted using a Fastprep24 bench top homogenizer (MP Biomedicals, Santa 
Ana, (CA) USA). To this end, cell pellets (~10 g wet weight each) are thawed on ice and each 
pellet is resuspended 1:1 in Buffer A (20 mM HEPES pH 7.5, 100 mM NaCl, 10 mM MgCl2, 
10% glycerol, 2mM ATP, 0.5 mM DTT) containing 20U DNaseI, 1 mM PMSF, one complete 
EDTA-free mini protease inhibitor cocktail tablet. After adding 25 ml glass beads (0.25-
0.5 mm diameter, Carl Roth GmbH, Kalrsuhe) to 20 ml cell suspension, cells are disrupted at 
6.5 M/s for 30 s at RT. Runs are repeated 8-10 times, thereby cooling the samples between 
each run for 5 minutes on ice. Examining the samples using a light microscope monitored 
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lysis efficiency. Cell lysate is recovered by centrifugation for 3 minutes at 1000 rpm (219 x g), 
4°C, through pricked holes at the bottom of the 50 ml tube into a fresh tube.  
2.5.4 Equilibration of IgG Sepharose beads 
250-300 µl IgG Sepharose 6 Fast flow beads (GE Healthcare Bio-Sciences AB, Uppsala, 
Sweden) are equilibrated in an Econo-Pac chromatography column (Bio-Rad Laboratories 
GmbH, München) with 15 column volumes (= equivalent to volume of packed bed) TST 
buffer (10 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.05 % (v/v) Tween-20), 30 column volumes 
0.5 M HAc pH 3.4 and 15 column volumes buffer B (20 mM HEPES pH 7.5, 100 mM NaCl, 
10 mM MgCl2, 10 % (v/v) glycerol). After affinity purification and TEV cleavage, IgG beads 
are regenerated through washing with 10 column volumes 0.5 M HAc pH 3.4 and 30 column 
volumes TST buffer. IgG beads are stored at 4°C and reused up to three times. 
2.5.5 Immunopurification of Pex1/6 protein A fusion proteins from S. cerevisiae 
After mechanical cell disruption, cell lysate is cleared by centrifugation using a SS-34 rotor 
(Sorvall RC Evolution centrifuge, Thermo Fisher) for 30 minutes at 15000 rpm (25099 x g), 
4°C. The supernatant is repeatedly applied (3 times) on equilibrated IgG Sepharose beads  
2.5.4). Subsequently, the beads are washed with 15 column volumes buffer A, 15 column 
volumes Buffer A containing 500 mM NaCl followed by 15 column volumes Buffer A. TEV 
cleavage of immobilized proteins is performed for 1h 20 min at 20°C in 3 column volumes 
buffer A. Liberated Pex1/6 complexes are eluted by gravity flow and IgG beads are washed 
with 2 x 3 column volumes Buffer A to recover remaining complexes from the matrix. Pex1/6 
containing fractions are pooled and subjected to analytical ultracentrifugation (see section 
2.5.6) 
2.5.6 Glycerol density gradient centrifugation 
600 µl-1200 µl of eluted Pex1/6 complexes are separated from contaminants and TEV 
protease by centrifugation through a 10%-40 % glycerol gradient in Buffer A without glycerol 
or through a 20 %-50 % glycerol gradient in Buffer A, respectively. Proteins and molecular 
complexes migrated through centrifugation in a SW40 rotor (Beckman Coulter, Inc., Pasadena 
(CA), USA) at 40000 rpm for 16 h, 4°C. Gradients are formed in 14 x 95 mm poly clear 
centrifuge tubes (Seton Scientific, Petaluma, CA, US) using a BioComp Gradient Station 
(BioComp Instruments, Inc., Fredericton, NB, Canada). Separated proteins are fractionated 
(600 µl), 50-100 µl precipitated as described in 2.5.8, and analysed by SDS-PAGE or Western 
blot (see sections 2.5.9 or 2.5.11).  
2.5.7 Protein concentration and buffer exchange 
Concentration and buffer exchange of purified Pex1/Pex6WBATP complexes obtained after 
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glycerol density gradient centrifugation is performed using Amicon Ultra Centrifugal Filters 
(0.5 ml, 50 K MWCO, Millipore GmbH, Schwalbach). 300 µl protein complexes are 
concentrated by centrifugation (5 minutes, 8452 x g, 4°C) to a final volume of 100 µl. In order 
to reduce the amount of glycerol, concentrated samples are washed three times with 100 µl 
buffer A containing 10 % glycerol and three times with 100 µl buffer A containing 5 % 
glycerol. 
2.5.8 Protein TCA precipitation 
Pex1/6 protein samples are mixed with 100 µl 0.15 % (w/v) sodium desoxycholate and 100 µl 
72 % (w/v) trichloroacetic acid (TCA) and incubated for 15 minutes at RT. Precipitated 
proteins are pelleted by centrifugation for 10 minutes at 13000 rpm (16060 x g) at 4°C. Protein 
pellets are washed with 500 µl ice-cold acetone and spun down (5 minutes, 16060 x g, 4°C). 
The protein pellets are air-dried, dissolved in 1 x Laemmli buffer and analyzed by SDS-PAGE 
or Western Blot (see sections 2.5.9 or 2.5.11). 
2.5.9 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Analytical separation of proteins within an electrical current according to their molecular 
weight is performed using discontinuous SDS-PAGE (Laemmli, 1970). SDS-polyacrylamide 
gels are prepared as described in Table 2.11.  
 
Table 2.11 Preparation of SDS-polyacrylamide gels (results in 2 gels) 
 
Resolving gel 
solution 12 % 10 % 7.5 % 
Stacking gel 
solution  
H2O 3.5 ml 4 ml 4.85 ml dH2O 3.05 ml 
1.5 M Tris-HCl 
 pH 8.8 2.5 ml 2.5 ml 2.5 ml 
0.5 M Tris-HCl 
pH 6.8 1.25 ml 
10 % SDS 100 µl 100 µl 100 µl 10 % SDS 50 µl 
30 % acrylamide 4 ml 3.3 ml 2.5 ml 30 % acrylamide 0.65 ml 
10 % APS 100 µl 100 µl 100 µl 10 % APS 25 µl 
TEMED 10 µl 10 µl 10 µl TEMED 5 µl 
 
The resolving gel is covered with 50 % isopropanol while the gel matrix polymerizes. 
Stacking and resolving gels are allowed to polymerize 30 minutes before electrophoresis. 
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Protein samples are mixed with either 4 x Laemmli buffer (16 % (v/v) 200 mM Tris-HCl 
pH 6.8, 20 % (v/v) glycerol, 1.6 % (w/v) SDS, 3.1 % (w/v) DTT, 0.016 % (w/v) bromophenol 
blue) or resuspended in 1 x Laemmli buffer, boiled for 5-10 minutes at 95°C, followed by a 
quick spin-down at 13000 rpm (16100 x g) for 25 s. Roti-Mark Standard (Carl Roth GmbH + 
Co. KG, Karlsruhe) and PageRuler Unstained Protein Ladder (Fischer Scientific GmbH, 
Schwerte) are used as protein molecular weight markers. The electrophoretic run is carried out 
using a Mini-Protean Tetra Cell system (Bio-Rad Laboratories GmbH, München) in the 
presence of 1x SDS–PAGE running buffer (25 mM Tris-HCl, 200 mM glycin, 0.1% (w/v) 
SDS) at 200 V for 55-75 minutes. 
2.5.10 Coomassie blue staining of SDS-polyacrylamide gels 
Coomassie Brilliant Blue integrates with nonpolar, cationic and hydrophobic amino acids of 
polypeptide side chains. Coomassie blue staining was used to visualize protein bands in SDS-
polyacrylamide gels. For this purpose, protein bands are fixed and stained within the gel 
matrix by boiling the gel for 5 s in Coomassie solution (0.1 % (w/v) Coomassie R250, 10 % 
(v/v) acetic acid, 40 % (v/v) methanol) followed by 10 minutes incubation at RT, gently 
shaking. Subsequent incubation for 1 h in destain solution (45 % (v/v) methanol, 10 % acetic 
acid) removed background staining.  
For protein identification, the SDS-polyacrylamide gels are stained with Coomassie Blue (see 
sections 2.5.10) and subsequent mass spectrometry was carried out by Thomas Fröhlich in the 
laboratory for functional gene analysis (LAFUGA, Gene Center Munich). 
2.5.11 Western blot (semi-dry) 
Western blot allows electrophoretic transfer of proteins from SDS-polyacrylamide gels to a 
(nitrocellulose) membrane and subsequent immunodetection of specific proteins (Towbin et 
al., 1979). For this purpose, nitrocellulose membrane (0.45 µm pore size, Whatman, GE 
Healthcare) and filter papers are soaked quickly in blotting buffer (5 % (v/v) 10 x SDS 
running buffer [250 mM Tris, 2 M glycine], 20 %(v/v) methanol, 0.25 % (v/v) 20 % SDS). 
The SDS-polyacrylamide gel is placed on top of the nitrocellulose membrane and sandwiched 
between two pieces of filter paper on each side. Protein transfer is carried out at 400 mA and 
30 V for 90 minutes using a semi-dry electroblotter (PEQLAB Biotechnologie GmbH, 
Erlangen). Transfer efficiency is verified by amido black staining of the nitrocellulose 
membrane. For this purpose, the membrane is soaked in 45 ml dH2O mixed with 5 ml amido 
black staining solution (0.1 % (w/v) amido black, 40 % methanol, 10 % acetic acid) for 
5 minutes at RT. For immunodetection, the membrane is washed thoroughly with dH2O and 
blocked with 5 % (w/v) skim milk powder in dH2O for 30 min at RT to avoid unspecific 
antibody binding. In order to detect His6 tagged proteins, the primary antibody (α-His 
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antibody from mouse, unconjugated, Dianova GmbH, Hamburg) is directly added to the 
blocking solution (1:1000 (v/v)) and incubated over night at 4°C with gentle shaking. Next, 
the membrane is washed three times with 10 ml TST buffer (50 mM Tris-HCl pH 7.4, 150 
mM NaCl, 0.1 % (v/v) Tween 20) for 10 minutes at RT and subsequently incubated with the 
HRP-conjugated secondary α-mouse antibody (from rabbit, Dianova GmbH, Hamburg) 
1:10000 (v/v) in 5 % (w/v) skim milk powder solution for 2 h at RT, gently shaking. Last, the 
membrane is washed three times with TST buffer for 10 minutes at RT and quickly rinsed 
with water. To detect HRP-conjugates the membrane is incubated for 1 minute in 10 ml ECL 
solution containing equal parts of solution A (100 mM Tris HCl pH 8.5, 90 mM coumaric 
acid, 250 mM luminol) and solution B (100 mM Tris HCl pH 8.5, 0.03 % H2O2). Emitted 
signals are detected on a X-ray film (Amersham Hyperfilm TM ECL, GE Healthcare, Little 
Chalfont, UK) and developed with an Optimax X-RAY Film Processor. 
2.6 Oleate growth assays 
Complementation assays are performed as described in (Birschmann et al., 2005) with minor 
modifications as follows. S. cerevisiae cells expressing wild type, no or mutant Pex1 and Pex6 
alleles (Table 2.8) are grown in 3 ml YPD in sterile capped glass tubes at 28°C for 16 h with 
shaking (120 rpm). Next, the optical density (OD600) of yeast cultures is determined. 
Subsequently, 1 ml cells are pelleted by centrifugation at 5000 rpm (2372 x g) for 5 minutes at 
RT and washed with sterile water (5 minutes, 2372 x g, RT). Cell pellets are resuspended in 
1 ml sterile water and a 10-fold serial dilution starting with 2 x 104 cells are spotted on agar 
plates containing 0.67 % (w/v) yeast nitrogen base (without ammonium sulfate and without 
amino acids), 0.2 % (v/v) oleic acid, 0.5 % Tween 20 (v/v), 0.3 % (w/v) yeast extract, 0.5 % 
(w/v) ammonium sulfate and suitable amino acids, adjusted to pH 6. Control plates include 
0.2 % glucose instead of oleic acid. Oleate plates are incubated for 5-6 days and control plates 
for 3 days at 28°C.  
2.7 Electron microscopy (EM) techniques and single particle analysis 
2.7.1 Plasma cleaning of EM grids 
Initially hydrophilic, carbon support films become gradually hydrophobic over time. 
Therefore, carbon coated EM grids are glow discharged prior to use allowing aqueous 
solutions to spread evenly onto the carbon film (Dubochet et al., 1971). Carbon coated copper 
grids are glow discharged at pressure level of 2.2 x 10-1 Torr using a plasma cleaner (Harrick 
Plasma, Ithaca NY, USA). 400 Cu mesh continuous carbon grids (Quantifoil Micro Tools 
GmbH, Jena) for negative stain EM are treated with a plasma cleaner for 45 seconds. 
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2.7.2 Negative staining of purified Pex1/6 protein complexes 
Standardized negative staining procedure was established by Brenner and Horne (Brenner and 
Horne, 1959), using solutions of soluble heavy metal salts, which form an amorphous stain 
around the biological sample examined. 
Wild type Pex1/6 complexes, purified from E. coli (~ 50 µg ml-1, kindly provided by Dr. 
D. Saffian and I. Grimm in collaboration with Prof. Ralf Erdmann’s lab, Ruhr-Universität 
Bochum) are incubated with ATPγS (2.5 mM) or ATP (5 mM) and Pex1GST/Pex6 complexes 
with ADP (5 mM) in 20 mM Tris-HCl pH 7.5, 20 mM NaCl, 10 mM MgCl2. To prepare the 
ADP-AlFx state, 2 mM AlCl3 and 8 mM NaF were added to purified wild type Pex1/6 
complexes diluted to concentrations stated above in 20 mM HEPES pH 7.5, 50 mM NaCl, 2 
mM MgCl2 and 2mM ADP (Chang et al., 2012). 3.5 µl protein solution are applied on glow 
discharged 400 Cu mesh continuous carbon grids (Quantifoil Micro Tools GmbH, Jena) and 
incubated for 45 seconds. After draining of excessive sample solution, proteins are stained 
twice with 2% (w/v) uranyl acetate (Ted Pella, Inc., Redding CA, USA) for 15 seconds, 
redrained and immediately air-dried. Mutant Pex1/6 complexes Pex1WBATP/6, Pex1/6WBATP, 
Pex1/6DWBATP, separated by density gradient centrifugation, are stained on successive drops 
of uranyl acetate. Grids are incubated for ~10 s on each drop of uranyl acetate and blotted to 
near dryness, according to (Lander et al., 2012). Separated Δ188Pex1/Pex6 complexes are 
incubated with ATPγS (2.5 mM) and stained accordingly.  
2.7.3 Acquisition of electron microscopy images 
For initial characterization of the presence, size and shape of negatively stained Pex1/6 
complexes, single images are recorded on a FEI Morgagni electron microscope operated at 
80 keV (FEI, Hillsboro OR, USA) equipped with a SIS Megaview 1K CCD camera using a 
nominal magnification of 60,000 x. Images for three-dimensional (3D) reconstructions are 
recorded using a Tecnai G2 Spirit transmission electron microscope, operating at 120 keV 
equipped with a 2048 x 2048 pixel CCD camera (FEI, Hillsboro OR, USA) under low-dose 
conditions (~18 e-/Å2). The micrographs are taken at a nominal magnification of 103,448 x 
and sampled at 2.9 Å per pixel at the specimen level. Defoci range from 350-1000 nm. 
2.7.4 Image pre-processing and particle selection of negative stain images 
The defocus and astigmatism of micrographs are determined using CTFFIND3 (Mindell and 
Grigorieff, 2003). Raw micrographs with more than 10 % astigmatism or uneven stain are 
excluded from further image processing procedures. CTF correction is done in SPIDER 
(Frank et al., 1996; Shaikh et al., 2008) through flipping the phases of negative CTF lobes of 
full electron images.  
A total of 3895 (ATPγS), 2948 (ATP), 1488 (ADP), 2394 (ADP-AlFx), 2064 (Pex1WB/6ATP), 
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2048 (Pex1/6WBATP), 2073 (Pex1/6DWBATP) and 400 (Δ188Pex1/6ATPγS) particles are 
manually selected using the MRC program Ximdisp (Crowther et al., 1996) or semi-
automatically using FindEM (Roseman, 2004), for which class averages with distinct views of 
primary picked particles serve as template. Selected particles are extracted using a box size of 
160 pixels. For initial single particle analysis of Pex1/6ATPγS a box size of 128 pixels was used. 
2.7.5 Multivariate statistical analysis (MSA) classification and multi-reference 
alignment of negatively stained single particles 
Initial analysis of Pex1/6 single particles is done in IMAGIC-5 (van Heel et al., 1996). Each 
datasets is normalized, masked and frequencies of single particles are band-pass filtered 
between 200 and 10 Å. Next, Pex1/6 particles are centered by iterative translational 
alignments to their rotationally averaged sum. Resulting class averages, containing 5-10 
images, serve as references to further group particles with distinct features based on 
multivariate statistical analysis (MSA) followed by multi-reference alignment (MRA). Three 
to seven rounds of MSA and MRA classification generate homogeneous classes, showing 
related in plane but diverse out of plane orientations. 
2.7.6 Determination of Euler angles (angular reconstitution)  
Initial 3D reconstructions are created in IMAGIC-5 by angular reconstitution imposing 3-fold 
symmetry. To this end, Euler angles are assigned to a range of 2D projections showing distinct 
views, which are classified and averaged by MSA and MRA, see section 2.7.5). The common 
line approach in IMAGIC-5 allows to define orientational relationships between those class 
averages and thereof the calculation of an initial 3D EM density map. This 3D reconstruction 
is re-projected in Euler-angle directions and visual analogy between re-projections and input 
2D projections serves as measure of the quality of the initial 3D model obtained. 
2.7.7 Iterative refinement by projection matching 
Low-resolution 3D reconstructions, obtained from angular reconstitution (2.7.6), are used as a 
reference for projection matching in SPIDER. Euler angles, rotation and shift parameters of 
negatively stained Pex1/6 particle images are refined iteratively. For each round, a stack of 
references projections is created according to α (psi) = 90°, β (theta) = 0-180° and γ (phi) = 0-
120 (operation ‘PF 3Q’) and aligned to Pex1/6 datasets (operation ‘AP SH’), thereby 
decreasing the angular step size of eulerian angle β from 8° to 4°. For asymmetric Pex1/6 3D 
reconstructions, Euler angle γ ranged from 0-360°. Defined Euler angles and parameters for 
translational and rotational cross correlation of Pex1/6 particles are stored separately and ~70 - 
80 % of best-matched Pex1/6 projections are included in reconstruction of 3D volumes 
imposing 3-fold symmetry (operation ‘BP RP’). Single-particle reconstructions are loosely 
masked in IMAGIC-5 before they are subjected to new rounds of projection matching. After 6 
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to 14 rounds, ~ 90% of Euler angles are stable and aligned Pex1/6 particles are averaged and 
classified by MSA and MRA (2.7.5). Final 3D reconstructions are re-projected in Euler-angle 
directions and visual analogy between re-projections and class averages of aligned Pex1/6 
projections serves as measure of the quality of the final 3D model obtained.  
2.7.8 Resolution assessment: Fourier Shell Correlation (FSC) 
To determine the resolution of final Pex1/6 3D reconstructions in SPIDER, each input dataset 
is split in two independent sets of Pex1/6 particles to calculate two separate 3D 
reconstructions (operation ‘RF 3’). The two half-reconstructions are compared and the 
correlation of every spherical shell at each frequency is calculated over the whole spectrum in 
Fourier Space and the final resolution estimated using 0.5 as correlation cut off.  
2.8 Protein sequence analysis 
2.8.1 Multiple sequence alignment  
To highlight sequence homology between protein sequences, multiple primary sequences are 
aligned using the ClustalW algorithm (Larkin et al., 2007; Goujon et al., 2010). Output files 
are visualized and edited using Jalview 2.7 (Waterhouse et al., 2009). 
2.8.2 Protein homology structure prediction 
Pex1 and Pex6 D1/D2 homology models are created using the HHpred server (Soding et al., 
2005) followed by model building using MODELLER (Sali and Blundell, 1993) based on 
known p97 crystal structures (pdb-ID: 3CF2, 3CF0, 3HU3). 
2.8.3 Atomic structure fitting 
The hexameric p97 crystal structure (pdb-ID: 3CF3) is automatically fitted using ‘Fit in Map’, 
implemented in the USCF Chimera package (Pettersen et al., 2004). Homology models of 
Pex1 and Pex6 D1/D2 AAA+ domains are automatically fitted into the Pex1/6ATPγS EM 
density map and optimized based on the best cross-correlation using ‘Fit in Map’. Testing 
several starting positions resulted in the same local optima of the models in the EM density 
map, indicating only one local minimum for each fit. Fitted Pex1/Pex6 D1 or D2 domains are 
symmetrized using ‘pdbsymm’ in Situs (Wriggers, 2010). All EM reconstructions are aligned 
to the ATPγS bound map in Chimera. Map segmentation is done using Chimera. All figures 
are prepared using either Pymol (www.pymol.org) or Chimera. In case of C1 (symmetry free) 
3D reconstructions, homology models of Pex1/6 ATPase domains are fitted automatically to 
each D2 domain individually. 
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3 Results 
Part of this study included developing a strategy in order to establish the expression of 
recombinant yeast Pex1 and Pex6 in S. cerevisiae. Moreover, the yield of purified Pex1/6 
proteins should be optimized to achieve satisfactory protein concentrations for structural 
analysis using negative stain EM and single particle analysis. 
 
3.1 Overexpression of S. cerevisiae Pex1 and Pex6 
The coding sequences of wild type and mutant yeast Pex1 and Pex6 are inserted into episomal 
plasmids pRS245-GAL1 and pYES2 under control of the inducible GAL1 promotor (see 
section 2.2). The transcription of genes under control of the GAL1 promoter is induced up to 
1000-fold when cells are grown in medium containing galactose as the sole carbon source 
(Johnston and Davis, 1984). The levels of ectopically expressed Pex1/Pex6 should be 
substantially elevated compared to endogenous Pex1/Pex6 protein levels. Furthermore, 
recombinant Pex1/Pex6 are overexpressed from 2 µ plasmids pRS425-GAL1 and pYES2, 
which are present in high copy numbers in the corresponding yeast cells. The yeast strain 
WCGa is transformed with Pex1 and Pex6 expression vectors for co-expression of protein A 
(ProA-) tagged Pex1/Pex6 and their mutant versions, respectively.  
 
3.1.1 Test overexpression of wild type Pex1 and Pex6 proteins 
To achieve co-expression of stable Pex1/Pex6 proteins in yeast, different conditions for the 
expression of soluble, C-terminally protein A tagged Pex1/Pex6 (Pex1-ProA/Pex6-ProA) are 
tested.  
First, the efficiency of overexpression is assayed in cultures with different densities to see 
whether the growth phase of the yeast cells has an influence on the amount of expressed 
protein. Notably, the yield of expressed Pex1-ProA/Pex6-ProA depends on the density of the 
respective yeast culture (Figure 3.1 A). Ectopic expression of Pex1-ProA/Pex6-ProA in cells 
in early- and mid-log phase (OD600= 0.7-2.9) is significantly higher compared to cells in late-
log phase (OD600= 5.9). To further optimize protein expression conditions for Pex1-
ProA/Pex6-ProA, the co-expression of both proteins is followed over time after the addition of 
galactose. The expression of recombinant proteins is induced from cells grown to an OD600= 
3.0. As analyzed by Western blot, expressed Pex1-ProA/Pex6-ProA can be detected after 6 h 
up to 21 h of galactose exposure (Figure 3.1 B). Induction of Pex1-ProA/Pex6-ProA 
expression seems to be delayed in cells, which are grown in glucose-containing medium prior 
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to induction with galactose, similar to earlier publications (Adams, 1972).  
 
 
Figure 3.1 Pex1/6 overexpression depends on cell density and time. (A) Pex1-ProA/Pex6-ProA 
proteins are co-expressed for 16 h in yeast cultures with cell densities (OD600) as indicated. (B) Pex1-
ProA/Pex6-ProA co-expression followed over time. 1 OD600 cells (~3 x 107 cells ml-1) are analysed per 
lane by Western Blot through detection of the protein A tag using α-mouse. Corresponding amido black 
staining is shown below.  
 
Thus, for subsequent large-scale affinity purifications of recombinant Pex1/Pex6 proteins, 
cells are grown to mid-log phase (OD600 = 3.0) and induced with 2 % galactose for 16 h.  
 
3.1.2 Test overexpression of modified Pex1 and Pex6 proteins 
To dissect the influence of individual nucleotide binding pockets in Pex1/6 complexes, 
conserved residues within the Walker B motif of Pex1D2 or Pex6D2 are mutated. Typically, 
mutations in the Walker B consensus sequence block ATP hydrolysis but not ATP binding 
(Wendler et al., 2012). Multiple sequence alignment shows that both, Pex1 and Pex6, harbour 
a highly conserved Walker B glutamate (Beyer, 1997), which is replaced by glutamine 
(Pex1E798Q/Pex6E832Q). Likewise to wild type Pex1/Pex6, the overexpression of recombinant 
Pex1/Pex6 Walker B (WB) proteins is tested. Recombinant Pex1WB-His6-ProA or His6-
Pex6WB-ProA subunits are expressed in cells containing either the wild type or a mutant 
version of the respective other subunit. 
Furthermore, a shortened version of Pex1 is generated to distinguish single protomers in 
Pex1/Pex6 assemblies using negative stain EM (see section 3.3.5). According to domain 
boundaries indicated in secondary structure predictions and to the existing crystal structure of 
the murine Pex1 N-terminal domain (pdb-ID: 1WLF; Shiozawa et al., 2004), the first 188 
amino acids of Pex1 are truncated and resulting ∆Pex188-His6-ProA is co-expressed with full-
length Pex6-ProA.  
Respective yeast strains are tested for the ectopic co-expression of mutated or truncated 
Pex1/Pex6 proteins and assayed using immunoblotting. Pex1/Pex6 proteins are detected after 
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induction with 2 % galactose for 8 h (Figure 3.2) and indicated Pex1/Pex6 proteins are present 
in all strains tested. This result implies that neither point mutation nor N-terminal truncation 
alter the stability of the Pex1/Pex6 complex. 
 
 
Figure 3.2 Pex1/6 overexpression strains. Pex1 and Pex6 proteins, fused to a C-terminal hexahistidin 
(His6-) protein A (ProA-) tag are expressed in the presence of galactose for 8 h. Up to 1 x 108 cells ml-1 
are analysed by Western Blot through detection of the protein A tag using α-mouse antibodies. 
Corresponding amido black staining are shown below.  
 
3.2 Purification of Pex1/6 complexes 
3.2.1 Protein affinity purification of protein A tagged Pex1/Pex6 
After optimization of Pex1/Pex6 co-expression conditions, a protocol for large-scale 
purification is established. Wild type Pex1/Pex6 proteins, both C-terminally fused to a TEV 
cleavable protein A tag, are isolated using IgG affinity chromatography in the presence of 
2 mM ATP. As analysed by SDS-PAGE, TEV protease cleavage releases wild type Pex1 and 
Pex6 in stoichiometric amounts from the IgG matrix (Figure 3.3 A). The identity of purified 
Pex1 and Pex6 was additionally confirmed by mass spectrometry. Since the purification 
protocol is established for the isolation of Pex1/Pex6 wild type proteins, also mutated and 
truncated Pex1/Pex6 proteins are affinity-purified via their C-terminal protein A tag and 
released upon TEV cleavage (Figure 3.3 B-E).  
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Figure 3.3 Protein A affinity purification of Pex1 and Pex6 proteins in the presence of 2 mM ATP. 
(A) and (B) 7.5 % SDS-PAGE or (C), (D) and (E) 10 % SDS-PAGE and Coomassie staining of 
fractions obtained through IgG affinity purification of Pex1/Pex6 proteins as indicated. High-salt wash 
was done using 500 mM NaCl, low-salt wash uing 100 mM NaCl. Pex1/Pex6 proteins are liberated by 
TEV protease cleavage in three fractions (TEV eluates) and remaining proteins are eluted from the 
affinity matrix using HAc pH 3.4 (HAc elution). All fractions are TCA precipitated and one-tenth in (A) 
and (B), one fifth in (C) and (D) or one-fourth in (E) of TEV eluates are analysed by SDS-PAGE. 
 
3.2.2 Glycerol density gradient centrifugation of isolated Pex1/6 complexes 
To further purify and detect whether eluted Pex1/Pex6 proteins assemble into a higher 
molecular weight complex in the presence of 2mM ATP, elution fractions are applied either 
on a linear 20 %-50 % or 10 %-40 % glycerol gradient, respectively, followed by 
ultracentrifugation. As analysed by SDS-PAGE (Figure 3.4 A) monodisperse Pex1/Pex6 or 
Pex1/His6-Pex6WB complexes migrated in stoichiometric amounts in the same higher 
molecular weight fractions (9-12, Figure 4.4 A), whereas TEV protease, unassembled 
Pex1/Pex6 proteins or putative Pex1 homotrimers are separated in lower molecular weight 
fractions (1-6, Figure 3.4 A).  
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Figure 3.4 Glycerol gradient fraction analysis showing heterohexameric Pex1/6 assemblies 
compared to the 20S proteasome as size marker. (A) Glycerol gradient centrifugation fractions (1-
24) of galactose induced wild type Pex1/Pex6 and mutated Pex1/His6-6WB purified from S. cerevisiae 
are TCA precipitated and analysed by 10 % SDS-PAGE. (B) and (C) show 10 % SDS-PAGE analysis 
of the migration behaviour of galactose induced wild type, mutated and truncated Pex1/6 complexes 
purified from S. cerevisiae as indicated, compared to peak fractions of similarly sized 20S proteasomes. 
20S proteasomes are visualized by Western blot analysis through detection of HA-tagged α4 subunits 
using an α-HA antibody. (D) SDS-PAGE and Coomassie staining of purified Pex1/Pex6 originating 
from overexpression in E. coli (~5 μg, lane 1, provided by Dr. D. Saffian and I. Grimm from Prof. Ralf 
Erdmann’s lab, Ruhr-Universität Bochum) or galactose induced Pex1/Pex6DWB co-expressed in 
S. cerevisiae (~5 μg, lane 2). 
 
As reported previously, native Pex1/6 proteins form heterohexameric assemblies of ~ 698 kDa 
(Saffian et al., 2012). Here, similarly sized yeast 20S proteasomes (~750 kDa, Groll et al., 
2000) serve as size marker for density gradient centrifugation. As judged from SDS-PAGE 
and immunoblotting, in the presence of ATP wild type Pex1/Pex6 (Pex1/6ATP) and the 
Walker B complex Pex1/His6-Pex6WB (Pex1/6WBATP) migrate in the same fractions as the 
20S proteasome (9-12, Figure 3.4 B). Thus, Pex1/6ATP and Pex1/6WBATP predominantly 
assemble into complexes with the molecular size of heterohexamers. 
Comparable results are obtained for complexes containing Pex1WB-His6/Pex6 
(Pex1WB/6ATP), Pex1WB-His6/His6-Pex6WB (Pex1/6DWBATP) and ∆188Pex1/Pex6ATP after 
purification and analysis by glycerol gradient centrifugation. In the presence of ATP, all 
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Pex1/6 species migrated as higher molecular weight complexes similar to the 20S proteasome 
(12-15, Figure 3.4 C). Although ∆188Pex1/Pex6ATP is estimated to assemble into a complex of 
~ 638 kDa, it mainly migrates in the same higher molecular weight fractions as Pex1WB/6ATP 
and Pex1/6DWBATP (13-15, Figure 3.4 C). Thus, differences in molecular weights of full-
length and truncated Pex1/6 complexes cannot be distinctly resolved by glycerol gradient 
centrifugation. However, neither mutation of the D2 Walker B motif of Pex1 or Pex6, 
respectively, nor truncation of the first 188 amino acids of Pex1 interferes with native complex 
formation.  
However, for subsequent structural analysis wild type Pex1/Pex6 proteins, which were 
heterogously expressed in Escherichia coli (E. coli), are obtained in collaboration with Prof. 
Ralf Erdmann’s lab, Ruhr-Universität-Bochum (samples are kindly provided by Dr. D. Saffian 
and I. Grimm). When compared, Pex1/6 complexes isolated from either E. coli or yeast 
overexpression systems are purified to near homogeneity (Figure 3.4 D) and served as input 
for single particle electron microscopy (EM). 
 
3.3 Structural characterisation of the Pex1/6 complex 
So far, there is only little knowledge about the three-dimensional (3D) structure of yeast 
Pex1/6 complexes. To gain further insight into the architecture of the Pex1/6 AAA+ complex, 
we determine the structure of this type II AAA+ heterohexamer.. Moreover, this is the first 
comprehensive structural study of full-length Pex1/6 including structural and functional 
characterization of modified Pex1/6 assemblies.  
 
3.3.1 Sequence similarity search 
Earlier structural analyses of Pex1 and Pex6 AAA+ proteins lead to the crystal structure of the 
N-terminal 180 amino acids of murine Pex1 (Shiozawa et al., 2004), showing strong 
architectural similarity to the N-terminal domains of type II AAA+ proteins p97/Cdc48 and 
NSF/Sec18 (Figure 1.5). Besides 3D analogy, multiple sequence alignments reveal hexameric 
p97/Cdc48 as closest homolog of Pex1 and Pex6 (Figure 3.5). The alignment profile shows 
that the D2 domains of both, Pex1 and Pex6 are well conserved. The D2 domains harbour the 
consensus sequence of the Walker A and the Walker B motif, two closely spaced arginine 
fingers and an aromatic-hydrophobic-glycine (F/YIG) pattern, corresponding to substrate-
binding loop region 1 in related AAA+ proteins (Hinnerwisch et al., 2005; Martin et al., 
2008). However, the D1 domains of Pex1/Pex6 are weakly conserved. While Pex1D1 displays 
a Walker A motif, the highly conserved glutamic acid of the Walker B motif is replaced by 
asparagine, presumably resulting in no or inefficient ATP hydrolysis. Amino acid residues 
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within the Pex6D1 Walker A motif deviate from the consensus sequence but allow either ADP 
or ATP binding (Birschmann et al., 2003). Furthermore, Pex6D1 lacks the Walker B motif 
and neither Pex1 nor Pex6 contains well-conserved aromatic residues in the D1 pore loop 
region. Notably, the Pex6 D1 domain exhibits two poorly conserved arginine fingers, likely 
facilitating nucleotide dependent interactions with the neighbouring Pex1D1 domain. 
 
Table 3.1 Output from Clustal W: Percent identity matrix. Sequences of yeast Pex1/6, p97 (Cdc48) 
and NSF (Sec18) homologs, Clp-type proteins (Hsp104, ClpB, ClpA) and SV40 large T antigen are 
aligned using ClustalW (Chenna et al., 2003); (Ec, Escherichia coli; sc, Saccharomyces cerevisiae; mm, 
Mus musculus; hs, Homo sapiens). 
 
Protein name |mmp97|hsp97|Cdc48|Sec18|hsNSF|Hsp104|EcClpB|EcClpA|scPex1|scPex6|LTSV40 
|mmp97|      |100.0|100.0|69.73|22.86|23.87|11.02 |10.89 |9.52  |21.47 |21.51 |8.45 
|hsp97|      |100.0|100.0|69.73|22.86|23.87|11.02 |10.89 |9.52  |21.47 |21.51 |8.45 
|Cdc48|      |69.73|69.73|100.0|22.82|23.74|11.52 |10.26 |10.46 |20.41 |20.72 |8.28 
|Sec18|      |22.86|22.86|22.82|100.0|45.27|11.48 |10.82 |11.16 |13.21 |11.55 |8.35 
|hsNSF|      |23.87|23.87|23.74|45.27|100.0|10.78 |10.96 |10.86 |12.79 |12.43 |8.21 
|Hsp104|     |11.02|11.02|11.52|11.48|10.78|100.0 |43.95 |35.86 |9.12  |8.34  |7.58 
|EcClpB|     |10.89|10.89|10.26|0.82 |10.96|43.95 |100.0 |40.88 |8.16  |10.25 |8.48 
|EcClpA|     |9.52 |9.52 |10.46|11.16|10.86|35.86 |40.88 |100.0 |8.73  |8.76  |8.68 
|scPex1|     |21.47|21.47|20.41|13.21|12.79|9.12  |8.16  |8.73  |100.0 |18.39 |7.85 
|scPex6|     |21.51|21.51|20.72|11.55|12.43|8.34  |10.25 |8.76  |18.39 |100.0 |6.17 
|LTSV40|     |8.45 |8.45 |8.28 |8.35 |8.21 |7.58  |8.48  |8.68  |7.85  |6.17  |100.0 
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Figure 3.5 Multiple sequence alignment. Sequences of Pex1/6 homologs (sc, Saccharomyces 
cerevisiae; sp, Schizosaccharomyces pombe; ce, Caenorhabditis elegans; dm, Drosophila 
melanogaster; mm, Mus musculus; hs, Homo sapiens; at, Arabidopsis thaliana) and yeast Cdc48 (p97) 
and Sec18 (NSF) are aligned using ClustalW (Chenna et al., 2003) and visualized with JalView (Clamp 
et al., 2004). Canonical AAA+ elements are indicated as follows: Walker A (magenta bar), Walker B 
(turquois bar), substrate-binding loops (green dots), arginine fingers (yellow dots) and residues within 
ISS motif (brown bar).   
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3.3.2 Electron imaging and reference-free 2D analysis of Pex1/6ATPγS complexes 
To dissect the shape of Pex1/6 complexes, wild type proteins (provided by Dr. D. Saffian and 
I. Grimm, lab of Prof. Ralf Erdmann, Ruhr-Universität Bochum) are imaged with negative 
stain transmission EM. To this end, a solution of a soluble heavy metal salt serves as stain, 
which forms an amorphous cast around the complexes examined (Brenner and Horne, 1959).  
An aqueous solution of ~50 µg ml-1 wild type Pex1/6 proteins, incubated with the slowly 
hydrolysable ATP analogue ATPγS, is spread on a continuous carbon film and covered with 
an even, air-dried layer of uranyl acetate. As shown in Figure 3.6 A, a population of 
symmetric particles is homogeneously distributed across the carbon film. Remarkably, 
Pex1/6ATPγS particles show predominantly the shape of an equilateral triangle, although the 
peroxisomal complex was expected to resemble the overall shape of hexameric p97. A 
negative stain data set is collected for detailed structural analysis of Pex1/6 in the presence of 
ATPγS, resulting in 3895 randomly oriented particle images. Single particles are aligned and 
classified based on the cross-correlation of similar features using multivariate-statistical 
analysis (MSA) and multi-reference alignment (MRA). Resultant class averages from 
reference-free alignment show a trimeric symmetry in top view classes and a double tier like 
shape capped by additional density in side view classes (Figure 3.6 B).  
 
 
 
Figure 3.6 Wild type Pex1/6 ATPγS complex analysed by negative stain. (A) Raw negative stain 
electron micrograph of purified wild type Pex1/6 complexes (~ 50 µg ml-1) incubated with ATPγS, 
microscope was run at 80 keV. Scale bar, 100 nm. (B) Representative class averages, derived from 
multivariate statistical analysis, show characteristic top (upper row) and side views (lower row) of the 
Pex1/6ATPγS complex. Each class represents an average of five to ten images. Box size, 128 pixels. (C) 
First three eigenimages obtained after translational (upper row) or translational and rotational (lower 
row) alignment.  
 
To further exploit the degree of symmetry of Pex1/6ATPγS complexes, the variance of the data 
set is assessed through multivariate statistics. Initial eigenimages, obtained after statistical 
analysis of centred Pex1/6ATPγS particles, show the total sum of the data set (Figure 3.6 C, 1). 
Subsequent eigenimages display a trimeric symmetry as major density variation in the data set 
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(Figure 3.6 C, 2-3). However, alignment of rotational orientations shifts major variance 
towards main eigenimages, which clearly displays a central hexameric ring structure 
surrounded by a trimeric distributed density (Figure 3.6 D, 1). This indicates a central portion 
of Pex1/6 particles with a higher symmetry level. The density in subsequent eigenimages 2 
and 3 are related to the shape of side views of Pex1/6ATPγS complexes within the data set 
(Figure 3.6 D). 
 
3.3.3 Domain topology of Pex1/6 complexes 
In order to define the domain topology of the double-layered complex, a data set of Pex1/6 
complexes with Pex1 C-terminally fused to a GST-tag (Pex1GST/Pex6, provided by Dr. 
Saffian), assembled in the presence of ATPγS, is acquired. 1500 raw particle images are 
aligned and averaged by MSA and MRA. When compared to wild type Pex1/6ATPγS complexes 
without GST, resultant 2D side view classes display an additional blurry density emerging 
from to bottom layer of the Pex1GST/Pex6 complex (Figure 3.7 A, B). Furthermore, 
subtraction of Pex1GST/Pex6ATPγS from Pex1/6ATPγS side view class averages shows main 
density difference beneath the lower tier of the complex that is explained by the GST moiety 
emerging from the Pex1 C-terminus (Figure 3.7 C, D). Thus, the layer connected to the GST 
density comprises the D2 domain of Pex1/6, whereas the distal layer constitutes the D1 
domain. Accordingly, AAA+ domains D1 and D2 are stacked on top of one another in the 
central portion of the Pex1/6 complex, whereas the density at the complex periphery is most 
likely attributed to the Pex1/6 N-termini. 
 
 
 
Figure 3.7 Pex1/6 domain allocation. (A) Side view class averages of Pex1/6ATPγS and 
Pex1GST/Pex6ATPγS (B) complexes followed by difference images (C) between (A) and (B). Binarised 
difference images are shown in (D).  
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3.3.4 Negative stain structure of the Pex1/6ATPγS wild type complex  
Subsequent to 2D analysis of Pex1/6ATPγS particle images, class averages with characteristic 
views of Pex1/6 complexes (Figure 3.6 B) are used as input for initial model building using 
angular reconstitution in IMAGIC. After determination of particle orientations and Euler angle 
assignment, an initial 3D reconstruction is calculated, imposing 3-fold symmetry. Class 
averages, showing good visual similarity between input 2D projections and re-projections are 
used to get a consistent, initial low-resolution Pex1/6ATPγS 3D map. The initial model is refined 
iteratively against 3895 raw particle images until the final 3D reconstruction converged, 
imposing C3 symmetry. The resultant negative stain EM map shows the structure of the yeast 
Pex1/6 complex in the presence of nucleotide at a resolution of 21 Å with overall dimensions 
of ~ 158 Å in diameter and ~ 117 Å in height (Figure 3.8 A-C). When viewed from the top, 
Pex1/6 assemble into a trimeric shaped complex with a double-layered side view. The centre 
of the 3D reconstruction has 6-fold symmetry, although 3-fold symmetry is used throughout 
model building and refinement.  
 
Figure 3.8 Final EM reconstruction of Pex1/6 incubated with ATPγS. (A) Surface representation of 
the final wild type Pex1/6ATPγS negative stain 3D map shown as top, side and cut-open view (B) Cross-
section of AAA-D1 and AAA-D2 domains. Green lines indicate cross-section viewing planes for 
D1/D2 domains. (C) Fourier Shell Correlation (FSC) curve of the final 3D reconstruction at the 0.5 cut-
off criterion. The graph show the FSC plotted against spatial frequency [1/Å]. Inset: Euler plot for the 
Pex1/6ATPγS dataset after final refinement with projection matching. The polar (θ) and azimuthal (Φ) 
directions are indicated (directions for mirrored particles, θ’ and Φ’, are indicated in pink). The C3 
symmetry axis is placed in the centre of the Euler plot circle. (D) Representative class averages derived 
from multivariate statistical analysis show characteristic top and side views of Pex1/6ATPγS (upper row) 
and corresponding re-projections of the final 3D reconstruction in the Euler-angle directions assigned to 
the class averages (lower row). Each class contains an average of five to ten images. 
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The cut-open side view shows a central channel traversing the complex from the D1 to the D2 
domain, respectively, its diameter ranging from 10 Å (D2) up to 20 Å (D1). Additional density 
emerges from the top of the double tier, extending to the complex vertices, defining the 
trimeric appearance of the AAA+ complex. Furthermore, a small density appears at the 
channel entrance on the apical surface of D1. Class averages, obtained by MSA after the last 
round of refinement, are in very good agreement with resultant re-projections of the final 3D 
reconstruction (Figure 3.8 D), proving the quality of the final 3D volume. 
 
3.3.5 Pex1 and Pex6 protomer positioning within the AAA+ complex 
In order to trace Pex1 and Pex6 protomers within the AAA+ complex, truncated Pex1/6 
complexes, missing the first 188 amino acids at the Pex1 N-terminus (∆188Pex1/Pex6), are 
compared to full-length Pex1/6. Equally to wild type complexes, purified ∆188Pex1/Pex6 are 
assembled through incubation with ATPγS and negatively stained as described for Pex1/6ATPγS 
(Figure 3.9 A). After acquiring a negative stain data set of ~ 3000 raw particle images, only 
the best 400 2D projections are used for final 3D reconstruction. Preferred top view 
orientation of most ∆188Pex1/Pex6ATPγS complexes severely disturbed alignment and 
reconstruction procedures. Consequently, the amount of images displaying top view particles 
is reduced to ensure that the remaining 400 projections are distributed evenly across the Euler 
sphere. After initial model building using IMAGIC-5, the resulting 3D map is refined 
iteratively using projection matching in SPIDER, imposing C3 symmetry. The final 3D 
reconstruction of the ∆188Pex1/Pex6ATPγS complex at 29 Å resolution, depicts a trimeric shape 
with two distinct layers in side views and indicates a central 6-fold symmetry (Figure 3.9 B, 
C). The cut-open side view shows a central channel protruding from the D1 to the D2 domain, 
respectively, the diameter extending from 26 Å (D2) up to 40 Å (D1). When compared to the 
cut-open side view of the wild type Pex1/6ATPγS complex, the density on the symmetry axis 
above the central pore of the D1 domain is clearly missing and the central channel of 
∆188Pex1/Pex6ATPγS complex is accessible (Figure 3.9 B, orange circle). Notably, although 
overall dimensions of ∆Pex188/Pex6ATPγS are similar to wild type Pex1/6ATPγS, the truncated 
complex is less structured in the D1 and D2 ring. However, class averages and corresponding 
re-projections of the final 3D reconstruction show a satisfactory visual similarity, proving the 
quality of the final EM density map (Figure 3.9 A, inset). 
Additionally, subtraction of EM density maps ∆188Pex1/Pex6ATPγS from wild type Pex1/6ATPγS 
reveals missing density in every second subunit that cannot be explained by conformational 
rearrangements of ∆188Pex1/Pex6ATPγS D1/D2 domains (red circle, Figure 3.9 D, E). Hence, 
Pex1 N-termini reside on top of the complex whereas Pex6 N-termini are mainly placed at the 
periphery of the central AAA+ core (Figure 3.9 C). Accordingly, single D1 and D2 domains 
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can now be assigned to either Pex1 (D1 orange, D2 red) or Pex6 (D1 pale blue, D2 blue). 
Thus, the Pex1/6 complex consists of an alternating order of Pex1 and Pex6 subunits and 
assembles as a trimer of dimers. 
 
 
Figure 3.9 Negative stain 3D reconstruction of ∆188Pex1/Pex6 incubated with ATPγS for 
Pex1/Pex6 protomer assignment. (A) Raw negative stain electron micrograph of purified 
Δ188Pex1/Pex6ATPγS complexes (~ 40 µg ml-1), microscope was run at 80 keV. Scale bar, 100 nm. 
Representative class averages derived from MSA show top and side views of Δ188Pex1/Pex6ATPγS 
complexes (inset, upper row) and corresponding re-projections of the final 3D reconstruction (inset, 
lower row). Each class contains an average of five to ten images. (B) Top, side and cut-open view of 
final ∆188Pex1/Pex6ATPγS 3D map compared to the side cut-open view of the final Pex1/6ATPγS 3D 
reconstruction, with the N-terminal density on the symmetry axis encircled in orange. (C) FSC curve of 
the final 3D reconstruction at the 0.5 cut-off criterion. The graph show the FSC plotted against spatial 
frequency [1/Å]. Inset: Euler plot for the ∆188Pex1/Pex6ATPγS dataset after final refinement with 
projection matching. The polar (θ) and azimuthal (Φ) directions are indicated (directions for mirrored 
particles, θ’ and Φ’, are indicated in grey). The C3 symmetry axis is placed in the centre of the Euler 
plot circle. (D) Top and side views of surface representations of Δ188Pex1/Pex6ATPγS hexamers (grey 
surface) overlaid with full-length Pex1/6ATPγS hexamers (dark grey mesh). (E) The difference map 
between Pex1/6ATPγS and Δ188Pex1/Pex6ATPγS hexamers is shown in green. Difference density is 
encircled in red. (E) Surface representation of Pex1/6ATPγS with Pex1 and Pex6 protomers highlighted 
according to their domain structure. The colour code is as follows: Pex1D1 (1D1, orange), Pex1D2 
(1D2, red) and Pex6D1 (6D1, pale blue), Pex6D2 (6D2, blue). N-terminal domains of Pex1 (1N) and 
Pex6 (6N) are coloured grey. 
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3.3.6 3D comparison of Pex1/6 and p97  
With the protomer allocation established and as a result of the close sequence based 
relationship of yeast Pex1 and Pex6 to p97, appearance and dimensions of the Pex1/6ATPγS 3D 
reconstruction are compared to a low-pass filtered p97 crystal structure bound to ADP (pdb-
ID: 3CF3, Davies et al., 2008; Figure 3.10 A). Although additional p97 X-ray structures with 
the D2 domain bound to different nucleotides exist (pdb-ID: 3CF2 ADP-AlFx; pdb-ID: 3CF1 
AMP-PNP), the crystal structures show only minor deviation from 6-fold rotational symmetry. 
Thus, p97 bound to ADP is selected as template for structural comparison and as described 
below, is used as atomic structure for initial fitting of the Pex1/6ATPγS EM density map.  
The width and height of the central Pex1/6 AAA+ double-layer are in good agreement with 
p97 (Figure 3.10 A). Similarly, Pex1/6ATPγS D1 and D2 domains exhibit hexameric symmetry, 
which is typical for type II AAA+ assemblies and also applies to other complexes whose 
structure have been determined by cryo-EM (Rouiller et al., 2002; Wendler et al., 2007; 
Chang et al., 2012). In contrast, the asymmetric distribution of Pex1/6 N-terminal domains is a 
unique feature and has not been observed so far for other AAA+ proteins. The first 180 amino 
acids of murine Pex1 show a strong structural homology to p97 and NSF (Shiozawa et al., 
2004), but Pex1 and Pex6 N-termini are 400 amino acids long and twice as large as the N-
termini of their homologs (Figure 1.5). Consequently, the overall dimension differs because 
the N-terminal Pex1/Pex6 densities contribute to the overall height of the complex. p97 
structures with elevated N-terminal domains are available but most structures, mainly those 
solved by X-ray crystallography, show p97 N-termini coplanar with the D1 layer (DeLaBarre 
and Brunger, 2003; Huyton et al., 2003; Davies et al., 2005; DeLaBarre and Brunger, 2005). 
Besides differences in the N domains, the D1 ring of the Pex1/6ATPγS complex is somewhat 
wider compared to the compact appearance of p97 D1. The central channel in Pex1/6 D1 
opens up to 20 Å and the axial pore extends to the bottom of the D2 domain (Figure 3.10 A, 
B) similar to EM structures of ClpA- and ClpB- type AAA+ hexamers (Wendler et al., 2009; 
Effantin et al., 2010). The latter thread substrate proteins through their open central pore, a 
mechanism that seems not to apply to the tightly packed arrangement of p97. However, 
dramatic conformational changes of p97 are so far only captured by SAXS and cryo-EM 
studies (Rouiller et al., 2002; Davies et al., 2005; Yeung et al., 2014), whereas 
crystallographic constraints might determine domain orientations in p97 X-ray structures. For 
subsequent atomic structure fitting, homology models of Pex1/Pex6 single D1 and D2 
domains are created based on the aforementioned p97 crystal structures neglecting the N-
terminal domains. Without the N terminal domains, hexameric p97 (pdb-ID: 3CF3) readily fits 
the density of the D2 layer of Pex1/6ATPγS complex, confirming that the stain does not 
significantly alter the Pex1/6ATPγS complex integrity and all AAA+ domains are well resolved 
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in the negative stain reconstruction at 21 Å resolution (Figure 3.10 C, left). Furthermore, the 
good agreement of the fit in the D2 domain determines unambiguously the handedness of the 
Pex1/6 complex. The homology models of the Pex1/6 D1 and D2 ATPase domains are placed 
as rigid bodies into the EM density using the automated fitting procedure in UCSF Chimera. 
Several starting positions are tested and all ended in the same fit of the D1/D2 ATPase 
domains. Subsequently, docked models are symmetrized and resulting pseudo-atomic models 
 
 
 
Figure 3.10 Pex1/6ATPγS EM reconstructions compared to low-pass filtered p97 and rigid body 
fitting to the Pex1/6 3D volume. (A) Pex1/6ATPγS EM density map as side, top and cross-section views 
of D1 and D2 rings. Equivalent views of p97 (pdb-ID: 3CF3) filtered to 20Å are shown for comparison. 
p97 single subunits are coloured alternately light and dark grey. Cross-section viewing planes are 
indicated by green lines. (B) Cut-open side views of the low-pass filtered p97 crystal structure with p97 
D2 placed into the EM density map and of Pex1/6ATPγS map with fitted Pex1D2 and Pex6D2 homology 
models. Black dotted lines indicate the central channel (upper row). Cartoon representation of a p97 
protomer without N domains and of a Pex1 protomer homology model, seen from the side of the 
complex. Domain offset between Pex1D1 and Pex1D2 is indicated by green dotted lines. Walker A, 
Walker B motifs are shown as spheres and coloured as in Figure 1.5 (middle row). Side view of a p97 
dimer fitted as rigid body into low-pass filtered p97 crystal structure and Pex1/6 heterodimer docked to 
Pex1/6ATPγS 3D map. Domains are coloured as in Figure 3.9 F (lower row). (C) D1 and D2 cross-section 
views of p97 (pdb-ID; 3CF3) docked into the Pex1/6ATPγS map (left). Rigid body fitting of the Pex1/6 
homology model into the ATPγS EM map as indicated. Domains are coloured as in Figure 3.9 F. Pore 
facing aromatic residues Pex1F771 and Pex6Y805 are depicted as green spheres. 
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fit both tiers of the Pex1/6ATPγS complex very well (Figure 3.10 C, right), revealing densities 
for 12 individual ATPase domains. Notably, the resulting arrangement of the D1 and D2 ring 
differs strongly between p97 and the Pex1/6 complex. While D1 and D2 domains are 
symmetrically stacked on top of each other in the p97 crystal structure, the D1 domains in 
Pex1/6 hexamers are rotated anticlockwise by ~ 30° relative to the D2 domain (Figure 3.10 B, 
middle row). This is also the reason for the low correlation between the p97 D1 ring and the 
Pex1/6 D1 ring when the p97 hexamer is fitted to the Pex1/6 hexamer (Figure 3.10 C, left). 
Consequently, the arrangement of D1 and D2 AAA+ rings in Pex1/6 is structurally closer to 
the one of type II AAA+ proteins ClpA and Hsp104 (Guo et al., 2002; Wendler et al., 2007; 
Effantin et al., 2010) than to the one of p97. 
 
3.3.7 EM reconstructions of Pex1/6 in ADP-AlFx, ATP and ADP states  
In order to dissect conformational states of Pex1/6 throughout ATP binding and hydrolysis, 
the hexameric assembly is reconstructed with saturating quantities of different nucleotides (see 
section 2.7.2). Wild type Pex1/6 is incubated with either the transition state analogue ADP-
AlFx or ATP and the previously mentioned Pex1GST/Pex6 complexes are incubated with 
ADP. Subsequently, samples are negatively stained according to Pex1/6ATPγS and imaged by 
EM (Figure 3.11, A-C). A negative stain data set is acquired for every nucleotide state 
resulting in 2394 (Pex1/6ADP-AlFx) 2948 (Pex1/6ATP) and 1488 (Pex1/6ADP) raw particle images. 
After classification by MSA and MRA, initial 3D models are build in IMAGIC-5 by angular 
reconstitution and further refined in SPIDER throughout repetitive cycles using projection 
matching, imposing 3-fold symmetry. Final EM density maps of the Pex1/6 complexes in 
different nucleotide states at resolutions of 23 Å-24 Å (Figure 3.11 D, E), retain distinct 
trimeric symmetry and double-layered side views (Figure 3.12). The overall dimensions for all 
reconstituted complexes are similar and mainly the orientation of the N-terminal domains 
contributes to differences in height (117 Å-103 Å) and width (158 Å-164 Å). Aside from the 
loosely packed D2 layer of Pex1/6ADP, the central AAA+ core of all complexes shows clear C6 
symmetry and well-resolved densities for ATPase domains. Again, upon hexamerisation 
Pex1/Pex6 N-terminal densities emerge apical from the D1 layer, sitting on the top and at the 
vertices of Pex1/6 complexes. Particularly, in the presence of ADP, D1 domains rotate away 
from the central symmetry axis providing a platform for a continuous N-terminal density 
distribution at the rim of the D1 domain. This constitutes an entrance to a large cavity in D1, 
extending up to 48 Å in diameter. Among all nucleotide states, Pex1/6ADP displays the largest 
axial pore and has the most relaxed appearance. Addition of ATP alters the complex towards a 
more compact conformation, indicating nucleotide binding.  
In contrast to Pex1/6 captured in the presence of ADP, the overall shape of Pex1/6ATP almost 
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resembles that of Pex1/6ATPγS. Again, upon hexamerisation, Pex1/Pex6 N-terminal densities 
emerge apical from the D1 layer, sitting on the top and at the vertices of Pex1/6 complex. 
Densities for AAA+ domains are oriented towards the symmetry axis, which is accessible 
from the top of the complex. The Pex6 N-terminal densities arrange in discrete domains 
establishing contacts to Pex1D2 (yellow asterisk, Figure 3.12). This interaction is also present 
in the Pex1/6ATPγS complex and might be associated with nucleotide binding to the D2 layer. 
This notion is consistent with previous publications showing that nucleotide binding of the 
Pex1 D2 domain is crucial for the interaction with Pex6. However, the diameter of the pore in 
Pex1/6ATP D1 (26 Å) and D2 (19 Å) domains is still extended compared to Pex1/6 bound to 
ATPγS. 
 
 
Figure 3.11 Wild type Pex1/6 complexes in the presence of different nucleotides analysed by 
negative stain. Raw negative stain electron micrographs of purified wild type Pex1/6 complexes (40-
50 µg ml-1) treated with (A) ADP-AlFx, (B) ATP and (C) ADP. Microscope was run at 80 keV. 
Representative class averages derived from MSA show top and side views of Pex1/6 complexes (A-C 
inset, upper row) and corresponding re-projections of the final 3D reconstruction in the Euler-angle 
directions assigned to the class averages (A-C inset, lower row). Each class contains an average of five 
to ten images. Scale bar, 100 nm. (D) FSC curves of final 3D reconstructions with C3 symmetry 
applied, measured at the 0.5 cut-off criterion (colour code and resolutions are given). The graphs show 
the FSC plotted against spatial frequency [1/Å]. Inset: Euler plots for Pex1/6 datasets as indicated after 
final refinement with projection matching. The polar (θ) and azimuthal (Φ) directions are indicated for 
Pex1/6ADP-AlFx (directions for mirrored particles, θ’ and Φ’, are indicated in purple). The C3 symmetry 
axis is placed in the centre of each Euler plot circle. 
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In comparison to Pex1/6ATPγS, major domain re-arrangements are observed when the complex 
is reconstituted in the presence of the transition state analogue ADP-AlFx. Domain rotations 
closes the central pore of the D2 domain simultaneously opening the central channel of the D1 
domain to 26 Å. Again, contacts between Pex1D2 and Pex6N are clearly visible, apparently 
based on nucleotide occupancy in the D2 domain. Unlike Pex1/6 in the presence of ADP or 
ATP, Pex1/6ADP-AlFx N-termini shield the entry to the central cavity of the complex.  
 
 
Figure 3.12 Negative stain structures of Pex1/6 complexes treated with different nucleotides. 
Negative stain EM reconstructions of Pex1/6 complexes in the presence of ATPγS (Pex1/6ATPγS), ADP-
AlFx (Pex1/6ADP-AlFx), ATP (Pex1/6ATP) and ADP (Pex1/6ADP) seen as side views (upper row), followed 
by cut-open side views, top views and cross-sections of the D1 and D2 layers (lower rows). Domains 
are coloured according to Figure 3.9 F. 
 
Obviously, different nucleotides cause domain motions in the Pex1/6 complex that are 
strikingly different between N domains, D1 or D2 layers. While the pore of the D1 ring never 
closes, the pore diameter of the D2 ring never exceeds 24 Å and closes in the presence of the 
transition state analogue ADP-AlFx. The size of the central channel is dynamically adapted 
through distinctive nucleotide-induced motions of AAA+ domains within the D1 and D2 ring. 
Furthermore, ATP binding to the D2 ring structures this layer towards tighter domain 
arrangements. N-terminal domains are apparently altered dependent on the nucleotide present, 
too, communicating with the D2 domain through direct and/or long-range contacts.  
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3.3.8 Comparison of Pex1/6ATPγS and Pex1/6ADP-AlFx EM reconstructions 
To further explore whether nucleotide hydrolysis induces domain movements, the 3D 
reconstructions of Pex1/6 in the presence of ATPγS or ADP-AlFx are compared in more 
detail. 
In the molecular structure of the non-hydrolysable nucleotide analogue ATPγS, a sulfur atom 
replaces the γ-phosphate, avoiding rapid nucleotide turn over in AAA+ proteins (Chen et al., 
2007). Binding of ATPγS to Pex1/6 assembles the complex into a stable, hexameric 
arrangement with a distinct 6-fold symmetry in the D1 and D2 domains (Figure 3.8) and likely 
traps the complex in an ATP bound state. For mimicking ATP hydrolysis in the Pex1/6 
ATPase domain, the complex is mixed with ADP-AlFx. The transition state analogue forms a 
trigonal bipyramidal geometry within the nucleotide binding pocket and captures the ATPase 
between the ATP and ADP bound state (Braig et al., 2000). Notably, ATP hydrolysis causes 
the D1 domains in Pex1/6ADP-AlFx to move apart. The domains re-arrange thereby slightly 
tilting downwards and away from the central cavity. At the same time, the central pore of the 
D2 ring closes resulting in strong connecting densities between Pex1D1 and Pex6D2 at the 
outside of the complex that cannot be seen in Pex1/6 complexes bound to ATPγS (yellow 
circle, Figure 3.12). This diagonal inter-domain communication is only possible because of the 
displaced arrangement of ATPase domains in D1 and D2 rings (Figure 3.10 B). The N-
terminal densities move towards the symmetry axis at the top of the complex, further closing 
the central opening into the cavity of Pex1/6ADP-AlFx. Closer examination of dynamic re-
arrangements in the D2 domain within the 3D reconstructions of both states reveals that 
ATPase domains flip down towards the exit of the central pore thereby closing the ring 
(Figure 3.13 A). As judged from the negative stain EM maps, D2 domains undergo a dramatic 
downward rotation upon ATP hydrolysis. As described above for Pex1/6ATPγS, Pex1/Pex6 
homology models are docked automatically into the density of the Pex1/6ADP-AlFx D2 ring 
using Chimera. The resulting pseudo atomic model fits this layer readily (Figure 3.13 B). 
Moreover, upon pore closure the ATPase domains are coming closer together in a tight 
hexameric arrangement. When viewed from the side, the fitted homology models further 
support the downward directed orientation of the Pex1/Pex6 domains in the D2 layer of 
Pex1/6ADP-AlFx.  
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Figure 3.13 Correlation of the Pex1/6ATPγS and Pex1/6ADP-AlFx 3D reconstruction. (A) Side view 
surface representation of Pex1/6ATPγS and Pex1/6ADP-AlFx. One heterodimer is omitted from the 3D 
reconstructions. Underneath, a cartoon representation based on rigid body fits of homology models into 
negative stain EM maps is shown. (B) D2 cross-section views (upper row) and side view surface 
representation (lower row) of EM reconstructions as indicated. Pex1/6 homology models are 
automatically fitted to the D2 domain and are coloured as in Figure 3.9 F  . Conserved aromatic residues 
Pex1F771 and Pex6Y805 are shown as green spheres. Movements of pore loops are indicated by black 
dotted lines. 
 
To verify the underlying processing procedures resulting in these dramatic differences 
between the ATPγS and ADP-AlFx state, both 3D reconstructions are refined from 
interchanged starting models. Those refinements result in the original EM density map, 
proving that the information for domain motions and overall re-arrangements source from 
intrinsic orientations captured in the respective raw data sets (Figure 3.14).  
The domain orientations observed in the 3D reconstructions are considered reliable and the 
position of conserved aromatic residues in substrate binding loop region 1 of Pex1 or Pex6 
(Pex1F771, Pex6Y805) are highlighted in automatically fitted homology models. As depicted in 
Figure 3.13 B, pore-facing residues Pex1F711 and Pex6Y805 are oriented towards the central 
opening of the D2 domain in hexameric homology models. During ATP hydrolysis, they move 
in plane towards the symmetry axis thereby closing Pex1/6 D2 and also translocate out of 
plane along the central channel of the Pex1/6 complex (Figure 3.13 B, lower row). It was 
reported earlier that ATPase subunits of Hsp104 move in a nucleotide dependent manner 
(Wendler et al., 2009). Observed displacement of residues Pex1F771 and Pex6Y805, respectively, 
induced by ATP hydrolysis points to a similar motion in the Pex1/6 complex. 
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Figure 3.14 Refinement of Pex1/6 ATPγS and Pex1/6ADP-AlFx from interchanged starting models. (A) 
Top and side view of initial 3D model derived from angular reconstitution of Pex1/6ADP-AlFx 
 
data set. 
(B) Final EM reconstruction after projection matching of ATPγS treated single particles to starting 
model in (A) shown as side, top and side cut open view. (C) Final EM reconstruction after projection 
matching of ATPγS Pex1/6 data set to starting model in (D) depicted as side, top and side cut open 
view. (D) Top and side view of initial 3D model derived from angular reconstitution of Pex1/6ATPγS data 
set. (E) Final EM reconstruction after projection matching of ADP-AlFx treated single particles to 
starting model in (D), shown as side, top and side cut open view. (F) Final EM reconstruction after 
projection matching of ADP-AlFx Pex1/6 data set to starting model in (A) depicted as side, top and side 
cut open view. 
 
3.3.9 Asymmetric reconstructions of Pex1/6 in the presence of ATPγS and ATP 
Recent cryo-EM studies of related AAA+ hexamers show a distorted symmetry in AAA+ 
rings (Matyskiela et al., 2013; Zhao et al., 2015), resulting in an asymmetric arrangement of 
individual subunits. This domain organization is assumed to be functionally relevant for 
substrate processing. 
It is impossible to define the exact nucleotide state of single active sites within Pex1/6 
complexes at the resolution obtained. However, to elucidate the orientations of individual 
Pex1/6 AAA+ domains, the position of each protomer in the complex is examined. To this 
end, Pex1/6ATPγS and Pex1/6ATP initial 3D models are refined without imposing symmetry (C1) 
using projection matching in SPIDER. Final EM density maps of the Pex1/6 complexes 
preserve a distinct trimeric symmetry in top views and double-layered side views (Figure 3.15 
A, B). Although no symmetry was applied during refinement, the D1 and D2 layer of both 
complexes occupy a distinct 6-fold symmetry. The symmetry-free EM reconstructions show 
similar dimensions for the central AAA+ core compared to the symmetrized EM density 
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maps. The resolution of the final C1 Pex1/6 EM maps is somewhat lower (Figure 3.15 C), 
however, densities for all 12 AAA+ ATPase domains are well resolved and clearly 
distinguishable. Differences in overall height of Pex1/6ATPγS C1 trace back to movements of 
N-terminal domains. The overall shape of the complex is almost identical to the symmetrized 
wild type complex. The densities are homogeneously distributed throughout the 3D 
reconstruction and dimensions of the central channel of the D1 and the D2 ring differ 
marginally from the C3 Pex1/6ATPγS EM map. Homology models of Pex1D2 or Pex6D2, 
respectively, are fitted automatically into each density of individual domains within the D2 
ring using Chimera (Figure 3.15 D). Notably, the presence of ATPγS causes a planar domain 
orientation in the D2 layer, emphasized by the position of the aromatic residues Pex1F771 and 
Pex6Y805 located within the substrate binding loops (Figure 3.15 E).  
Asymmetric reconstruction has a bigger impact on Pex1/6 complexes in the presence of ATP 
(Figure 3.15 A). In the Pex1/6ATP C1 complex, the distribution of N domains is similar to the 
N-terminal arrangement found in the symmetrized Pex1/6ADP EM density map (Figure 3.12). 
Particularly, N-terminal densities assigned to Pex1 move flexibly on top of the D1 domains. 
The latter occur stretched in the Pex1/6ATP C1 EM reconstruction, caused by an outward 
rotation of the D1 domains. Furthermore, one connection between a Pex1D2 and a Pex6N 
domain is lost, caused by the out of plane movement of the Pex1/6 D2 domain and contraction 
of the Pex6N domain (yellow asterisk, Figure 3.15 A). This is accompanied by an expansion 
of the D1 ring, forming a cavity which is 10 Å wider compared to the symmetrized 
counterpart. Thus, refinement without symmetry constraints reveals domain re-arrangements 
in the Pex1/6 D1 domain resulting in varying pore sizes in this layer. Domain movements are 
even more pronounced in the D2 layer of the Pex1/6ATP C1 complex. While the pore size is 
almost identical to the symmetrized Pex1/6ATP EM reconstruction, automated fits of Pex1/6 
homology models reveal an asymmetric arrangement in the D2 ring of Pex1/6ATP C1 (Figure 
3.15 E). The arrangement of ATPase subunits in different planes might constitute a dynamic 
domain organization that is essential for substrate processing along the central pore. Pex1/6 
ATPase sites are most likely only partially occupied by ATP in the D2 ring of Pex1/6ATP C1, 
indicating preferred nucleotide states of AAA+ domains. Highlighted by the orientation of 
Pex1F771 and Pex6Y805 in rigid body fits, in Pex1/6ATP C1 AAA+ subunits clearly move out of 
plane, arranging in a staircase like manner. 
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Figure 3.15 Asymmetric 3D reconstruction of Pex1/6ATPγS and Pex1/6ATP. (A) Final Pex1/6ATPγS 
and Pex1/6ATP C1 or C3 EM reconstructions as side views (upper row), followed by top views and 
cross-sections of the D1 /D2 layers (lower rows). (B) Representative class averages derived from MSA 
show characteristic top/side views (upper row) and corresponding re-projections (lower row) of the 
final Pex1/6ATPγS C1 (left) and Pex1/6ATP C1 (right) EM density maps in the Euler-angle directions 
assigned to the class averages. (C) FSC curves of final 3D reconstructions without symmetry applied, 
measured at the 0.5 cut-off criterion (colour code and resolution are given). The graphs show the FSC 
plotted against spatial frequency [1/Å]. Inset: Euler plots for Pex1/6 datasets after final asymmetric 
refinement by projection matching. The polar (θ) and azimuthal (Φ) directions are indicated for 
Pex1/6ATPγS C1 (directions for mirrored particles, θ’, are indicated in blue). The central axis is placed in 
the centre of each Euler plot circle. (D) Pex1/6 homology models fitted to final Pex1/6ATPγS C1 (left) and 
Pex1/6ATP C1 (right) 3D maps. (E) Surface representation of each protomer of Pex1/6ATPγS C1 and 
Pex1/6ATP C1 complexes. Underneath, a cartoon representation based on rigid body fits of homology 
models into negative stain EM maps of each D2 domain is shown. The black dotted line indicates the 
position of pore facing loops of D2 domains in Pex1/6ATPγS C1 complex and the green dotted line the 
asymmetric arrangement of D2 domains in the Pex1/6ATP C1 complex.  
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3.4 Functional analysis of Pex1/6 central pore and arginine finger residues 
Functional studies of peroxins in yeast exploit the cell’s ability to grow on non-fermentable 
carbon sources in the absence of glucose (Erdmann et al., 1991; Faber, 1998; Kiel et al., 
1999). In this study, comparable complementation assays are performed in order to dissect the 
effect of so far uncharacterized Pex1 and Pex6 mutants toward yeast cell viability.  
As described in 3.3.8, the negative stain EM structures of Pex1/6 complexes demonstrate 
significant, nucleotide dependent domain re-arrangements, moving pore-facing residues 
Pex1F771 and Pex6Y805 along the central symmetry axis, thereby crossing the channel in the D2 
domain. Previous studies showed, that mutations within the conserved aromatic-hydrophobic-
glycine (F/YVG) sequence do not interfere with ATPase activity but abolish enzyme function 
(Hinnerwisch et al., 2005; DeLaBarre et al., 2006; Martin et al., 2008). To analyse whether 
aromatic residues in potential Pex1/6 substrate binding loop regions affect complex function, 
modified Pex1/6 alleles are tested in oleate growth assays. Target amino acid residues in Pex1 
and Pex6 are identified through multiple sequence alignments (Figure 3.5). In addition to the 
conserved tryptophan of Pex1D2 (Pex1F771), Pex1 carries two poorly conserved aromatic 
residues in the D1 domain (Pex1Y488, Pex1H495). Similarly, Pex6 harbours a weakly conserved 
tyrosine in the D1 domain (Pex6Y528) and the well-conserved tyrosine in the D2 domain 
(Pex6Y805). It was reported earlier that in crystal structures of related AAA+ proteins the 
conserved residues of the aromatic-hydrophobic-glycine pattern within substrate binding loops 
typically line the central pore (Schlieker et al., 2004; Siddiqui et al., 2004; Mueller-Cajar et 
al., 2011). Consistent with these observations, the conserved aromatic Pex1/Pex6 residues face 
the axial channel of the Pex1/6 complex when highlighted in homology models, which are 
automatically fitted to Pex1/6ATPγS (Figure 3.16 A). For subsequent functional characterization, 
specified aromatic residues are replaced by alanine. Modified Pex1/Pex6 alleles are expressed 
under the control of their native promotors and expression is induced upon oleate exposure. 
When grown on oleic acid-medium cells lacking endogenous Pex1 or Pex6 (pex1∆, pex6∆), 
show no growth (Figure 3.16 B). In contrast, cells expressing Pex1Y488A, Pex1H495A or 
Pex6Y528A proliferate at comparable levels to cells, which ectopically express the wild type 
gene. Surprisingly, cells expressing mutants Pex1F771A or Pex6Y805A fail to grow on oleate as 
the single carbon source. These results emphasize that the biological activity of Pex1/6 
complexes depends on functional pore loops in the D2 domains, most likely to preserve 
interactions with the substrate. The impact of mutations tested in oleate growth assays and the 
flexibility of substrate binding loops of D2 domains demonstrated in Pex1/6 3D 
reconstructions proposes a mechanism for substrate translocation through the central pore of 
the D2 domain.  
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Figure 3.16 Pex1/6 pore loop and arginine finger mutants tested in oleate growth assays. (A) Cut-
open side view surface representation of the Pex1/6ATPγS EM reconstruction. Pex1/6 homology models 
are automatically fitted to the D1 and D2 domain and are coloured as in Figure 3.9 F. Conserved 
aromatic residues of D1 or D2 domains are highlighted as green spheres. (B) Growth of strains 
expressing either wild type (PEX1, PEX6), no (pex1Δ, pex6Δ) or mutated pex1, pex6 alleles with 
modified pore loop (pex1Y488A, pex1H495A, pex1F771A, pex6Y528A, pex6Y805A) or arginine finger residues 
(pex1R855K, pex6R607K, pex6R611K, pex6R892K) on either glucose or oleate as single carbon source. (C) D1 
and D2 cross-section views of the Pex1/6ATPγS EM reconstructions. Pex1/6 homology models are 
automatically fitted to the D2 domain and are coloured as in Figure 3.9 F. Yellow spheres highlight 
Pex1 and Pex6 arginine fingers as indicated. 
 
Besides conserved substrate binding loop regions, Pex1 and Pex6 also contain arginine 
residues, which match position 1 and 2 arginine fingers of p97 (Figure 3.5). Available crystal 
structures of oligomeric AAA+ proteins of the classic clade display two conserved arginine 
fingers at subunit interfaces, of which at least one extends into the ATP binding pocket of the 
neighbouring protomer (Wendler et al. 2012). Together with a multitude of mutational 
analysis, arginine fingers are found to be essential for ATPase activity of respective 
complexes and stabilize oligomeric assemblies of AAA+ proteins (Wendler et al., 2012).  
As depicted in Figure 3.16 C, potential arginine fingers of Pex1D2 (Pex1R852, R855) or Pex6D1 
(Pex6R607, R611) and Pex6D2 (Pex6R889, R892), respectively, are located at the interface between 
adjacent subunits. To exploit their role in the Pex1/6 complex in vivo, target arginine residues 
are replaced by lysine and examined in oleate growth assays as described above.  
On plates containing oleate as the sole carbon source, cells expressing Pex6R611K proliferate 
compared to cells expressing the wild type gene from an ectopic location, whereas Pex6R607K 
cells are somewhat sensitive towards oleate exposure (Figure 3.16 B). Notably, expression of 
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mutants Pex1R855K and Pex6R892K abolishes cell growth on oleate, hinting that functional 
arginine fingers in Pex1/6 D2 domains are essential for complex function and/or stability in 
vivo. In contrast, arginine residues in Pex6D1 have only a minor effect on peroxisome 
biogenesis. Although the increased sensitivity of cells expressing Pex6R607 in oleate growth 
assays suggests an intermolecular catalytic mechanism between adjacent Pex6D1 and Pex1D1 
domains. 
 
3.5 Capturing the ATPase cycle of Pex1/6: single and double Walker B mutants 
The detailed structural comparison of Pex1/6ATPγS and Pex1/6ADP-AlFx negative stain EM maps 
revealed striking differences in their overall structure triggered by dynamic domain 
movements upon ATP binding and hydrolysis (Figure 3.13). Particularly D2 domains undergo 
major nucleotide dependent re-arrangements. Furthermore, 3D reconstructions without 
symmetry constraints demonstrated an asymmetric arrangement of single AAA+ domains 
within the D2 layer of Pex1/6ATP (Figure 3.15) most likely caused by different nucleotide 
occupancy. Thus, as a heterohexamer the active sites in the Pex1/6 complex might be 
functionally non-equivalent. Here, Pex1/6 ATPase-deficient variants are analysed to dissect 
mutually exclusive inter-subunit communication coordinated by ATP hydrolysis. To this end, 
Pex1 and Pex6 are modified independently and the effects of altered protomers are studied 
functionally and structurally to further elucidate the mechanism of ATP binding and 
hydrolysis in Pex1/6 complexes. 
Mutagenesis, ATPase activity and parts of oleate growth assays have been performed in 
collaboration with Prof. Ralf Erdmann’s lab (Ruhr-Universität Bochum). Part of the data is 
kindly provided by I. Grimm (also indicated in figure legends). 
 
3.5.1 Role of single Pex1/Pex6 subunits in ATPase activity and in vivo function 
For the purpose of analysing the impact of individual nucleotide binding sites of Pex1/6 D2 
domains on overall ATPase activity in vitro, modified Pex1 or Pex6 proteins, devoid of ATP 
hydrolysis, are subjected to ATPase activity assays. Multiple sequence alignment shows that 
both, Pex1 and Pex6 exhibit a highly conserved aspartate and glutamate within the Walker B 
(WB) consensus sequence of D2 domains (Figure 3.5). Earlier publications of related AAA+ 
proteins revealed that substitution of Walker B aspartate or glutamate by uncharged 
equivalents (D/E→N/Q) block ATP hydrolysis but not ATP binding (Weibezahn et al., 2003; 
Dalal et al., 2004; Schaupp et al., 2007). Therefore, corresponding glutamates of either 
Pex1D2 or Pex6D2 are mutated to glutamine (Pex1E798Q, Pex6E832Q). Co-purification of 
mutated gene products from E. coli with the wild type of the respective other subunit 
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(Pex1WBATP/6, Pex1/6WBATP) or co-expression of mutated subunits (Pex1/6DWBATP), results 
in monodisperse complexes, used for subsequent activity assays (Figure 3.17 A). 
As reported previously, the overall ATPase rate of isolated wild type Pex1/6 complexes with a 
km of ~ 0.17 mM and a Vmax of ~ 0.35 nmol min-1 µg-1 is comparable to type II AAA+ 
ATPases p97 or NSF (Saffian et al., 2012). As depicted in Figure 3.17 B, mutations in the 
Walker B motif of Pex1 reduces the ATPase activity to ~ 80 % of wild type levels. In contrast, 
Pex1/6WBATP complexes lost the ability to hydrolyse ATP despite the presence of wild type 
Pex1. Moreover, ATPase activity of double Walker B complexes is completely compromised. 
Notably, Walker B mutations in individual subunits result in different in vitro ATPase 
activities of Pex1/6 complexes. Thus, Pex1D2 and Pex6D2 domains contribute differently to 
the complex’ ATPase activity.  
 
Figure 3.17 Pex1/6 Walker B variants tested in ATPase activity and oleate spotting assays. (A) 
Size exclusion chromatography A290nm profiles of purified Pex1/6 complexes used for ATPase 
activity assays. Colour code is given. (B) Michaelis Menten plot of enzyme activity of wild type 
Pex1/6ATP and single Walker B mutants (Pex1WBATP/6, Pex1/6WBATP) at various ATP concentrations. 
Error bars represent standard deviation of six experiments. (C) ATPase activities of the wild type 
Pex1/6 complex (Pex1/6ATP) and double Walker B mutants (Pex1/6DWBATP), as indicated. Assays were 
performed in the presence of 1mM ATP and 5mM Mg2+ at 37°C. Error bars represent standard 
deviation of five experiments. (D) Growth of strains expressing wild type (PEX1, PEX6), no (pex1Δ, 
pex6Δ) or mutated Pex1, Pex6 alleles with modified Walker B motifs (pex1E798Q, pex6E832Q,) on either 
glucose or oleate as single carbon source. All figures are kindly provided by I. Grimm (in collaboration 
with the lab of Prof. Ralf Erdmann, Ruhr-Universität Bochum). 
 
Next, to dissect the influence of Pex1/6 D2 active sites on complex function in vivo and to 
compare it to in vitro hydrolysis activity, respective ATPase-deficient variants are tested for 
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genetic complementation. To this end, modified Pex1/Pex6 alleles (pex1E798Q, pex6E832Q) are 
expressed under the control of their native promotors and tested towards cell viability upon 
oleate exposure. In line with the results obtained from ATPase activity assays, Pex1E798Q cells 
are apparently associated with normal growth comparable to wild type cells (PEX1/PEX6, 
Figure 3.17 C). In contrast, cells expressing Pex6E832Q are not viable under oleic acid-
conditions.  
Hence, Pex1WBATP/6 complexes retain ~ 80 % of wild type hydrolysis activity and are 
functionally active in vivo. In contrast, mutating the conserved glutamate of the Pex6 D2 
domain results in loss of in vitro ATPase activity and Pex1/6 complex function in vivo. This 
implies functional differences between Pex1 and Pex6 subunits. While ATP hydrolysis in 
Pex6D2 is essential for functionally active complexes, hydrolytic activity of Pex1D2 is 
dispensable for in vivo function.  
Surprisingly, these findings are in contrast to previous publications that showed that a non-
conservative aspartate-to-glutamine mutation in the Walker B motif of Pex1D2 (Pex1D797Q) 
results in non-functional complexes in vivo (Birschmann et al., 2005). To pursue these 
contradictory results, a more common aspartate-to-asparagine mutation is introduced in the 
Pex1D2 Walker B motif (Pex1D797N) and tested towards cell viability under oleic-acid 
conditions. As depicted in Figure 3.18 A, growth of Pex1D797N cells is abolished upon oleate 
exposure.  
 
 
Figure 3.18 Cell viability and negative stain analysis of Pex1 Walker B mutant. (A) Growth of 
strains expressing either wild type (PEX1), no (pex1Δ) or mutated Pex1 allele with modified Walker B 
motif (pex1D797N) on either glucose or oleate as single carbon source. (B) Raw negative stain electron 
micrograph of purified Pex1D797N/Pex6 complexes treated with 4 mM ATP.  
 
Subsequently, Pex1D797N is co-purified with wild type Pex6 followed by size exclusion 
chromatography in the presence of ATP (performed by I. Grimm, data not shown) and 
samples of purified Pex1D797N/Pex6ATP complexes are investigated using negative stain EM. To 
this end, Pex1D797N/Pex6ATP gel filtration fractions corresponding to the molecular weight of 
hexamers are mixed with ATP, negatively stained and visualized by EM. The raw micrograph 
shows some single particles resembling the expected size of Pex1/6 complexes, mainly devoid 
of expected trimeric symmetry, though (Figure 3.18 B). Also, a substantial number of small 
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particles representing unassembled protein are clearly visible. This result demonstrates a 
significantly reduced ability of Pex1D797N/Pex6ATP to promote nucleotide-dependent 
hexamerisation. Accordingly, limited growth of corresponding alleles under oleic acid-
conditions could be explained by disturbed complex formation.  
Pex1D797Q/Pex6ATP samples could not be further pursued by negative stain EM because protein 
concentrations after co-purification have been too low, hinting that the Walker B mutation 
Pex1D797Q also interferes with the complex’ capability to form stable hexamers. Thus, 
diminished complex function upon expression of Pex1D798Q in vivo most likely correlates with 
impaired hexamerisation. 
 
3.5.2 Structural architecture of negatively stained Pex1/6 Walker B complexes  
To provide a three-dimensional framework of ATPase-deficient Pex1/6 variants in context of 
wild type hexamers, the negative stain structures of mutant complexes are determined.  
To this end, hetero-oligomers mutated either in the Pex1D2 domain (Pex1WBATP/6), in the 
Pex6D2 domain (Pex1/6WBATP) or both domains (Pex1/6DWBATP) are expressed and isolated 
from yeast. In the presence of ATP, fractions from glycerol density gradient centrifugation 
corresponding to the molecular weight of heterohexamers (Figure 3.4 B, C) are negatively 
stained and subsequently imaged using EM (Figure 3.19 A-C). A negative stain data set is 
acquired for every Pex1/6 Walker B complex resulting in 2073 (Pex1/6DWBATP), 2048 
(Pex1/6WBATP) and 2064 (Pex1WBATP/6) raw particle images. After classification by MSA 
and MRA, initial 3D models are build in IMAGIC by angular reconstitution and further 
refined in SPIDER throughout repetitive cycles using projection matching, imposing 3-fold 
symmetry. Class averages, obtained by MSA after the last round of refinement, are in very 
good agreement with resultant re-projections of the final 3D reconstructions (Figure 3.19 A-C, 
inserts). Final Pex1/6 Walker B EM density maps at resolutions of 23 Å (Figure 3.19 D, E) 
display a trimeric symmetry in top views and double-capped side views (Figure 3.20). The 
overall dimensions for all reconstituted complexes are similar in height (110 Å-120 Å) and 
width (161 Å-165 Å). The central AAA+ core of the Walker B complexes shows C6 
symmetry and well-resolved densities for ATPase domains. Particularly, the 3D reconstruction 
of Pex1/6DWBATP resembles a well-structured domain arrangement in the D1 and D2 layers 
and is almost identical to Pex1/6ATPγS. Apparently, the presence of ATPγS or mutations of the 
conserved Walker B glutamate in both, Pex1D2 and Pex6D2 locks the active sites in a 
nucleotide bound state. Hence, ATP binding to the Pex1/6 D2 domains directs the AAA+ 
domains into an arrangement similar to hexameric crystal structures of p97. 
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Figure 3.19 Negative stain analysis of Pex1/6 Walker B complexes. Raw electron micrographs of 
~ 40-50 µg ml-1 Pex1/6DWBATP (A), Pex1/6WBATP (B) and Pex1WBATP/6 (C) mixed with 2 mM ATP. 
Representative class averages derived from MSA show averaged 2D top and side view projection (A-C 
inset, upper row) and corresponding re-projections of the final 3D volume in the Euler-angle directions 
assigned to the projections (A-C inset, lower row). Each class contains on average five to ten images. 
Scale bar, 100 nm. (D) FSC curves of final 3D volumes, measured at the 0.5 cut-off criterion (colour 
code and resolutions are given). The graphs show the FSC plotted against spatial frequency [1/Å]. (E) 
Euler plots for Pex1/6 datasets after final refinement with projection matching. The polar (θ) and 
azimuthal (Φ) directions are indicated for Pex1/6DWBATP (directions for mirrored particles, θ’ and Φ’, 
are indicated in pink). The C3 symmetry axis is placed in the centre of each Euler plot circle. 
 
The similarity between independently generated 3D reconstructions Pex1/6ATPγS and 
Pex1/6DWBATP further verifies the structural integrity of the complexes during negative 
staining procedures and emphasizes the consistency of the underlying image processing 
procedures. As observed for wild type Pex1/6 complexes, upon hexamerisation Pex1/Pex6 N-
terminal densities emerge apical from the D1 layer, sitting on the top and at the vertices of the 
Pex1/6DWBATP complex. The N-termini arrange in discrete domains making contacts between 
Pex1D2 and Pex6N. Moreover, the Pex1/6DWBATP complex features a central channel 
traversing the complex from the D1 to the D2 domain, respectively, its diameter ranging from 
14 Å (D2) up to 23 Å (D1). Similar to Pex1/6ATPγS, a small N-terminal density appears at the 
symmetry axis on the apical surface of D1, thereby blocking the central pore.  
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Figure 3.20 Final EM reconstructions of Pex1/6 single and double Walker B complexes. Negative 
stain EM maps of Pex1/6 complexes harbouring a mutation in the Walker B motif of Pex1D2 and 
Pex6D2 (Pex1/DWBATP), Pex6D2 (Pex1/6WBATP) or Pex1D2 (Pex1WBATP/6) in the presence of ATP as 
side views (upper row), followed by top views, and cross-sections of the D1 and D2 layers (lower 
rows). Pex1/6ADP-AlFx EM reconstruction is shown for comparison. Pex1/6 protomers are coloured 
corresponding to Figure 3.9 F. 
 
In contrast, flexible N domains of single Walker B complexes protrude towards the central 
symmetry axis above the D1 domains. While N-termini of Pex1WBATP/6 still restrict the 
access to the central channel, Pex1/6WBATP complexes display an N-terminal entrance into a 
large cavity. The pore diameter of the Pex1WBATP/6 D1 domain is significantly extended 
compared to all other Pex1/6 3D reconstructions described so far in this study. However, 
intriguingly, the D1 layer of Pex1/6WBATP expands even more to a large central cavity of 61Å 
diameter. In line with previous studies of AAA+ protein Hsp104 (Wendler et al., 2007), 
domains in Pex1/6WBATP D1 presumably adopt an atypical arrangement in this layer. Hence, 
in Pex1/6WBATP individual D1 domains are likely only marginally attached to each other. 
As judged from the negative stain EM reconstructions of single Walker B complexes, N- 
terminal and D1 domains exhibit a significant degree of freedom. Furthermore, permanent 
binding of ATP in Pex6D2 might trigger inter-domain communications that cause the 
described outward movement of D1 domains, comparable to the architecture of yeast type II 
AAA+ protein Hsp104.  
However, when compared to the overall shape of Pex1/6ADP-AlFx, the orientation of Pex1/6 N-
termini and D1 domains of single Walker B complexes are somewhat similar. Accordingly, 
the D2 domains of Pex1/6ADP-AlF, Pex1WBATP/6 or Pex1/6WBATP are closed, depicting a 
tightly packed domain arrangement in this layer. Strong connecting densities between Pex1D1 
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and Pex6D2 appear at the outside of the Pex1/6WBATP complex comparable to Pex1/6ADP-AlFx 
(Figure 3.20, yellow ring). In analogy to Pex1/6ADP-AlFx, this result indicates that Pex1 
protomers might adopt a transition state like orientation when Pex6 is permanently bound to 
ATP.  
3.6 Pex1/6 Walker B complexes: dissecting steps of ATP binding and hydrolysis 
ATPase activity assays revealed that Pex1 and Pex6 D2 domains contribute differently to the 
complex’ overall hydrolysis activity. Furthermore, when the conserved glutamate of the 
Pex1D2 Walker B motif is exchanged to glutamine, the resultant Pex1WBATP/6 complex is 
still functional (Figure 3.17). Thus, the Pex1WBATP/6 EM map shows a hydrolytically active 
complex. Intriguingly, the overall shape of the hexamer is not significantly altered compared 
to the inactive Pex1/6WBATP assembly. In contrast, the appearance of single Walker B 
complexes is very distinct from Pex1/6DWBATP assemblies. To further dissect structural 
differences induced by ATP binding to individual subunits in D2 domains of either Walker B 
complex, Pex1/6 D2 domain movements are examined in more detail. 
In analogy to wild type complexes, Pex1/Pex6 homology models can be readily fitted into the 
EM densities of the D2 domains of all Pex1/6 Walker B complexes using the automated fitting 
procedure in Chimera (Figure 3.21 A).  
 
 
 
 
Figure 3.21 Docking of Pex1/6 homology models to the D2 domain of Pex1/6 Walker B EM 
density maps. (A) D2 cross-section views and side view surface representation of EM reconstructions 
as indicated. Pex1/6 homology models are automatically fitted to the D2 domain and are coloured as in 
Figure 3.9 F. (B) Side view surface representation of 3D maps as indicated. One heterodimer is omitted 
from the 3D reconstructions. Underneath, a cartoon representation based on rigid body fits of homology 
models into negative stain EM maps is shown. Pex1/6ATPγS and Pex1/6ADP-AlFx are depicted in grey for 
comparison. Pore facing aromatic residues Pex1F771 and Pex6Y805 are shown as green spheres. 
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The positions of conserved pore-facing residues Pex1F771 and Pex6Y805 are highlighted in 
automatically fitted homology models. As depicted in Figure 3.21 A, Pex1F711 and Pex6Y805 
protrude towards the central opening of the D2 domain in the hexameric homology models. 
Furthermore, fitted homology models emphasize that the ATPase domains of the D2 ring are 
firmly connected in all Pex1/6 Walker B 3D reconstructions.  
Next, domain re-arrangements and resulting localization of Pex1F711 and Pex6Y805 in 
reconstructed Walker B complexes are examined in the context of ATP binding and hydrolysis 
that is structurally described by Pex1/6ATPγS and Pex1/6ADP-AlFx EM density maps.  
As judged from negative stain 3D reconstructions, orientations of Pex1 and Pex6 D2 domains 
are almost identical in Pex1/6ATPγS or Pex1/6DWBATP complexes (Figure 3.21 B). ATP 
binding to Pex1D2 or Pex6D2, respectively, places the D2 domains and concomitantly 
Pex1F711 and Pex6Y805 in one plane.  
In line with this result, the orientation of Pex6Y805 in the Pex1/6WBATP complex verifies 
Pex6D2 domains in an ATP locked state. Surprisingly, the position of Pex1F771 resembles a 
transition state like orientation, similar to Pex1/6 complexes captured in the presence of ADP-
AlFx. Pex1F771 translocates downwards towards the pore exit. Hence, ATP binding to Pex6D2 
induces ATP hydrolysis in adjacent Pex1D2 domains.  
Intriguingly, in Pex1WBATP/6 complexes domain movements of Pex1D2 or Pex6D2 hint at 
ATP hydrolysis in both D2 domains. Aromatic residues Pex1F771 and Pex6Y805 point toward 
the channel exit in D2, resulting from a downward movement of those domains. 
 
3.7 ATPase activity of Pex1/6 arginine finger and ISS motif mutants 
As judged from rigid body fits to negative stain EM reconstructions of Pex1/6 single Walker B 
complexes, Pex1 possibly hydrolyses ATP in the D2 domains. Thus, potential intersubunit-
signalling pathway between protomers might be responsible for an inhibitory effect on ATP 
hydrolysis in Pex1.  
Previous publications on heterohexameric m-AAA protease Yta10/12 from yeast 
demonstrated a close signalling network between protomers that involves the arginine finger 
and residues in the inter-subunit signalling (ISS) motif (Augustin et al., 2009). Corresponding 
mutations in Pex1 might uncouple an intrinsic hydrolysis activity when tested in ATPase 
activity assays. Besides a conserved aspartate in the ISS motif consensus sequence of Pex1 
(Pex1D826), multiple sequence alignment also reveals arginine residues that match position 1 
and 2 arginine fingers of p97 (Figure 3.5, Pex1R852, Pex1R855). For subsequent analysis in 
activity assays, the aspartate within the ISS motif of Pex1 is modified to valin in Pex1/6WBATP 
complexes (Pex1D826V/6WBATP, performed by I. Grimm) whereas the highly conserved 
position 2 arginine finger of Pex1 is substituted by lysine (Pex1R855K/6, performed by I. 
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Grimm). If Pex1 ATPase activity is influenced by intersubunit communication, the aspartate-
to-valin mutation should uncouple Pex1D2 active sites from ATP bound Pex6 and allow 
nucleotide cycling in Pex1. The conservative arginine-to-lysine mutation should similarly 
separate Pex1D2 from adjacent Pex6D2 nucleotide binding pockets. However, negative stain 
EM of Pex1R855K/6 complexes and analytical gel filtration of Pex1D826V/6WBATP imply that 
those mutations impair complex formation (Figure 3.17 A, Figure 3.22 B). Thus, when 
examined in ATPase activity assays, both mutations in Pex1 result in negligible hydrolytic 
activity (Figure 3.22 A, performed by I. Grimm). The abolished capability to form stable 
hexamers might also explain the abolished viability of cells expressing pex1R855K arginine 
finger mutant (Figure 3.16 B). 
 
 
Figure 3.22 ATPase activity and negative stain analysis of arginine finger and ISS motif mutants. 
(A) Raw negative stain EM micrograph visualizing arginine finger variant Pex1R855K/6 in the presence 
of 4 mM ATP. Scale bar, 100 nm. (B) ATPase activities of the wild type Pex1/6 complex (Pex1/6ATP), 
Pex1 arginine finger (Pex1R855K/6) or ISS motif (Pex1D826V/6WBATP) mutants, as indicated. Assays were 
performed in the presence of 1 mM ATP and 5 mM Mg2+ at 37°C. Error bars represent standard 
deviation of five experiments. Figure is kindly provided by I. Grimm.  
 
In summary, permanent binding of ATP to Pex6D2 domains blocks most of the complex’ 
hydrolytic activity in vitro and abolishes complex function in vivo. In contrast, ATPase 
activity of Pex1D2 is non-essential. However, in vivo assays show that Pex1 and particularly 
conserved pore-facing residue Pex1F771 are crucial for functional complexes. Furthermore, 
domain rotations observed in the Pex1/6WBATP EM structure suggests ATP hydrolysis in 
Pex1D2. Still, Pex6D2 exhibit the main catalytic activity of the complex, whereas Pex1D2 
seem to be indispensible for the structural integrity of the complex. 
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4 Discussion 
The AAA+ proteins Pex1/Pex6 are central components of the peroxisomal matrix protein 
transport system in yeast and humans (Collins et al., 2000; Miyata and Fujiki, 2005). Primary 
action upon ATP consumption involves release of protein import receptor Pex5 from the 
peroxisomal membrane to the cytosol (Miyata and Fujiki, 2005; Platta et al., 2005). Single 
mutations in mammalian Pex1 or Pex6 severely affect normal development in humans 
(Geisbrecht et al., 1998; Birschmann et al., 2003; Birschmann et al., 2005), highlighting the 
importance of these peroxins in peroxisome synthesis. 
Our study provides a comprehensive structural characterization of the heterohexameric Pex1/6 
AAA+ complex using negative stain EM. The role of ATP turnover in individual Pex1/6 
active sites is addressed in biochemical assays, revealing that D2 domains are functionally 
non-redundant. EM analysis of Pex1/6 in the presence of different nucleotides gives valuable 
mechanistic insights on ATP dependent inter- and intra-domain communications, like diagonal 
inter-domain contacts between D1 and D2 domains upon ATP hydrolysis in the D2 ring. 
Furthermore, the Pex1D2 small helical domain interacts with Pex6 N domains in all wild type 
Pex1/6 complexes incubated with ATP and nucleotide hydrolysis is enabled when two 
adjacent D2 domains are bound to ATP. Varying pore sizes of D1 or D2 domains likely results 
from intra-domain communication.  
Summarizing the functional and structural data obtained, leads to a model in which the 
peroxisomal AAA+ complex hydrolyzes ATP in a non-concerted manner to thread its 
substrate along the central pore.  
 
4.1 Unique architecture of Pex1/6 complexes 
Purified Pex1/Pex6 proteins assemble into double-tiered hexamers depicting a unique 
architecture, yet not observed for other members of the AAA+ family. While the AAA+ 
domains constitute the central hexameric core of the complex, the N-terminal domains are 
located lateral and apical of the D1 domains. A comparison of EM structures of wild type 
Pex1/6 and truncated complexes (∆188Pex1/Pex6), allocates Pex1 N domains on top of the 
complex in every second subunit, whereas Pex6 N domains reside at the periphery of the 
central hexameric fold, resulting in the shape of an equilateral triangle. Accordingly, Pex1/6 
hexamers comprise an alternating subunit arrangement, forming a trimer of heterodimers. 
These results overlap with a recent study (Gardner et al., 2015), which was published while 
this thesis was in preparation. The authors verify the protomer assignment of Pex1 and Pex6 
within the hexamer, using an N-terminal maltose-binding protein (MBP) tag on Pex6.  
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According to Pex1/6 EM reconstructions in the presence of ATP, ATPγS or double Walker B 
mutations, Pex1 N-termini arrange as globular densities apical of the D1 domains. On the 
other hand, in all transition states (ADP-AlFx, Pex1WBATP/6, Pex1/6WBATP), Pex1N close or 
almost close the central channel. Shiozawa et al. (2004) proposed that the N-terminal double 
ψ-barrel fold domain of Pex1 binds adaptors or substrates comparable to its homologs NSF or 
p97. Hence, flexibility of Pex1N might enable rapid structural adaption required for substrate 
coordination or adaptor protein interactions. Additionally, in case of a substrate threading 
mechanism through the central pore of Pex1/6 complexes, dynamic re-arrangements of Pex1 
N-terminal domains likely sustain directed substrate translocation.  
In contrast, the Pex6 N-termini are thought to locate the ATPase complex to the peroxisomal 
membrane through binding to Pex15 (Birschmann et al., 2003). The static appearance of 
Pex6N in all nucleotide states suggests a physiological conformation. Thus, placing the 
complex to the peroxisomal membrane via interactions with Pex15 does not require major 
conformational re-arrangements in Pex6 N domains. 
The unique architecture of Pex1/6 complexes is attributed to the heterohexameric arrangement 
and differences in the dimensions of the N-terminal domains. In comparison to AAA+ 
proteins p97 or NSF, N domains of Pex1 or Pex6 are double the size, thus allowing 
particularly Pex6N to range from the D1 down to the D2 domain at the outside of the 
hexameric AAA+ core. Accordingly, peripheral Pex6 N-termini might help to maintain the 
hexameric state of Pex1/6 complexes. Furthermore, extension of Pex6 N domains along the 
AAA+ rings enables inter-domain contacts with the Pex1D2 small α-helical domain, which 
are visible in all wild type Pex1/6 EM structures in the presence of ATP. These contacts 
possibly further stabilize the hexameric arrangement or are required for domain cooperativity.  
 
4.2 The Pex6 D2 domains energize the complex 
Hexamer assembly provides a molecular arrangement, which allows efficient ATP hydrolysis 
in Pex1/6 complexes. Exchanging the glutamate in the conserved Walker B motif in either 
Pex1D2 (Pex1E798Q) or Pex6D2 (Pex6E832Q) reveals the impact of these individual nucleotide-
binding sites on overall ATPase activity in vitro. The hydrolytic activity is abolished in 
complexes mutated in Pex6D2 (Pex1/6WBATP), whereas ATPase activity of Pex1D2 mutant 
complexes (Pex1/6WBATP) results in about ~ 80 % of wild type level. Moreover, mutations in 
both D2 domains (Pex1/6DWBATP) entirely compromise ATP hydrolysis. Thus, the hydrolytic 
behaviour of Pex1/6 D1 and Pex1 D2 domains is negligible and catalytic activity traces back 
to Pex6D2. Correspondingly, the D1 domains are inactive compared to the D2 domains. 
Differences in the catalytic activity between AAA+ rings in p97 or other type II AAA+ 
ATPases suggested a division of labour between D1/D2 domains, divided into an 
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oligomerisation domain and a hydrolytically active domain (Matveeva et al., 1997; Schlee et 
al., 2001; Song et al., 2003; Briggs et al., 2008). Hence, the Pex1/6 D1 domain might be 
needed to stabilize oligomerisation whereas the D2 domain is the main site for ATP 
hydrolysis.  
According to the results from ATP hydrolysis assays, the contribution of Pex1D2 or Pex6D2 
to overall hydrolytic activity differs significantly. It is possible that Pex1D2 ATPase activity is 
compromised in the isolated complex under the conditions assayed. A similar dependency of 
ATP turnover coupled to experimental conditions was reported for type II AAA+ protein 
Hsp104. The ATPase activity of Hsp104 varies depending on salt concentrations of the buffers 
used (Hattendorf and Lindquist, 2002; Schaupp et al., 2007), with Hsp104 starting to 
dissociate when ionic strength is elevated above 50 mM salt (Schirmer et al., 1998; Schirmer 
et al., 2001). On the other hand, related type II AAA+ proteins p97, ClpA or NSF generally 
tolerate salt concentrations up to 300 mM in ATP hydrolysis assays (Rockel et al., 2002; 
Hinnerwisch et al., 2005; Zhao et al., 2010)  
Alternatively, catalytic activity of Pex1 could be elevated in the presence of substrate. The 
addition of substrates or substrate mimics was shown to stimulate ATPase turnover of HslU 
(Yoo et al., 1996), Yta10/Yta12 (Augustin et al., 2009) or Hsp104/ClpB (Mogk et al., 2003; 
Schaupp et al., 2007). Additionally, an ample analysis of AAA+ crystal structures by Zhang 
and Wigley (2008) propose a signalling network between ATPase subunits and ligand binding 
sites. The authors state that ATP hydrolysis does not proceed until corresponding complex-
ligand interactions are fully established. Thus, hydrolytic activity of Pex1 might be induced 
once the substrate is bound to the complex. Additionally, the aforementioned inter-domain 
contact between Pex6N and Pex1D2 small α-helical domain might contribute in the regulation 
of the ATPase activity in Pex1D2. In contrast, ATP hydrolysis in Pex6D2 has been suggested 
to coordinate ATP dependent Pex15 anchoring to the peroxisomal membrane (Birschmann et 
al., 2003). Accordingly, the catalytic activity of Pex6 might be less strictly coupled to 
substrate interactions.  
4.3 Possible specialisation of Pex1 and Pex6 D2 domains 
To validate the observed in vitro hydrolysis activities, growth on oleate as the sole carbon 
source demonstrates that Pex1WBATP/6 complexes are functional in vivo. In contrast, mutating 
the conserved glutamate of the Pex6 D2 domain affects viability of cells expressing 
Pex1/6WBATP complexes. Those results corroborate major functional differences between 
Pex1 and Pex6 subunits. While ATP turnover in Pex6D2 is crucial for complex activity, 
hydrolytic activity of Pex1D2 is dispensable for in vivo function.  
Surprisingly, these results are in contrast to previous publications that showed that a non-
conservative aspartate-to-glutamine mutation in the Walker B motif of Pex1D2 (Pex1D797Q) 
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results in inactive complexes in vivo (Birschmann et al., 2005). In our study, a more conserved 
aspartate-to-asparagine (Pex1D797N) mutation also interferes with complex function and 
stability. We could show that diminished complex function upon expression of Pex1D798N (this 
study) or Pex1D798Q in vivo (Birschmann et al., 2005) results from impaired hexamerisation. 
It is possible that exchanging the Pex1 Walker B aspartate to either asparagine or glutamine in 
the nucleotide binding pocket sterically compromises ATP binding to Pex1D2 and thus, 
complex formation. This assumption could be verified in future mutational studies, examining 
the effect of aspartate-to-alanine mutations on complex hexamerisation. Accordingly, correct 
positioning and coordination of ATP in Pex1D2 active sites might be essential to perpetuate 
the structural organisation of the Pex1/6 complex in vivo and in vitro, while hydrolytic activity 
in Pex6D2 allows the complex to fulfil physiological tasks.  
In line with these observations, it was shown that ATP binding to Pex1D2 promotes complex 
formation (Birschmann et al., 2005; Saffian et al., 2012) and functional D2 domains of both, 
Pex1 and Pex6 are linked to act on substrate Pex5 (Platta et al., 2005). Furthermore, it was 
suggested that the N-termini of Pex1 bind the substrate (Shiozawa et al., 2004). It is therefore 
possible that responsibilities of Pex1 and Pex6 D2 domains vary during Pex5 relocation to the 
cytosol. ATP binding to Pex1D2 may drive hexamerisation and thus, function as structural 
subunits in Pex1/6 complexes to bridge interactions with Pex5, whereas Pex6 D2 domains 
supply the dislocation reaction with energy from ATP hydrolysis.  
Previous publications on other heterohexameric AAA+ proteins Mcm2-7, the replicative 
sliding-clamp loader complex, the F1 ATPase or dynein could demonstrate that individual 
ATPase sites in this complexes adapt distinct roles with only a subset of nucleotide binding 
sites being catalytically active (Boyer, 1993; Jeruzalmi et al., 2001; Kon et al., 2004; 
Bochman et al., 2008).  
 
4.4 EM structures suggest that all D2 domains hydrolyse ATP  
While biochemical studies have already produced evidence for communication between 
consecutive subunits in AAA+ rings (Augustin et al., 2009, Martin et al., 2005, Moreau et al., 
2007) EM reconstructions of hetero-oligomers, Pex1WBATP/6, Pex1/6WBATP or 
Pex1/6DWBATP are used to structurally dissect the influence of nucleotide binding to distinct 
binding pockets.  
In EM reconstructions of Pex1/6ATPγS or Pex1/6DWBATP complexes, Pex1 and Pex6 D2 
domains show a planar, crystal structure like arrangement. Rigid body fits of Pex1/6 
homology models to those EM maps highlight an upward directed position of D2 domains, 
arranging in one plane. Hence, it can be assumed that the presence of ATPγS or mutations of 
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the conserved Walker B glutamate in both, Pex1D2 and Pex6D2 locks the active sites in a 
nucleotide loaded state, thereby placing the domains in an elevated orientation. 
The orientation of mutated Pex6 D2 subunits in 3D reconstructions of single Walker B 
complex Pex1/6WBATP suggest, that ATP occupies these subunits. Remarkably, the position of 
the adjacent Pex1 D2 domain adopts a transition state like orientation, comparable to the 
domain rotation observed for Pex1D2 in the Pex1/6ADP-AlFx EM map. Hence, nucleotide binding 
to Pex6D2 may force Pex1D2 in a post-hydrolysis state. Furthermore, this finding implies that 
ATP hydrolysis is not blocked completely in Pex1 D2 domains. Since Pex6D2 mutant 
complexes are not hydrolytically active in vitro, it is possible that ATP hydrolysis in Pex1D2 
occurs only once before these active sites become stalled without releasing nucleotide.  
In line with aforementioned results, when Pex1D2 carries a Walker B mutation, adjacent Pex6 
D2 subunits are placed in a transition state like orientation as suggested by downward directed 
motions of this domain in rigid body fits to the Pex1WBATP/6 EM reconstruction. Intriguingly, 
the domain arrangement of mutated Pex1D2 subunits in the complex hint at ATP hydrolysis, 
too. This is somewhat surprising since the Walker B mutation should lock Pex1D2 in an ATP 
bound state as seen in Pex1/6DWBATP complexes. However, since Pex1WBATP/6 complexes 
actively hydrolyse ATP, the EM map might represent a mixture of conformational states and 
the interpretation of observed orientations of D2 domains is challenging and less reliable. One 
explanation for the downward translation of Pex1D2 could be that the down rotation of 
Pex6D2 causes Pex1D2 to follow.  
 
4.5 Intersubunit signalling 
The Walker B mutations in Pex1 and Pex6 have revealed differences between the two proteins 
in the complex, although nucleotide hydrolysis seems to be dependent on the nucleotide state 
of neighbouring active sites. Conserved residues that sense the nucleotide occupancy in either 
binding pocket of Pex1/6 D2 domains likely communicate across subunits thereby regulating 
ATP hydrolysis. Previous publications on type I m-AAA protease Yta10/Yta12 from yeast 
demonstrated that the ATPase activity of the heterohexamer is alleviated to 30% of the wild 
type level when the Walker B motif in Yta10 is mutated, whereas ATPase activity is 
diminished upon mutation of the Walker B motif in Yta12 (Augustin et al., 2009). The authors 
suggest an intimate communication between protomers that involves the arginine finger and 
residues of the inter-subunit signalling (ISS) motif that regulates ATP hydrolysis in Yta10 
when Yta12 is ATP loaded.  
In our study, oleate growth assays established that both Pex1/6 D2 domains posses functional 
position 2 arginine fingers and corresponding mutation in Pex1 is surveyed in ATPase assays 
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and negative stain EM (Pex1R855K). Accordingly, arginine finger mutation Pex1R855K interferes 
with complex hexamerisation and impaired ATP hydrolysis of Pex1R855K/6 complexes results 
from compromised capability to assemble into hexamers. It is therefore plausible that the 
position 2 arginine finger is essential for hexamer stability rather than ATP hydrolysis. 
However, Gardner et al. (2015) could show that the mutation of position 1 arginine finger in 
Pex1 (Pex1R852K) could not release hydrolytic activity in Pex1D2 either. Similarly, exchanging 
the conserved aspartate of the Pex1D2 ISS motif (Pex1D826V, this study) results in negligible 
ATPase activity. 
 
4.6 Implications for a substrate threading mechanism in Pex1/6 
In the first crystal structure of full-length p97, a zinc ion occludes the D1 domain (DeLaBarre 
and Brunger, 2003) and following structural studies showed that p97 crystallised 
predominantly into tightly packed hexamers, independent of the nucleotides present (Huyton 
et al., 2003; Davies et al., 2008; Tang et al., 2010). Hence, it was assumed that the 
physiological function of p97 during ERAD does not involve polypeptide translocation 
through its central pore. In contrast to p97 crystal structures, the diameter of the inner pore of 
Pex1/6 D1 or D2 domains varies considerably. Furthermore, while D1 and D2 domains are 
symmetrically stacked on top of each other in p97, the displaced arrangement of D1 and D2 
AAA+ rings observed in EM reconstructions of Pex1/6 complexes is structurally closer to the 
one of ClpA and Hsp104 (Guo et al., 2002; Wendler et al., 2007; Effantin et al., 2010).  
AAA+ members from the Clp/Hsp100 protein family are thought to process substrates via 
translocation through their central pore, involving conserved pore loops (Weibezahn et al., 
2004; Hinnerwisch et al., 2005; Martin et al., 2008; Kress et al., 2009). Our EM structures 
show that Pex1 and Pex6 assemble into double-ring hexamers, featuring a central channel, 
which extends from the D1 to the D2 domain in most nucleotide states. In rigid body fits of 
Pex1/6 homology models to EM reconstructions of wild type or mutated Pex1/6 complexes, 
conserved substrate binding residues surround the pore of the D2 ring. Those residues 
correspond structurally and sequentially to pore 1 loops of related AAA+ proteins 
(Hinnerwisch et al., 2005; DeLaBarre et al., 2006; Martin et al., 2008), shown to be essential 
for substrate processing. In Pex1 or Pex6, mutations of those pore-protruding residues 
severely affect complex function in vivo, suggesting physiological substrate interaction with 
both, Pex1 and Pex6, respectively, during the ATPase cycle of Pex1/6 complexes.  
The positions of those substrate interacting residues in rigid body fits to the Pex1/6ATPγS or 
Pex1/6DWBATP EM reconstructions show that D2 domains rotate into the pore, moving pore 1 
loops upward into similar axial planes and closer together (Figure 4.1, full ATP). ATPγS is 
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generally thought to prolong the ATP bound state of AAA+ proteins and has been shown to 
stimulate substrate binding (Bolon et al., 2004). Thus, positioning of the substrate binding 
loops in the upmost position of the D2 ring compares to grabbing of the substrate. ATP 
hydrolysis in D2 domains, structurally presented by the Pex1/6ADP-AlFx complex, induces 
domain translocation downwards along the central channel, placing substrate binding loops at 
the C-terminal exit of the D2 layer, concomitantly closing the ring. The latter movement 
possibly prevent the substrate from slipping or translocating back. Accordingly, large-scale 
domain translocation upon ATP hydrolysis creates a power stroke, which would pull the 
substrate towards the pore exit (Figure 4.1, post-hydrolysis). A comparable out of plane 
rotation of entire AAA+ domains upon ATP hydrolysis has been observed for p97 D2 
domains, highlighted by structural comparison of ADP and AMPPNP bound p97 crystal 
structures (DeLaBarre et al., 2006). In our study, Pex1/6 D2 domains are translocated by 
~10Å when ATP is hydrolysed. This step size agrees to data obtained in single molecule 
studies for ClpX during substrate threading (Aubin-Tam et al., 2011; Maillard et al., 2011).  
 
 
 
Figure 4.1 Model for Pex1/6 movements during ATP binding and hydrolysis. The Pex1/6 complex 
anchors to the peroxisomal membrane via binding of Pex6 N domains to Pex15. Pex1 N domains 
establish interactions with substrate Pex5. ATP binding to Pex1D2 and Pex6D2 (full ATP, ATPγS) 
elevates substrate-binding loops in D2, ready to establish interactions with Pex5. ATP hydrolysis 
induces a power stroke that rotates the D2 domains downwards and pulls bound substrate along the pore 
(post-hydrolysis, ADP-AlFx). ATP consumption in Pex6D2 (Pex1/6WBATP, Pex1WBATP/6) 
energizes substrate threading along the central pore. One Pex1 and Pex6 protomer are denoted as simple 
cartoon representation. Pex1/6 are coloured as in Figure 3.9 F. Conserved aromatic residues of 
substrate-binding loops are shown as green dots. Representative tertiary structures of substrate protein 
Pex5 (purple) and membrane anchor Pex15 (green) are depicted as cartoon representations. Nucleotide 
occupancy of each D2 domain is indicated by T for ATP or Pi for the transition state. 
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Thus, continuous re-arrangements of entire ATPase domains between ATPγS and ADP-AlFx 
bound states might constitute the driving force behind substrate threading in Pex1/6 
complexes. Furthermore, our EM structures suggest that ATP hydrolysis in D2 domains 
requires two adjacent subunits to be bound to ATP. This is further corroborated by 
orientations of D2 domains in Pex1/6 complexes harbouring a single Walker B mutation. ATP 
binding to one D2 subunit forces the right hand neighbour in a transition state like orientation. 
In Pex1/6WBATP complexes, substrate binding loops arrange in a staggered fashion with 
Pex6D2 occupied by ATP, as suggested by upward directed pore loops in rigid body fits, thus 
ready to engage with the substrate (Figure 4.1, Pex1/6WBATP). Upon ATP hydrolysis in 
Pex6D2 (Figure 4.1, Pex1WBATP/Pex6), those domains translocate downwards along the 
central channel. Hence, repeated cycles of ATP hydrolysis in Pex6D2 could create a 
downward pull in Pex1/6 D2 domains, forcing the bound substrate along the pore. 
In contrast to the more active Pex1/6 D2 domains, D1 domains lack hydrolytic activity and 
well-conserved substrate binding residues. The here presented EM structures suggest that D1 
domains function as a structural hub. Therefore it is possible that D1 domains transmit 
conformational changes during ATP hydrolysis in D2 domains into larger N-terminal motion. 
In the presence of the transition state analogue ADP-AlFx or single Walker B mutations D1 
domains stretch, concomitantly closing the central pore via the N-terminal domains. 
Accordingly, closure of D2 domains induces a significant expansion of the D1 ring. 
Particularly, in complexes harbouring a Walker B mutation in Pex6D2, the D1 domains adopt 
an atypical arrangement in this layer and neighbouring AAA+ domains cannot be tightly 
connected to each other, in line with flexible domain motions observed in cryo-EM 
reconstructions of Hsp104 (Wendler et al., 2007). In contrast, binding of ATPγS results in 
expansion of D2 domains, while D1 domains narrow the central cavity, possibly pushing 
bound substrate towards the substrate binding loops in the D2 ring. Furthermore, flexible 
conformational dynamics of D1 domains imply that Pex1/6 accommodate larger structural 
elements of substrate intermediates while cycling through different nucleotide states.  
4.7 Non-uniform ATP occupancy in Pex1/Pex6 D2 domains 
Efficient translocation of the substrate can only occur when not all subunits let go at the same 
time. Symmetry free EM maps and rigid body fits thereof imply that Pex1/6 D2 domains 
hydrolyse and exchange nucleotide in an asymmetric manner in the presence of ATP. 
Substrate binding loops arrange in different axial planes, indicating a preferred order of 
nucleotide states. Obviously, Pex1 and Pex6 D2 domains do not hydrolyse ATP 
simultaneously, suggesting a sequential or rotary sequence for the ATPase cycle. Domain 
arrangements imply that the hydrolytic capacity in individual AAA+ subunits levers entire 
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AAA+ domains along the central pore. Accordingly, non-uniform nucleotide occupancy 
results in individual ATPase site and pore loop orientations, which likely enable a substrate 
translocation mechanism upon ATP hydrolysis. The asymmetric Pex1/6ATP complex deviates 
from an inter-locked domain arrangement observed in crystal structures of p97 (Zhang et al., 
2000; Huyton et al., 2003; Davies et al., 2008), corroborating remarkable conformational 
dynamics in Pex1/6 while cycling through different nucleotide states. Furthermore, EM 
densities of N-terminal domains in symmetry free Pex1/6ATP complexes display an 
asymmetrical arrangement, which differs among individual subunits. Hence, Pex1/6 N 
domains are likely coupled to the nucleotide states in D2 domains.  
In contrast, symmetry free EM reconstructions in the presence of ATPγS reveal a high level of 
symmetry with an almost planar arrangement in the D1 and D2 domains. Thus, active sites 
might be almost equally occupied by nucleotide. Hence, symmetry breaks in the D2 ring 
might occur after ATP hydrolysis or when substrate is bound. 
 
4.8 Outlook 
In this thesis we provide 8 different EM structures of hexameric Pex1/6 complexes in the 
presence of different nucleotides. The Pex1/6 structures adopt a unique triangular overall 
shape, mainly attributed to an asymmetric arrangement of Pex1/6 N-termini being a special 
feature of the complex. However, lacking structural information, homology modelling of those 
domains fails. Thus, in order to further clarify the function of the N domains, high-resolution 
structural analysis would be very beneficial. Nevertheless, our negative stain reconstructions 
already established a structural theme for Pex1/6 N-termini and observed positions of the 
corresponding densities seem to be biological relevant. However, future work will have to 
focus on the interactions of Pex1/6 with its substrate Pex5. Thus far, ATP and ubiquitin 
dependent extraction of the PTS1 receptor from the peroxisomal membrane has been 
established, possibly sustained by adaptor proteins like Ubp15. Biochemical evidence for 
direct binding of Pex5 by Pex1/6 is missing, though. Cross-linking experiments with full-
length Pex5 or substrate mimics could capture dynamic interactions of this protein with the 
AAA+ complex, further corroborating a substrate translocation mechanism as proposed in our 
study. Furthermore, characterising the potential influence of Pex5 on the hydrolytic activity of 
Pex1/6 could unravel the physiological role of ATPase activity in Pex1D2. Notably, the 
impact of Pex15 on the hydrolytic behaviour of Pex1/6 complexes was published recently 
(Gardner et al., 2015). The authors show that Pex15 decreases ATP hydrolysis of Pex1/6 
complexes to ~13 % of wild type level. Gardner et al. claim that Pex15 allosterically 
influences catalytic activity of Pex1D2. When compared to our results, reduction of overall 
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ATPase activity would rather trace back to impaired ATP turnover in Pex6D2, which could be 
a rate-limiting step for substrate engagement at the peroxisomal membrane. Thus, future 
experiments will be required to elucidate cooperativity between Pex1/6 complexes and Pex15 
at the peroxisomal membrane. 
The function and mechanism of the Pex1/6 complex strictly depends on ATP consumption. 
Here, we provide first structural evidence for an asymmetric nucleotide loading of D2 
domains, which was already observed for related AAA+ proteins, likely representing a 
conserved feature in AAA+ proteins. Nevertheless, high resolution cryo EM structures of 
Pex1/6 complexes bound to different nucleotides have to be obtained, which enable us to 
identify the nucleotide state in each binding pocket of the AAA+ domains. 
Our structural and functional work might provide a starting point to improve the 
understanding of non-functional Pex1/6 proteins and molecular consequences in the human 
system. Patients devoid of functional peroxisomes suffer from genetic diseases of the 
Zellweger spectrum. The here presented structures might not only allow to literally visualize 
the importance of both peroxins in complex function and stability, but could also provide a 
spatial framework for substrate and adaptor binding sites, amenable to future drug testing. 
Thus, our findings, obtained in collaboration with work from Ralf Erdmann’s lab, might add 
up to existing data and initialize future experiments to broaden our knowledge in the field of 
peroxisome biogenesis and further explore common functions and mechanism of AAA+ 
proteins.  
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6 List of abbreviations 
3D 
µ 
three-dimensional 
micro 
Å Ångström 
AAA+ ATPases associated with various cellular activities 
ADP adenosin-5’-diphosphate 
Amp  ampicillin 
ATP adenosine-5’-triphosphate 
ATPγS adenosin-5’-O-(3-thio)-triphosphate 
APS ammonium peroxydisulfate 
bp base pair 
CCD charged-coupled device 
C-terminal carboxy-terminal 
CTF contrast transfer function 
dNTP  deoxynucleoside triphosphate 
DTT dithiothreitol 
e- electron 
ECL enhanced chemiluminescence 
EDTA ethylenediaminetetraacetic acid 
EM electron microscopy 
FSC Fourier shell correlation 
g gram 
h hour 
HA human influenza hemagglutinin 
HAc acetic acid 
His histidin 
HRP horseradish peroxidase 
IgG Immunoglobulin protein G 
kb kilo base pairs 
kDa kilo Dalton 
l liter 
LB lysogeny broth 
MCS multiple cloning site 
m milli 
M molar 
MAT mating type 
min minutes 
MSA multivariate statistical analysis 
MRA multi reference alignment 
MW molecular weight 
n nano 
N-terminal amino-terminal 
NaDoc sodium deoxycholate 
OD optical density 
ORF open reading frame 
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PAGE polyacrylamide gel electrophoresis 
PBDs Peroxisomal biogenesis disorders 
PCR polymerase chain reaction 
Pex peroxin 
PMSF phenylmethylsulfonyl fluoride 
ProA protein A 
PTS1 peroxisomal targeting signal 1 
PTS2 Peroxisomal targeting signal 2 
rpm revolutions per minute 
RT room temperature 
s second 
SDS sodium dodecyl sulfate 
TBE tris, boric acid, EDTA 
TCA trichloroacetic acid 
TEV tobacco etch virus  
Tris tris(hydroxymethyl)aminomethane 
TST tris buffered saline, tween-20  
U unit 
UA uranyl acetate 
Ub  ubiquitin 
V volt 
v/v volume per volume 
w/v weight per volume 
YP yeast bactopeptone 
 
